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1. Background: 
1.1 Introduction: 
The Diels-Alder, Aldol, Grignard and Wittig reactions are four most important carbon-
carbon bond forming reactions which played decisive roles in shaping today’s science of 
chemical synthesis. During the last three decades two more reactions came in the play as 
complementary of the aforementioned carbon-carbon bond forming reactions. They are 
(i) the palladium-catalyzed cross coupling reactions1 and (ii) metathesis reactions.2 Olefin 
metathesis reactions unambiguously influenced and shaped the new horizon of synthetic 
organic chemistry more than any other single chemical reaction over the last 15 years.  
 
1.1.2 Olefin metathesis. A short historical account:  
Derived from the Greek words meta (change) and thesis (position), olefin metathesis is 
the exchange of the parts of the two substances, AB + CD to AC + BD, where the 
reactants are olefins (Scheme 1.1). 
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Scheme 1.1. The most commonly employed alkene-metathesis reactions in organic synthesis. 
 
The history of olefin metathesis is fascinating. It started nearly 50 years ago through to 
the design and application of the latest catalyst (initiator) available today. The generally 
 
 
 9
accepted mechanism was first proposed by Hérisson and Chauvin in 1971,3 with key 
experimental evidences provided by the Casey,4 Katz5 and Grubbs groups6 (Scheme 1.2). 
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Scheme 1.2. Mechanism for the olefin metathesis. 
 
A key milestone in the evolution of olefin metathesis was demonstrated by Katz and co-
workers in 1976 that, single component, well defined tungsten carbenes could initiate 
olefin metathesis without added coactivators (Scheme 1.3).7 
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Scheme 1.3. The evolution of single-component olefin metathesis catalyst and their functional group 
tolerance. 
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Thus from 1976 onwards, the use of multi-component catalyst systems gradually lost its 
importance and the field of olefin metathesis catalyst development emerged. The 
evolution of single-component olefin metathesis catalysts developed by different groups 
and their functional group tolerance is shown in Scheme 1.3.8, 9 
The drawback of the catalyst 1 family is its sensitivity to both oxygen and moisture, since 
the “Mo” metal center is highly oxophilic. So both the preparation and handling of 1 
require glove box techniques to establish an inert atmosphere as well as purified, dried 
and degassed solvents. In 1992, Grubbs and co-workers discovered an alternative catalyst 
2 that can overcome many of those shortcomings.10 Over time catalyst 2 has been 
optimized to 3 which is far easier to prepare (Scheme 1.4).11 
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Scheme 1.4. Recent development in olefin metathesis catalyst. 
 
Catalyst 4 is a variation of 1, developed by Schrock and Hoveyda; in which the 
molybdenum center is coordinated to a chiral derivative of BINOL, creating a homochiral 
environment that can induce catalytic asymmetric olefin metathesis.12 As the activity of 
ruthenium based catalysts is due to the presence of a strong electron donating ligand, 
Herrmann and co-workers in 1998 developed catalyst 5 bearing more strongly σ-donating 
N-heterocyclic carbene ligands.13 Despite this potential beneficial feature, the overall 
activity of the catalyst 5 is only a slight improvement over 3 because the N-heterocyclic 
carbenes are strongly σ-donating; they are far less labile, thus leading to a more sluggish 
initiator. Based on this behaviour Grubbs and co-workers anticipated that a highly 
powerful catalyst for metathesis could be obtained by combining the beneficial properties 
of 3 and 5 into a single system 6, in which the phosphine ligand can dissociate, while the 
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better σ-donating imidazoline type ligand remains attached to the ruthenium core.14 
Moreover unlike catalyst 2 and 3 which are less thermally stable, catalyst 6 remains 
active even at elevated temperatures. In this regard, the bulky mesityl ligands likely 
shield the metal center from reaction with air, thus decrease the rate of catalyst 
decomposition.  
 
1.1.3 Olefin metathesis in total synthesis: 
Olefin ring-closing metathesis reaction has become one of the most powerful and reliable 
methods for ring formation in the natural product synthesis. A countless array of ring 
systems including medium or large, carbocyclic or heterocyclic has been synthesized by 
this sharp tool.15 
 
1.1.3.1 Ring-closing metathesis in the total synthesis of natural 
products: 
Amir Hoveyda and co-workers were the first to report a successful ring-closing 
metathesis reaction as part of the total synthesis of a complex molecule. Targeting the 
natural product Sch38516 (9), having activity against the Influenza A virus, they showed 
that the trisubstituted olefinic compound 8 can be formed from a ring-closing metathesis 
reaction of 7 upon exposure to a 20 mol% loading of Schrock’s catalyst 4 in benzene (60 
oC) in 90% yield (Scheme 1.2).16 
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Scheme 1.5. Application of RCM in the total synthesis of Sch38516. 
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The Nicolaou group investigated solid phase synthesis to epothilone A (13), keeping in 
mind the metathesis technology in the context of combinatorial chemistry. The designed 
strategy worked remarkably well, as upon treatment of precursor 10 with the catalyst 3 
under slightly longer reaction time, cycloreleased from the resin leading to epothilone C 
(12) macrocycles as an expected mixture of four products in 52% combined yield 
(Scheme 1.6).17 Those isomers could then be separated by high pressure liquid 
chromatography (HPLC). 
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Scheme 1.6. Application of RCM in the solid phase total synthesis of epothilone A and C. 
 
Recently Boehringer Ingelheim pharmaceutical company in Germany has used olefin 
metathesis for the commercial preparation of 400 kg of BILN 2061 ZW (17), which has 
promising results against the Hepatitis C virus (Scheme 1.7). The key step of the 
synthetic route is the conversion of the diene 14 to the 15-membered macrocycle 16 by 
the ring-closing metathesis reaction using 1st generation Hoveyda’s catalyst 15. The most 
important issue in the synthetic route is the first scale-up of a ring-closing metathesis 
reation to form a 15-membered macrocycle in the industrial set up.18 
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Scheme 1.7. Commercial application of ring-closing metathesis to synthesize BILN 2061 ZW. 
 
1.1.3.2 Alkene cross metathesis: 
Alkene cross metathesis has long been of great importance in the industrial field. In 
industry the cross metathesis has been applied to convert propene into ethylene and 
butene and polymers to improve durability. But use of cross metathesis in the total 
synthesis as a viable methodology is a very much recent affair.19 The biggest challenge in 
cross metathesis is the chemo- and stereoselective formation of the desired compound 
from the mixture of potential reaction products. Applications of cross metathesis reaction 
in total synthesis can be divided into two classes mainly-(i) chain elongation process and 
(ii) fragment coupling reactions including the dimerization process. Alkene cross 
metathesis was efficiently used in chain elongation in the total synthesis of azaspiracid-1 
(21, Scheme 1.8) by the Nicolaou group.20  
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Scheme 1.8. Application of alkene cross metathesis in the total synthesis of azaspiracid-1. 
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When the tetracyclic compound 18 was treated with alkene 19 in presence of catalyst 6 
(10 mol%) in refluxing DCM, the desired cross metathesis product 20 was formed in 60% 
yield and with good stereoselectivity (E/Z = 10:1). 
An excellent use of cross metathesis has been demonstrated by the Ghosh group in the 
total synthesis and structure revision of amphidinolide W (25, Scheme 1.9).21 When the 
advanced intermediates 22 and 23 were exposed with catalyst 6 (6 mol%) in refluxing 
DCM for 15h, the cross metathesis product 24 was formed in 85% yield in good E 
selectivity (E/Z = 11:1). 
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Scheme 1.9. Cross metathesis in total synthesis of amphidinolide W. 
 
1.1.3.3 Enyne ring-closing metathesis: 
The use of ruthenium carbene complexes in the enyne metathesis chemistry was first 
introduced by the Mori group, demonstrating its utility in the formation of five-, six- and 
seven-membered nitrogen containing heterocyclic rings.22  
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Scheme 1.10. Application of enyne ring-closing metathesis in the total synthesis of (-)-stemoamide. 
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The same group reported the first application of an enyne metathesis reaction in a total 
synthesis of the tricyclic alkaloid (-)-stemoamide (26, Scheme 1.10) in 1996.23 
One of the most exciting and powerful applications of enyne metathesis reaction is its use 
in the cascade reaction to generate complex polycyclic structures from simple open chain 
precursor. Grubbs and co-workers reported the first example of tandem enyne metathesis 
reaction to generate the polycyclic frame work 28 (Scheme 1.11).24 The exposure of the 
acyclic compound 27 to the catalyst 3 (4 mol%) in benzene at ambient temperature 
triggered a cascade reaction resulting the formation of steroid-type compound 28 in 70% 
yield. In this cascade sequence four new carbon-carbon bonds and four new rings were 
formed in a regioselective manner.  
 
Me
OTBDPS
3 (4 mol%), benzene, 25 oC
Me
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LnRuMe
OTBDPS
1
23
4
OTBDPS
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28
27
 
 
Scheme 1.11. Application of domino enyne ring-closing metathesis sequence for the construction of a 
steroid-type polycyclic 28. 
 
1.1.3.4 Alkyne ring-closing metathesis: 
Since its discovery, alkyne metathesis has found very limited application in organic 
synthesis. However a ground breaking work was reported by the Fürstner group to show 
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the power of alkyne ring-closing metathesis. One of the very few shortcomings of olefin 
ring-closing metathesis reactions is the lack of control over the configuration of the newly 
formed double bond if the reaction is applied to the macrocycles. The products formed 
are usually obtained as mixtures of the E and Z isomers, with the former dominating in 
most of the recorded cases. The Fürstner group showed the strength of alkyne ring-
closing metathesis reaction in the total synthesis of epothilone C (12) as a single isomer 
(Scheme 1.12).25 
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Scheme 1.12. Alkyne ring-closing metathesis in the total synthesis of epothilone C. 
 
2. Aim of the project: 
Seven-, eight- and nine-membered oxygen heterocycles with one or two double bonds 
embedded into the heterocyclic ring systems are characteristic structural frameworks of 
various natural products.26 This project aimed at the synthesis of such natural product 
frameworks employing the ring-closing metathesis (RCM) reaction as key 
transformation.2a Since the last couple of decades the ring-closing metathesis reaction has 
rapidly become an important tool to form carbon-carbon bonds.27 Intramolecular diene-
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ene ring closing metathesis has been used extensively to prepare many macrocyclic 
natural products with mostly large ring sizes very efficinetly.28 In the formation of small 
to medium ring ethers the behaviour of conjugated diene and olefin under ring-closing 
metathesis conditions has not yet been explored. Open chain conjugated diene-ene ethers 
show a very different and interesting reactivity in ring-closing metathesis to synthesize 
small and medium rings.    
 
O
Rn
a
b path apath b
O Rn
n = 1, 2, 3
30
n = 1, 2, 3
31
O
R
n
n = 1, 2, 3
32  
 
Scheme 2. Strategy for the synthesis of medium sized cyclic ethers by means of diene-ene ring-closing 
metathesis employing differently substituted pentadienyl ethers as substrates. 
 
In particular, the diene-ene ring-closing metathesis reaction employing pentadinenyl 
ethers 30 as substrates (Scheme 2) attracted immense interest since it would give rise to 
seven- to nine-membered cyclic dienes that would be amenable to substantial structural 
variation by means of various transformations. In this context the regioselectivity of the 
ring-closing metathesis reaction giving either rise to the larger dienyl ethers 31 or the 
smaller monounsaturated ethers 32 was of particular interest. The main aim of this project 
in one hand is to explore the regioselectivity between conjugated diene and olefin under 
the ring-closing metathesis conditions on the pentadienyl ether to explore either it gives 
the small rings or the larger ring ethers exclusively. In this regard the competition 
between the formation of smaller and larger rings in this metathesis condition will also be 
surveyed. On the other hand the aim of this project is to determine the underlying 
conditions which could guide the regioselectivity in this conjugated diene-ene metathesis 
reactions. In this perspective how the regioselectivity upon introduction of the bulk in one 
part of the olefin changes the course of the reactivity of the precursor in ring-closing 
metathesis was also investigated.  
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3. Results and discussions: 
3.1 Retrosynthetic analysis: 
The precursor of the decisive ring-closing metathesis 33 was intended to synthesize from 
the commercially available propargyl alcohol 40. The retrosynthetic analysis is shown in 
Scheme 3.1. 
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Scheme 3.1. Retrosynthetic analysis of the targeted small and medium dienyl cyclic ethers. 
 
The dienyl cyclic ethers 31 can be envisioned to be synthesized by ring-closing 
metathesis from the open chain triene precursor 33. The later can be synthesized from the 
key diene aldehyde 34 by means of allylation or vinylation by allyl or vinyl Grignard 
reagents or by Wittig olefination. The aldehyde 34 can be obtained from the diene ester 
35 by reduction, whereas the diene moiety in 35 can be obtained by the Pd catalyzed 
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Stille cross coupling reaction from the vinyl halide 36, which in turn can be synthesized 
from the acetylinic halide 37 by means of selective reduction of alkyne to the Z-olefin. 
The ether moiety in 37 intermediate can be tethered by the etherification of the 
substituted halogenated propargyl alcohol 39 and bromoethyl acetate 38. The 
commercially available substituted propargyl alcohol 40 can be halogenated to synthesize 
39. Based on this blue print journey was commenced to synthesize the ring-closing 
metathesis precursors 33 from commercially available substituted propargyl alcohol 40. 
 
3.2 Synthesis of the ether moiety: 
The synthetic strategy proceeded from the commercially available substituted propargyl 
alcohol 41. Compound 41 was first doubly protected by trimethyl silyl (TMS) group 
using ethyl magnesium chloride, trimethyl silyl chloride (TMSCl) in THF from 0 oC to 
room temperature for 5h, giving rise to 42 in 80% yield. The alcohol in compound 42 was 
then selectively deprotected by using 1N HCl in THF to produce 43 in 81% yield 
(Scheme 3.2).29  
 
HO TMSO
TMS
EtMgCl, TMSCl, THF
0 oC to rt, 5h, 80%
HO
TMS
1N HCl, THF
0 oC to rt, 1h, 81%
41 42 43  
 
Scheme 3.2. Synthesis of 43 from 41. 
 
Ether formation of compound 43 by ethyl bromo actetate in the presence of sodium 
hydride (NaH) as a base in THF at 0 oC to room temperature for 3h, yielded along with 
desired product 44, an undesired product 45 in 1:1 mixture in total 65% yield (Scheme 
3.3).30 
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Scheme 3.3. Ether formation reaction. 
 
Compound 45 was treated with ethyl magnesium chloride and trimethylsilyl chloride 
(TMSCl) in THF at 0 oC to room temperature to produce 44 again. Different reaction 
conditions (Table 3.1) were tested changing the temperature for protecting the alkyne in 
45, but in all cases decomposition of the starting material was observed with no trace of 
44.  
 
Table 3.1. Use of different base and temperature to convert 45 to 44. 
 
Entry Base Temperature Product 
1 EtMgCl -78 oC to rt Decomposition of 45 
2 nBuLi -78 oC to rt Decomposition of 45 
3 NaHMDS -78 oC to rt Decomposition of 45 
 
Since the trimethylsilyl group (TMS) was not stable enough in the presence of a base 
such as sodium hydride and half of the product was lost, it was decided to halogenate the 
alkyne first and then to carry out the ether formation reaction. Thus 43 was treated with 
N-bromosuccinimide (NBS) in  the presence of catalytic amounts (20 mol%) of silver 
nitrate in DMF at room temperature for 45 minutes.31 The bromo derivative 46 was 
formed in nearly quantitative yield (98%). Then the ether formation reaction set off very 
smoothly when 46 was deprotonated with sodium hydride and treated with ethyl 
bromoacetate in THF at 0 oC to room temperature for 6h to afford the ether 47 in 70% 
yield (Scheme 3.4). 
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Scheme 3.4. Synthesis of ether 47. 
 
3.3 Stille cross coupling: 
The subsequent step was to reduce the alkyne moiety in 47 to form the Z-vinyl bromide 
48. The reduction of 47 was accomplished by in situ formation of the diimide from the 
dipotassium salt of aza dicarboxylic acid in the presence of acetic acid in 1:1 solvent 
mixture of 1,4-dioxane and isopropanol at room temperature for 4h to afford the Z-vinyl 
bromide 48 in 90% yield (Scheme 3.5).32a, b The Z-geometry was determined by the small 
coupling constant (JHa-Hb = 7.2 Hz) between Ha and Hb by 1H NMR spectroscopy. 
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Scheme 3.5. Attempted synthesis of 49. 
 
The decisive palladium catalyzed Stille cross coupling reaction was endeavored with Z-
vinyl bromide 48 and tributyl vinyl tin in presence of 5 mol% of Pd(CH3CN)2Cl2 catalyst 
in DMF at room temperature to afford the diene 49.33 But the Stille cross coupling 
reaction did not yield the desired diene compound 49 and decomposition of the starting 
material 48 was observed.  
It materialized that the vinyl bromide 48 was not the best substrate for the attempted 
palladium catalyzed Stille cross coupling to generate the diene 49. Keeping the idea in 
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mind that the vinyl iodide analogue of 48 could give rise to 49 by Stille cross coupling, 
the synthesis of vinyl iodide was set off from the same commercially available oct-1-yn-
3-ol 41. Instead of treating 41 with NBS, it was then treated with N-iodosuccinimide 
(NIS) in the same reaction condition in presence of 20 mol% of AgNO3 in DMF at room 
temperature for 45 minutes to afford the iodo derivative 50 in 98% yield (Scheme 3.6).32a, 
b, 34 Ether 51 was prepared in 75% yield using ethyl bromoacetate and NaH. The alkyne 
moiety in 51 was reduced to Z-vinyl iodide 52 in 80% yield using the reduction protocol 
discussed before. In compound 52 the Z-geometry of the olefin was confirmed by the 
small coupling constant (JHa-Hb = 7.6 Hz) between Ha and Hb by 1H NMR spectroscopy.  
When the vinyl iodide 52 was treated with tributyl vinyl tin in presence of 5 mol% of 
Pd(CH3CN)2Cl2 catalyst in DMF at room temperature, the diene 49 was achieved in 70% 
yield (Scheme 3.6).33 
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Scheme 3.6. Synthesis of the diene 49. 
 
 
3.4 Synthesis of the aldehyde intermediate 53: 
Achieving diene 49 in a smooth way, the following step was to reduce the ethyl ester to 
the aldehyde to acquire the key intermediate 53. The diene ethyl ester 49 was treated with 
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diisobutylaluminiumhydride (DIBAL-H) in DCM at -78 oC temperature for 30 minutes to 
afford the 1:1 mixture of both the desired aldehyde 53 and undesired over reduced 
alcohol 54 in 70% yield (Scheme 3.7).35 The products ratio was determined based on the 
isolated yield. 
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Scheme 3.7. Attempted reduction of 49 to 53. 
 
After chromatographic separation, the oxidation of alcohol 54 to aldehyde 53 was 
attempted under different reaction conditions (Table 3.2) but not a single procedure gave 
the desired aldehyde 53. 
 
Table 3.2. Different oxidizing agents and conditions to convert 54 to 53. 
 
Entry Starting 
material 
Conditions Product 
1 54 PCC36 
DCM, rt, 3h 
decomposition 
2 54 IBX37 
DMSO, 0 oC to rt, 3h 
decomposition 
3 54 TEMPO38 
NaOCl, KBr,  
DCM,-10 oC, 5h 
decomposition 
4 54 (CO)2Cl2, DMSO, Et3N39 
DCM, -78 oC, 2h 
decomposition 
 
 
 
 24
It appeared from the above table, that in all the cases the starting alcohol 54 was sensitive 
to both the acidic and basic conditions and it decomposed. 
Thus the remedy of the above mentioned problem was to reduce the ethyl ester moiety to 
aldehyde selectively. Changing the solvent from DCM to diethyl ether and using high 
dilution solved the problem. Hence treating 49 with diisobutylaluminiumhydride in 
diethyl ether in very diluted solution under vigorous stirring and slow addition of 
DIBAL-H at -78 oC temperature, the aldehyde 53 was obtained exclusively in 75% yield 
without any trace of the alcohol 54 (Scheme 3.8). 
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Scheme 3.8. Synthesis of 53 from 49 by DIBAL-H reduction. 
 
3.5 Regioselectivity between five- and seven-membered 
ring formations: 
With the key aldehyde intermediate 53 in hand, the path was set to synthesize different 
diene-ene precursor to investigate the metathesis reactions on them to get the idea about 
their regioselectivity. To explore the regioselectivity between the five-membered and 
seven-membered ring, the precursor 55 was synthesized by the Wittig olefination of the 
aldehyde 53. The Wittig salt was generated in situ by treatment of triphenylmethyl 
phosphonium bromide in the presence of n-butyl lithium as a base in THF at 0 oC for 30 
minutes. The Wittig ylide was then treated with the aldehyde 53 at 0 oC to room 
temperature for 1h to get the diene-ene precursor 55 in 75% yield (Scheme 3.9).40 When 
55 was exposed separately with either 10 mol% of Grubbs 1st generation catalyst 3 or 5 
mol% of 2nd generation Grubbs catalyst 6 in refluxing DCM, a mixture of five- and 
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seven-memebered ring ethers 56 and 57 in 2:3 ratio in 28% and 42% yield respectively in 
5 minutes. The products ratio was based on isolated yield. 
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Scheme 3.9. Competition between the five and seven membered ring ethers 56 and 57. 
 
3.6 Regioselectivity between six- and eight-membered 
ring formations: 
Next the competition between the six-membered and the eight-membered ring ethers was 
explored. The requisite precursor was directly synthesized from the intermediate 53 by 
treating it with vinylmagnesiumbromide in THF at 0 oC to room temperature for 2h to 
furnish the allylic alcohol 58 as 1:1 inseparable mixture of two isomers in 70% yield 
(Scheme 3.10). The isomeric ratio was determined by the 1H NMR spectroscopy.  
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Scheme 3.10. Competition between the six and eight membered ring ethers 59 and 60. 
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When 1:1 isomeric mixture of 58 was treated with Grubbs 1st generation catalyst 3 (20 
mol%) in refluxing DCM for 18h, only the six membered cyclic ether 59 was formed 
exclusively in 60% yield as 1:1 inseparable mixture of two isomers (ratio determined by 
1H NMR spectroscopy) without any trace of the eight membered cyclic diene ether 60. 
The same result was found when compound 58 was treated with 10 mol% of 2nd 
generation Grubbs catalyst 6 in refluxing DCM. 
 
3.7 Regioselectivity between seven- and nine-membered 
ring formations: 
The aldehyde 53 was treated with allylmagnesiumbromide in THF at 0 oC to room 
temperature for 2h to afford the homoallyl alcohol 61 as 1:1 mixture of two diastereomers 
in 70% yield (Scheme 3.11). The diastereomeric mixture was determined by 1H NMR 
spectroscopy. 
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Scheme 3.11. Competition between the seven- and nine-membered ring ethers 63 and 65. 
 
The homoallyl alcohol 61 was then protected as tertiary butyl dimethylsilyl ether 62 by 
treatment with tertiary butyl dimethyl silylchloride (TBSCl) in the presence of imidazole 
as base in DMF at room temperature for 18h in 75% yield. Ring-closing metathesis of 
this TBS-protected homoallyl alcohol 62 using 20 mol% of 3 in refluxing DCM for 18h 
afforded the seven-membered mono olefinic cyclic ether 63 as 1:1 inseparable mixture of 
two isomers in 65% yield devoid of any trace of the doubly unsaturated nine-membered 
 
 
 27
cyclic ether 65. The same result was observed using 10 mol% of 6 as the metathesis 
catalyst.  
From the above study about the regioselectivity in ring-closing metathesis it could be 
concluded that in all the cases the generation of the ruthenium carbene complex initiated 
in the isolated olefin moiety and then terminated in the diene moiety to generate the 
smaller possible rings. The only exception observed was in the case of the competition 
between the five- and seven-membered ring formations, where both were formed. To 
investigate whether the ring-closing metathesis reaction was kinetically or 
thermodynamically controlled two further experiments were carried out. 
On one hand, the formation of five- and seven-membered ethers 56 and 57 was followed 
by means of GC-MS. The treatment of dienyl ether 55 with first generation Grubbs 
catalyst 3 in refluxing DCM within 5 min led to complete consumption of the starting 
material, and the initially determined product ratio did not change if the refluxing was 
continued for 1h. At room temperature, the reaction required 2 h to proceed to completion 
with the product ratio showing the same distribution. On the other hand, if the seven-
membered cyclic dienyl ether 57 was subjected to the conditions of the ring-closing 
metathesis, that is, refluxing in DCM in presence of 10 mol% of 3 and ethylene for 3h, 
formation of the five-membered cyclic ether 56 was detected by GC-MS.41 Assuming that 
the five-membered ring ether is more stable than the seven-membered cyclic ring ether, 
these results indicate that this ring-closing metathesis reaction is thermodynamically 
controlled. 
 
3.8 Introduction of bulk in the isolated olefin moiety: 
3.8.1 Crotylation of aldehyde 53: 
As it was speculated from the behavior of the regioselectivity in the ring-closing reactions 
in the diene-ene ethers that the metathesis reaction initiated by the formation of the 
ruthenium carbene in the isolated olefin followed by the termination in the diene-moiety, 
the investigations were directed towards the formation of the initial ruthenium carbene at 
the diene moiety, so that the termination can happen in the isolated olefin to give rise to 
the larger ring ethers. The initial ruthenium carbene can only be formed in the diene 
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moiety if its formation can be prevented in the isolated olefin moiety. This can be done 
by increasing the bulk in the isolated olefin. 
One methyl group was chosen as the smallest bulky group to be introduced in the isolated 
olefin moiety. The reaction of unhindered carbonyl compounds with substituted allylic 
organometallic reagents such as M = Li, Mg, Cu, Zn, Cd, B, Al, Si, Sn, Ti, Zr, Cr and 
Mn, generally results in products where the allylic group is attached at the more highly 
substituted position forming the γ-adduct. On the other hand the regioreversed addition is 
one of the difficult problems in the organic synthesis (Scheme 3.12). But the reaction of 
carbonyl compounds with crotylmagnesiumchloride in the presence of AlCl3 at -78 oC 
gives predominantly products in which the allylic group is attached at the less substituted 
position (α-adduct).42 
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Scheme 3.12. Regioselectivity of crotylation. 
 
The aldehyde 53 was treated with 1-bromo-2,3-butene and Mg metal in THF to 
synthesize the homoallyl alcohol 66 (Scheme 3.13), in different conditions (Table 3.3).  
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Scheme 3.13. Attempted synthesis of 66. 
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Unfortunately in all the cases the homo-coupled product from the halide was found as the 
main product with the recovery of the starting material 53. But when the reaction was 
carried out in diethyl ether as solvent and in the presence of the additive aluminium 
chloride as a Lewis acid the expected product 66 was formed in 40% yield as 1:1 mixture 
of the two isomers, together with the homo coupled product from the bromide.42 The 
isomeric ration was determined by 1H NMR spectroscopy. 
 
Table 3.3. Conditions to synthesize 66. 
 
Entry Conditions Additive Solvent Product 
1 0 oC to rt, 2h - THF Homo-coupled diene 
2 -78 oC to rt, 4h - THF Homo-coupled diene 
3 -78 oC, 4h AlCl3 (3 equiv) Et2O Homo-coupled diene 
4 -78 oC to rt, 2h AlCl3 (3 equiv) Et2O 66 (40%) + homo-coupled diene 
 
There are two plausible mechanisms for the regioreversed addition of crotylmagnesium 
halide to 53 in presence of AlCl3 (Scheme 3.14).  
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Scheme 3.14. Mechanism of the regioreversed additon of crotylmagnesium halide. 
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In the first case, the transmetalation of crotyl magnesium reagent to aluminium reagent 
via SE2/ process followed by rapid SE2/ reaction of the resulting α-metallylaluminium 
reagent with carbonyl compounds. According to the second mechanism Mg-Al bridged 
species forms followed by the coordination of carbonyl group to Al-atom to produce α-
adduct through a six-membered cyclic transition state.  The intermediates are stable only 
at low temperature and must undergo facile rearrangement at higher temperature.42 
 
3.8.2 Attempted ring-closing metathesis of 66: 
When the 1:1 isomeric mixture of the advanced intermediate 66 was treated with 10 
mol% of 2nd generation Grubbs catalyst 6 in refluxing DCM for 18h, the mono 
unsaturated seven-membered ring 64 was formed as 1:1 inseprable mixture of two 
isomers  in 50% yield devoid of any sign of the expected doubly unsaturated nine-
membered ring ether 67 (Scheme 3.15). The isomeric ratio was determined by 1H NMR 
spectroscopy. 
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Scheme 3.15. Competition between seven- and nine-membered ring ethers on advanced intermediate 66. 
 
Therefore it was evident that only one methyl group on the isolated olefin moiety was not 
sufficiently bulky to drive the initial formation of the ruthenium carbene in the isolated 
olefin and termination in the conjugated diene moiety. Hence the synthesis of the 
advanced intermediate with two methyl groups in the isolated olefin moiety was intended. 
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3.8.3 Dimethylvinylation of aldehyde 53: 
To synthesize the dimethyl substituted advanced intermediate for the regioselective 
competition between the six- and eight-membered ring ethers, aldehyde 53 was treated 
with 2-methyl-1-propenyl-magnesiumbromide at 0 oC to room temperature in THF for 
8h.43 Alcohol 68 was formed in 80% yield as 1:1 inseparable mixture of two isomers. 
Alcohol 68 was protected to the TBS ether 69 with the treatment of t-butyl dimethyl silyl 
chloride (TBSCl) and imidazole as base in DMF at room temperature in 70% yield 
(Scheme 3.16). 
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Scheme 3.16. Synthesis of the advanced intermediate 69. 
 
3.8.4 Attempted dimethylallylation of aldehyde 53: 
After achieving 69 successfully the attention was focused on the synthesis of the dimethyl 
substituted advanced intermediate for the regioselective competition between the seven-
and nine-membered cyclic ethers. The aldehyde 53 was treated with dimethylallyl 
bromide and magnesium metal activated by iodine in THF under different conditions, but 
the desired product 70 was not formed. Only the undesired product 71 was formed in 
60% yield (Scheme 3.17 and Table 3.4). 
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Scheme 3.17. Attempted synthesis of 70. 
 
Table 3.4. Conditions for the attempted synthesis of 70. 
 
Entry Conditions Time 70 (yield) 71 (yield) 
1 -78 oC 3h - 50% 
2 -78 oC to room temperature 3h - 60% 
3 0 oC 3h - 60% 
4 0 oC to room temperature 3h - 65% 
 
The reason for the above result was that, as soon as the Grignard reagent formed from the 
dimethylallyl bromide, it rearranged to the most stable tertiary magnesium bromide 
reagent even at low temperature. To overcome this problem umpolung strategy was 
adopted to change the polarity of both the reagent and substrate.  
 
3.8.5 Umpolung of aldehyde 53: 
The aldehyde 53 was treated with 1,3-propane dithiol in the presence of boron trifluoride 
diethyl ether complex (BF3.Et2O) as a Lewis acid at -30 oC in DCM in 30 minutes to 
afford the dithiane product 72 in 70% yield (Scheme 3.18).44  
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Scheme 3.18. Attempted deprotonation of dithian 72 and alkylation. 
 
When the dithiane 72 was treated with n-butyl lithium in 10% hexamethylphosphoramide 
(HMPA) as protic solvent in THF at -78 oC with either crotyl bromide or dimethylallyl 
bromide for 2h, neither expected product 73 nor 74 were found. Only the starting material 
was recovered. The dithiane 72 was also treated with either crotonaldehyde or dimethyl 
crotonaldehyde separately in the same reaction conditions, but again the expected 
products 75 or 76 were not found. Here again the starting material was recovered.45 
The failure of the alkylation was reasoned due to the lack of the acidity of the dithiane 72. 
The dithiane 72 forms two interconverting six-membered chair conformations where the 
acidic proton contains either axial or equatorial position (Figure 3). In the axial 
conformation the deprotonation is very slow due to the insufficient overlap of the C-H 
axial bond with the C-S σ* orbital which is the main reason of the acidity of the dithiane 
proton. Moreover the diene part in the dithiane 72 also forms a six membered chair type 
transition state by which the π orbital of the diene donate its electron density to the C-S 
σ* orbital which is reason of the lack of acidity in the equatorial conformation.46 
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Figure 3. Conformations of the dithiane 72. 
 
3.8.6 Synthesis of advanced intermediate 79: 
Facing this dead end, a bypass synthetic strategy was adopted. The aldehyde 53 was first 
homologated to aldehyde 77 by Wittig olefination followed by the hydrolysis of the vinyl 
ether. The aldehyde 53 was added dropwise into the ylide prepared in situ by the 
treatment of triphenyl methoxymethylphosphonium chloride and n-butyl lithium solution 
at 0 oC and stirred the reaction at room temperature for 30 minutes, then the formed 
product was hydrolyzed by 1M hydrochloric acid for 8h to afford the homologous 
aldehyde 77 in 80% yield along with some decomposed product (Scheme 3. 19).40 The 
aldehyde 77 was then treated with 2-methyl-1-propenyl-magnesiumbromide in THF at 0 
oC to room temperature for 8h to afford the dimethylallyl alcohol 78 as 1:1 inseparable 
mixture of two isomers in 60% yield,43 which was then protected with t-butyl 
dimethylsilane using t-butyl dimethylsilyl chloride (TBSCl) and imidazole as base in 
DMF in 18h to afford the TBS protected alcohol 79 in 70% yield. 
 
 
 
 35
O
OH1. Ph3PCH2OMeCl, nBuLi
    THF, 0 oC to rt, 1h
2. 2M HCl, 8h, 80%
MgBr
THF, 0 oC to rt
8h, 60%
O
RO
TBSCl, imidazole
DMF, 18h, rt, 70%
O
H
O
1.
2.
53 77
78: R = H
79: R = TBS  
 
Scheme 3.19. Synthesis of the advanced intermediate 79. 
 
When both 69 and 79 were treated separately with 20 mol% of the 2nd generation Grubbs 
catalyst 6 in refluxing DCM and also in refluxing toluene, neither the doubly unsaturated 
eight-membered cyclic ether 80 nor doubly unsaturated nine-membered cyclic ether 81 
were formed (Scheme 3.20).  
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Scheme 3.20. Attempted synthesis of 80 and 81. 
 
Only the starting material was recovered in both cases, which suggested that dimethyl 
substituents were enough bulky not to initiate the metathesis in the isolated olefin moiety. 
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3.8.7 Cross metathesis on advanced intermediate 69: 
At this point it was considered whether the initial ruthenium carbene formed in the 
conjugated olefin moiety or not. To ensure this point precursor 69 (1:1 inseparable 
mixture of two isomers) was treated with methyl acrylate in the presence of 10 mol% of 
2nd generation Grubbs catalyst 6 in refluxing DCM for 18h and the cross metathesis 
product 83 was isolated as the Z-isomer in the newly formed olefin in 60% yield (Scheme 
3.21). The Z-geometry of the newly formed olefin was determined by the high coupling 
constant (JHa-Hb = 15.8 Hz) between Ha and Hb protons by 1H NMR spectroscopy.  
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Scheme 3.21. Cross metathesis reaction on 69 to synthesize 83. 
 
This experiment unambiguously showed that the ruthenium carbene was formed at the 
conjugated olefin moiety because the highly unstable β- carbonyl-carbene species 
[Ru]=CH(CO)OMe was not involved in the cross metathesis.  It was shown by the 
Grubbs group that ester-carbene complexes decompose within a few hours at room 
temperature in contrast to the long life time of catalyst 6 in cross metathesis. The 
typically low degree of conversion to an ester carbene with its instability and the 
formation of no homo-coupled product suggested that a β- carbonyl-carbene species 
[Ru]=CH(CO)OMe was not responsible for the formation of the bulk product (Scheme 
3.21).47 
 
3.8.8 Synthesis of the deoxy analogue of 58: 
To investigate whether the hydroxyl group in the substrates 58 and 61 has a determinant 
role directing ring-closing metathesis reaction toward the formation of an alkene rather 
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than a diene, the deoxygenated analogue of 58 was synthesized form the aldehyde 
intermediate 53 (Scheme 3.22). 
Aldehyde 53 was homologated by the Wittig homologation reaction mentioned before to 
synthesize 77 in 80% yield. The aldehyde 77 was then again subjected to Wittig 
olefination using triphenylmethylbromide salt and n-butyl lithium as base to afford the 
tri-olefin, which was immediately subjected to the ring-closing metathesis using both 
Grubbs catalyst 3 (10 mol%) or 6 (5 mol%) in refluxing DCM to afford the six-
membered cyclic mono olefin 84 as the sole product in 62% overall yield after 2 steps. 
This result indicates that the hydroxyl group does not direct the ring-closing metathesis 
reaction in this case. 
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Scheme 3.22. Synthesis of deoxygenated analogue 84. 
 
4. Summary and conclusion: 
In this project different diene-ene precursors 30 were synthesized form the commercially 
available substituted propargyl alcohol by means of iodination, ether formation, diimide 
reduction of the alkyne to Z-olefin, Pd-catalyzed Stille cross coupling reaction, DIBAL 
reduction, Wittig olefination and allylation or vinylation reactions with corresponding 
Grignard reagents. Those diene-ene precursors were then treated with commercially 
available 1st and 2nd generation Grubbs ruthenium carbene catalysts to explore the 
regioselectivity and reactivity of the diene-ene ring closure under the metathesis 
conditions to synthesize small and medium size ring ethers. In the formation of medium 
sized ethers by diene-ene ring-closing metathesis the formation of cyclic allyl ethers with 
smaller ring size and of pentadienyl ethers with larger ring size compete with each other. 
From the ring-closing metathesis study it was clear that the initial ruthenium complex 
was formed in the isolated olefin part and terminated in the conjugated diene part to form 
 
 
 38
mainly the small sized ring ether except in the case of the competition between five- and 
seven-membered ring ethers. When the bulk was increased in the isolated olefin part by 
dimethyl group the ring-closing metathesis reaction did not initiate in the isolated olefin 
but formed in the conjugated olefin part but it did not terminate in the isolated olefin to 
form the eight- and nine-membered ring ethers because eight- and nine-membered ring 
ethers are kinetically and thermodynamically difficult to form.  
In conclusion the behavior of conjugated diene with isolated olefin under ring-closing 
matathesis conditions in presence of 1st and 2nd generation Grubbs catalysts in the 
synthesis of small to medium size ring ethers has been studied. The formation of the 
small and medium size ring ethers in the metathesis conditions is totally 
thermodynamically controlled. In each case it was demonstrated that the 
thermodynamically controlled more stable rings were formed. In the competition between 
six-and eight-membered ring formation the more stable six-membered ring ether formed 
and in the competition between seven- and nine-membered rings the more stable seven- 
membered ring formed. Moreover it was also confirmed that increasing the bulk in the 
isolated olefin moiety the metathesis reaction did not form the higher membered ring 
ethers. So in the attempted formation of medium sized cyclic ethers by means of the 
diene-ene ring-closing metathesis with exception of the competition between five- and 
seven-membered rings the smaller ring sizes are formed.It was also shown that the 
alcohol group in the metathesis precursors did not direct the ring-closing metathesis 
reaction toward the smaller ring ethers.  
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6. Experimental part: 
6.1 General experimental procedure: 
1H and 13C-NMR spectra were recorded on a Varian Mercury 400 spectrometer at room 
temperature. Chemical shifts are expressed in part per million (ppm) and the spectra are 
calibrated to the solvent signals of CDCl3 (7.26 ppm and 77.16 ppm). Coupling constants 
are given in Hertz (Hz) and the following notations indicate the multiplicity of the 
signals: s (singlet), d (doublet), t (triplet), dd (doublets of doublet), m (multiplet), br 
(broad signal), dt (doublet of triplet). Gass chromatography-mass spectrometry (GC-MS) 
was measured on a Hewlett Packard 6890 GC system coupled to a Hewlett Packard 5973 
Mass Selective Detector. A HP 5TA capillary column (0.33 μm x 25 m x 0.2 mm) and 
helium flow rate of 2 mL/ min were used. High resolution mass spectra (HR-MS, 70 eV) 
were measured on a Jeol SX 102A spectrometer by using electron impact (EI), fast atom 
bombardment (FAB) techniques. The matrix used for FAB was 3-nitrobenzylalcohol (3-
NBA). Thin layer chromatography (TLC) was carried out on Merck precoated silica gel 
plate (60F-254) using ultra violet light irradiation 254 nm or the KMnO4 solution (1 g 
KMnO4, 6.6 g K2CO3, 1.67 mL of 5% NaOH solution, 100 mL water) as staining reagent. 
Purifications were performed using silica gel from J.T. Baker or Merck (particle size 40-
60 μm) under approximately 0.5 bar pressure. All reactions were performed under argon 
atmosphere with freshly distilled and dried solvents. All solvents were distilled using 
standard procedures. Unless otherwise stated all the reagents were obtained from Aldrich, 
Acros Chimica, Fluka, Advanced Chemtech, Avocado, J.T. Baker, Novabiochem, Riedel 
de Haen, Roth, Sigma or Lancaster and used without further purification. 
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6.2 General procedure for the ring-closing metathesis: 
The triene was dissolved in dry degassed DCM (0.002M) in a two neck round bottom 
flask under argon. The Grubbs catalyst was added and the solution was stirred at reflux 
until the starting material was totally consumed (monitored by TLC). The solvent was 
evaporated and the crude product was subjected to column chromatography. 
 
6.3 Experimental procedure and analytical data: 
6.3.1 Synthesis of compound 42: 
 
TMSO
TMS
42  
 
Ethyl magnesium bromide (1.7 mL, 3.5 mmol, 2M solution in THF) was   added 
dropwise into the solution of oct-1-yn-3-ol 41 (0.2 g, 1.58 mmol) at 0 oC and the solution 
was stirred for 30 minutes at 0 oC. Trimethylsilyl chloride (0.45 mL, 3.5 mmol) was 
added at 0 oC and the reaction mixtute was stirred at room temperature for 5h. The 
reaction was quenched with saturated ammonium chloride solution (10 mL) and the 
aqueous layer was extracted with ethyl acetate (2 x 10 mL) and the combined organic 
layer was washed with brine (2 x 10 mL), dried over Na2SO4, concentrated under reduced 
pressure and purified by silica gel chromatography (cyclohexane/ ethyl acetate 19:1) to 
furnish 0. 34 g of the product in 80% yield. 
1H NMR (400 MHz, CDCl3): δ = 4.27-4.24 (t, J = 6.5 Hz, 1H), 1.70-1.60 (m, 2H), 1.47-
1.39 (m, 2H), 1.32-1.29 (m, 4H), 0.91-0.87 (t, J = 7.3 Hz, 3H), 0.17 (s, 9H), 0.15 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ = 107.2, 88.6, 64.4, 38.1, 31.7, 25.0, 22.9, 14.3, 0.4, 0.0. 
HR-MS (FAB, 70eV): m/z calculated for C14H30OSi2 = 270.1835, found = 270.1800 
[M]+. 
Rf = 0.4 (cyclohexane/ ethyl acetate 19:1). 
 
 
 
 45
6.3.2 Synthesis of compound 43: 
 
HO
TMS
43  
 
1M HCl solution was added into 42 (0.05 g, 0.18 mmol) in THF at 0 oC and stirred for 1h 
at this temperature. The reaction was quenched with the saturated NaHCO3 solution (5 
mL) and the aqueous layer was extracted with ethyl acetate (2 x 5 mL) and the combined 
organic layer was washed with brine (2 x 5 mL), dried over Na2SO4, concentrated under 
reduced pressure and purified by silica gel chromatography (cyclohexane/ ethyl acetate 
9:1) to furnish 0.03 g of the product in 81% yield. 
1H NMR (400 MHz, CDCl3): δ = 4.30-4.28 (t, J = 6.5 Hz, 1H), 2.00 (bs, 1H), 1.72-1.67 
(m, 2H), 1.45-1.38 (m, 2H), 1.30-1.29 (m, 4H), 1.01-0.97 (t, J = 7.3 Hz, 3H), 0.16 (s, 
9H).  
13C NMR (100 MHz, CDCl3): δ = 106.5, 89.3, 64.0, 38.1, 31.7, 25.0, 22.9, 14.3, 0.0. 
HR-MS (FAB, 70eV): m/z calculated for C11H22OSi = 198.144, found = 198.1408 [M]+. 
Rf = 0.4 (cyclohexane/ ethyl acetate 9:1). 
 
6.3.3 Synthesis of compound 44 and 45: 
 
HO
TMS
43
O
TMS
O
O
O
O
O
+O
O
Br
NaH, THF
0 oC to rt, 3h
65%
(44:45 = 1:1)
44 45
 
 
A 50 mL two necked flask was charged with sodium hydride (95%) (0.05 g, 2.0 mmol, 2 
equiv), 20 mL of THF was added and the suspension was stirred and cooled to 0 oC. To 
the suspension was added dropwise over 20 minutes a solution of 43 (0.2 g, 1.0 mmol) in 
THF (10 mL). The reaction was warmed to 25 oC and stirred for 15 minutes. The reaction 
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was cooled to 0 oC and a solution of ethyl bromoacetate (0.13 mL, 1.2 mmol, 1.2 equiv) 
in THF (5 mL) was added dropwise over 30 minutes. The reaction was warmed to 25 oC, 
stirred for 3h and quenched with water (20 mL). The mixture was diluted with water (50 
mL) and diethyl ether (50mL) and separated. The aqueous layer was washed with diethyl 
ether (2 x 50 mL). The combined ether layers were washed with brine (2 x 10 mL), dried 
over Na2SO4, filtered and concentrated under reduced pressure and  purified by silica gel 
chromatography (cyclohexane/ ethyl acetate 9:1) to furnish 93 mg of the product 44 and 
70 mg of the product 45 (total 65% yield). 
 
6.3.3.1 Analytical data of compound 44: 
1H NMR (400 MHz, CDCl3): δ = 4.22-4.16 (m, 4H), 1.83-1.68 (m, 2H), 1.50-1.41 (m, 
2H), 1.30-1.21 (m, 4H), 1.29-1.26 (t, J = 7.1 Hz, 3H), 1.03-0.99 (t, J = 7.5 Hz, 3H), 0.16 
(s, 9H).  
13C NMR (100 MHz, CDCl3): δ = 170.4, 103.6, 91.8, 71.9, 65.7, 61.1, 35.9, 29.1, 14.6, 
14.3, 0.3. 
HR-MS (FAB, 70eV): m/z calculated for C15H28O3Si = 284.1808, found = 284. 1800 
[M]+. 
Rf = 0.6 (cyclohexane/ ethyl acetate 9:1). 
 
6.3.3.2 Analytical data of compound 45: 
1H NMR (400 MHz, CDCl3): δ = 4.23-4.22 (m, 1H), 4.21-4.20 (m, 2H), 4.18-4.17 (m, 
1H), 2.45-2.44 (d, J = 2.2 Hz, 1H), 1.84-1.75 (m, 2H), 1.52-1.40 (m, 2H), 1.32-1.20 (m, 
4H), 1.29-1.26 (t, J = 7.1 Hz, 3H), 1.04-1.01(t, J = 7.5 Hz, 3H).  
13C NMR (100 MHz, CDCl3): δ = 169.9, 81.6, 74.6, 70.9, 65.5, 60.8, 35.9, 31.7, 28.6, 
25.5 14.3, 14.0. 
HR-MS (FAB, 70eV): m/z calculated for C12H20O3 = 212.1412, found = 212.1400 [M]+. 
Rf = 0.4 (cyclohexane/ ethyl acetate 9:1). 
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6.3.4 Synthesis of compound 46: 
 
HO
Br
46  
 
Compound 43 (0.3 g, 1.5 mmol) was dissolved in DMF, N-bromosuccinimide (0.4 g, 2.27 
mmol, 1.5 equiv.) and silver nitrate (0.051 g, 0.3 mmol, 0.2 equiv) were added and the 
reaction mixture was stirred at room temperature for 45 minutes. The reaction was 
quenched with saturated ammonium chloride solution (10 mL) and the aqueous layer was 
extracted with diethyl ether (2 x 10 mL). The combined organic layers were washed 
thoroughly with water (3 x 10 mL) and brine (2 x 5 mL) and dried over Na2SO4, 
concentrated under reduced pressure and purified by silica gel chromatography 
(cyclohexane/ ethyl acetate 4:1) to furnish 300 mg of the product in nearly quantitative 
yield. 
1H NMR (400 MHz, CDCl3): δ = 4.50-4.46 (t, J = 6.5 Hz, 1H), 1.92 (bs, 1H), 1.72-1.66 
(m, 2H), 1.47-1.39 (m, 2H), 1.32-1.29 (m, 4H), 0.91-0.87 (t, J = 7.0 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 96.1, 64.4, 38.1, 31.7, 25.0, 22.9, 14.3. 
HR-MS (FAB, 70eV): m/z calculated for C8H13BrO = 204.015, found = 204. 0104 [M]+. 
Rf = 0.4 (cyclohexane/ ethyl acetate 4:1). 
 
6.3.5 Synthesis of compound 47: 
 
O
BrO
O
47  
 
A 100 mL two necked flask was charged with sodium hydride (95%) (0.055 g, 2.2 mmol, 
1.5 equiv), 30 mL of THF was added and the suspension was stirred and cooled to 0 oC. 
To the suspension was added dropwise over 20 minutes a solution of compound 46 (0.3 
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g, 1.47 mmol) in THF (10 mL). The reaction was warmed to 25 oC and stirred for 15 
minutes. The reaction was cooled to 0 oC and a solution of ethyl bromoacetate (0.24 mL, 
2.2 mmol, 1.5 equiv) in THF (5 mL) was added dropwise over 30 minutes. The reaction 
was warmed to 25 oC, stirred for 6h and quenched with water (10 mL). The mixture was 
diluted with water (50 mL) and diethyl ether (50 mL) and separated. The aqueous layer 
was washed with diethyl ether (2 x 50 mL). The combined ether layers were washed with 
brine (2 x 10 mL), dried over Na2SO4, filtered and concentrated under reduced pressure 
and  purified by silica gel chromatography (cyclohexane/ ethyl acetate 9:1) to furnish 0.3 
g of the product (70% yield). 
1H NMR (400 MHz, CDCl3): δ = 4.39-4.36 (t, J = 6.6 Hz, 1H), 4.25-4.14 (m, 4H), 1.80-
1.67 (m, 2H), 1.49-1.42 (m, 2H), 1.31-1.24 (m, 4H), 1.30-1.26 (t, J = 7.1 Hz, 3H), 0.89-
0.86 (t, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 170.5, 93.4, 71.8, 66.0, 61.2, 35.9, 31.7, 25.1, 22.8, 
14.5, 14.3. 
HR-MS (FAB, 70eV): m/z calculated for C12H19BrO3 = 290.0518, found = 290.0508 
[M]+. 
Rf = 0.4 (cyclohexane/ ethyl acetate 9:1). 
 
6.3.6 Synthesis of compound 48: 
 
48
O
O
O
Br Ha
Hb
 
 
To a solution of ethyl compound 47 (1.5 g, 5.17 mmol) and potassium azodicarboxylate 
(1.5 g, 7.7 mmol, 1.5 equiv), in dioxane (25 mL)/i-PrOH (25 mL) under N2 at room 
temperature, was added acetic acid (0.91 mL, 15.51 mmol, 3.0 equiv) by syringe pump 
over 1h. After addition was complete, the mixture was stirred for 1h at room temperature 
and additional potassium azodicarboxylate (1.5 g, 7.7 mmol, 1.5 equiv) was added. Again 
acetic acid (0.91 mL, 15.51 mmol, 3.0 equiv) was added slowly by syringe pump over 1h. 
After complete addition of acetic acid, the mixture was stirred for 1h and additional 
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potassium azodicarboxylate (0.5 g, 2.56 mmol, 0.5 equiv) and acetic acid (0.30 mL, 5.17 
mmol, 1.5 equiv) were added sequentially by the procedure describe above. The mixture 
was then stirred for 3h, quenched with 1M HCl solution (30 mL) and diluted with diethyl 
ether (100 mL). The aqueous layer was extracted with diethyl ether (2 x 50 mL), the 
combined organic layers were washed with water (3 x 20 mL) and brine (2 x 10 mL) and 
dried over Na2SO4 and concentrated under reduced pressure. Purification by silica gel 
chromatography (cyclohexane/ ethyl acetate 9:1) furnished 1.35 g of the product (90% 
yield). 
1H NMR (400 MHz, CDCl3): δ = 6.42-6.41 (dd, JHa-Hb = 0.9 Hz, 7.2 Hz, 1H), 6.05-6.01 
(dd, JHa-Hb = 7.2 Hz, 8.6 Hz, 1H), 4.36-4.30 (m, 1H), 4.26-4.15 (m, 2H), 4.10-4.00 (m, 
2H), 1.82-1.72 (m, 1H), 1.62-1.55 (m, 1H), 1.48-1.41 (m, 6H), 1.30-1.27 (t, J = 7.2 Hz, 
3H), 0.99-0.95 (t, J = 7.4 Hz, 3H).  
13C NMR (100 MHz, CDCl3): δ = 170.5, 134.9, 111.4, 79.3, 66.3, 61.1, 35.0, 31.2, 25.1, 
22.0, 14.3, 14.1. 
 HR-MS (FAB, 70eV): m/z calculated for C12H21BrO3 = 292.0674, found = 292.0650 
[M]+. 
Rf = 0.5 (cyclohexane/ ethyl acetate 9:1). 
 
6.3.7 Synthesis of compound 50: 
 
HO
I
50  
 
Compound 41 (3 g, 23.8 mmol) was dissolved in DMF, N-iodosuccinimide (6.7 g, 29.76 
mmol, 1.25 equiv.) and silver nitrate (0.809 g, 4.76 mmol, 0.2 equiv) were added and the 
reaction mixture was stirred at room temperature for 45 minutes. The reaction was 
quenched with saturated ammonium chloride solution (20 mL) and the aqueous layer was 
extracted with diethyl ether (2 x 50 mL). The combined organic layers were washed 
thoroughly with water (3 x 50 mL) and brine (2 x 10 mL) and dried over Na2SO4, 
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concentrated under reduced pressure and purified by silica gel chromatography 
(cyclohexane/ ethyl acetate 4:1) to furnish 6 g of the product in quantitative yield. 
1H NMR (400 MHz, CDCl3): δ = 4.50-4.46 (t, J = 6.5 Hz, 1H), 1.92 (bs, 1H), 1.72-1.66 
(m, 2H), 1.47-1.39 (m, 2H), 1.32-1.29 (m, 4H), 0.91-0.87 (t, J = 7.0 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 96.1, 64.4, 38.1, 31.7, 25.0, 22.9, 14.3. 
HR-MS (FAB, 70eV): m/z calculated for C8H12OI = 250.9933, found = 250.9938 [M-
H]+. 
Rf = 0.4 (cyclohexane/ ethyl acetate 4:1). 
 
6.3.8 Synthesis of compound 51: 
 
O
I
O
O
51  
 
A 250 mL two necked flask was charged with sodium hydride (95%) (1.2 g, 47.62 mmol, 
2 equiv), 50 mL of THF was added and the suspension was stirred and cooled to 0 oC. To 
the suspension was added dropwise over 20 minutes a solution of the compound 50 (6 g, 
23.81 mmol) in THF (20 mL). The reaction was warmed to 25 oC and stirred for 15 
minutes. The reaction was cooled to 0 oC and a solution of ethyl bromoacetate (3.16 mL, 
28.57 mmol, 1.2 equiv) in THF (10 mL) was added dropwise over 30 minutes. The 
reaction was warmed to 25 oC, stirred for 6h and quenched with water (20 mL). The 
mixture was diluted with water (100 mL) and diethyl ether (100 mL) and separated. The 
aqueous layer was washed with diethyl ether (2 x 200 mL). The combined ether layers 
were washed with brine (2 x 20 mL), dried over Na2SO4, filtered and concentrated under 
reduced pressure and  purified by silica gel chromatography (cyclohexane/ ethyl acetate 
9:1) to furnish 6 g of the product (75% yield). 
1H NMR (400 MHz, CDCl3): δ = 4.39-4.36 (t, J = 6.6 Hz, 1H), 4.25-4.14 (m, 4H), 1.80-
1.67 (m, 2H), 1.49-1.42 (m, 2H), 1.31-1.24 (m, 4H), 1.30-1.26 (t, J = 7.1 Hz, 3H), 0.89-
0.86 (t, J = 6.9 Hz, 3H). 
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13C NMR (100 MHz, CDCl3): δ = 170.5, 93.4, 71.8, 66.0, 61.2, 35.9, 31.7, 25.1, 22.8, 
14.5, 14.3. 
HR-MS (FAB, 70eV): m/z calculated for C12H20O3I = 339.0457, found = 339.0466 
[M+H]+. 
Rf = 0.4 (cyclohexane/ ethyl acetate 9:1). 
 
6.3.9 Synthesis of compound 52: 
 
O
O
O
I
52
Ha
Hb
 
 
To a solution of compound 51 (6 g, 17.75 mmol) and potassium azodicarboxylate (5.16 g, 
26.62 mmol, 1.5 equiv), in dioxane (15 mL)/i-PrOH (15 mL) under N2 at room 
temperature, was added acetic acid (3.07 mL, 53.25 mmol, 3.0 equiv) by syringe pump 
over 1h. After addition was complete, the mixture was stirred for 1h at room temperature 
and additional potassium azodicarboxylate (5.16 g, 26.62 mmol, 1.5 equiv) was added. 
Again acetic acid (3.07 mL, 53.25 mmol, 3.0 equiv) was added slowly by syringe pump 
over 1h. After complete addition of acetic acid, the mixture was stirred for 1h and 
additional potassium azodicarboxylate (1.72 g, 8.87 mmol, 0.5 equiv) and acetic acid 
(1.02 mL, 17. 75 mmol, 1.5 equiv) were added sequentially by the procedure describe 
above. The mixture was then stirred for 3h, quenched with 1M HCl solution (50 mL) and 
diluted with diethyl ether (100 mL). The aqueous layer was extracted with diethyl ether 
(2 x 50 mL), the combined organic layers were washed with water (3 x 20 mL) and brine 
(2 x 10 mL) and dried over Na2SO4 and concentrated under reduced pressure. Purification 
by silica gel chromatography (cyclohexane/ ethyl acetate 9:1) furnished 4.82 g of the 
product (80% yield). 
1H NMR (400 MHz, CDCl3): δ = 6.50-6.48 (dd, J = 0.8 Hz, 7.6 Hz, 1H), 6.12-6.08 (dd, 
J = 7.6 Hz, 8.4 Hz, 1H), 4.24-4.18 (m, 3H), 4.09-4.03 (m, 2H), 1.75-1.68 (m,1H), 1.67-
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1.49 (m, 1H), 1.32-1.26 (m, 6H), 1.30-1.26 (t, J = 7.1 Hz, 3H), 0.90-0.86 (t, J = 7.0 Hz, 
3H). 
13C NMR (100 MHz, CDCl3): δ =170.7, 141.2, 85.4, 82.3, 66.1, 61.0, 34.5, 32.0, 24.8, 
22.7, 14.5, 14.2. 
HR-MS (FAB, 70eV): m/z calculated for C12H22O3I = 341.0614, found = 341.0628 
[M+H]+. 
Rf = 0.5 (cyclohexane/ ethyl acetate 9:1). 
 
6.3.10 Synthesis of compound 49: 
 
O
O
O
49  
 
To a solution of compound 52 (6 g, 17.64 mmol) in DMF (20 mL) was added 
Pd(CH3CN)2Cl2 (0.045 g, 0.17 mmol, 0.01 equiv) and tributyl vinyl tin (7.77 mL, 26.47 
mmol, 1.5 equiv). The mixture quickly became black. The solution was stirred at room 
temperature for 30 minutes, quenched with saturated NH4Cl solution and diluted with 
diethyl ether (50 mL). The aqueous layer was washed with water (2 x 20 mL) and brine 
(2 x 10 mL), dried over Na2SO4, filtered and concentrated under reduced pressure and 
purified by silica gel chromatography (cyclohexane/ ethyl acetate 19:1) to furnish 3 g of 
the product (70% yield). 
1H NMR (400 MHz, CDCl3): δ = 6.62-6.52 (m, 1H), 6.23-6.17 (dt, J = 0.6 Hz, 11.4 Hz, 
1H), 5.30-5.28 (m, 1H), 5.27-5.24 (m, 1H), 5.18-5.16 (m, 1H), 4.21-4.20 (m, 1H), 4.21-
4.16 (m, 3H), 4.06-3.93 (q, J = 16.4 Hz, 2H), 1.76-1.70 (m, 1H), 1.55-1.43 (m, 1H), 1.36-
1.28 (m, 6H), 1.28-1.24 (t, J = 7.1 Hz, 3H), 0.93-0.89 (t, J = 7.2 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 171.0, 133.3, 131.8, 119.9, 75.7, 65.6, 60.9, 35.7, 
31.9, 25.1, 22.8, 14.4, 13.8. 
HR-MS (EI, 70eV): m/z calculated for C14H24O3 = 240.1725, found = 240.1741 [M]+. 
Rf = 0.5 (cyclohexane/ ethyl acetate 19:1). 
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6.3.11 Synthesis of compound 53 and 54: 
 
+
DIBAL-H, DCM
-78 oC, 30 min, 70%
(53:54=1:1)
O
O
O
49
O
O
H
53
OH
O
54
 
 
To a solution of compound 49 (3.5 g, 14.75 mmol) in DCM (500 mL) at -78 oC, 
diisobutyl aluminum hydride (1M solution in hexane, 22.12 mL, 22.12 mmol, 1.5 equiv) 
was added slowly by a syringe pumpe over 30 minutes. The solution was stirred at -78 oC 
for 20 minutes, quenched with 1M HCl solution and stirred for 1h. The solution was 
diluted with diethyl ether (50 mL). The aqueous layer was extracted with diethyl ether (2 
x 20 mL) and the combined organic layers were washed with water (2 x 10 mL) and brine 
(2 x 10 mL), dried over Na2SO4, filtered and concentrated under reduced pressure and 
purified by silica gel chromatography (cyclohexane/ ethyl acetate 9:1) to furnish 1 g of 
each of the product 53 and 54 (70% yield). 
6.3.11.1 Analytical data of compound 53: 
1H NMR (400 MHz, CDCl3): δ = 9.70-9.69 (t, J = 0.9 Hz, 1H), 6.60-6.51 (m, 1H), 6.23-
6.18 (dt, J = 0.8 Hz, 11.5 Hz, 1H), 5.30-5.29 (m, 1H), 5.29-5.24 (m, 1H), 5.21-5.18 (m, 
1H), 4.30-4.24 (m, 1H), 4.07-3.93 (dq, J = 0.9 Hz, 17.9 Hz, 2H), 1.76-1.69 (m, 1H), 1.51-
1.45 (m, 1H), 1.32-1.26 (m, 6H), 0.89-0.86 (t, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 201.4, 133.4, 131.4, 131.4, 120.35, 76.4, 74.0, 35.6, 
31.9, 25.1, 22.8, 14.2. 
HR-MS (FAB, 70eV): m/z calculated for C12H19O2 = 195.1385, found = 195.1396 [M-
H]+. 
Rf = 0.5 (cyclohexane/ ethyl acetate 9:1). 
 
6.3.11.2 Analytical data of compound 54: 
1H NMR (400 MHz, CDCl3): δ = 6.66-6.56 (m, 1H), 6.20-6.15 (dt, J = 0.8 Hz, 11.4 Hz, 
1H), 5.31-4.14 (m, 3H), 4.16-4.10 (m, 1H), 3.84-3.73 (m, 1H), 3.70-3.68 (m, 1H), 3.41-
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3.36 (m, 1H), 2.19 (bs, 1H), 1.78-1.59 (m, 2H), 1.30-1.21 (m, 6H), 0.90-0.87 (t, J = 7.0 
Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 133.0, 131.1, 131.4, 120.4, 76.4, 71.0, 62.5, 35.2, 
31.6, 25.5, 22.7, 14.2. 
HR-MS (FAB, 70eV): m/z calculated for C12H22O2 = 198.162, found = 198. 1600 [M]+. 
Rf = 0.3 (cyclohexane/ ethyl acetate 9:1). 
 
6.3.12 Synthesis of compound 53: 
To a solution of compound 49 (3.5 g, 14.75 mmol) in diethyl ether (500 mL) at -78 oC, 
diisobutylaluminumhydride (1M solution in hexane, 22.12 mL, 22.12 mmol, 1.5 equiv) 
was added slowly by a syringe pumpe over 30 minutes. The solution was stirred at -78 oC 
for 20 minutes, quenched with 1M HCl solution and stirred for 1h. The solution was 
diluted with diethyl ether (50 mL). The aqueous layer was extracted with diethyl ether (2 
x 20 mL) and the combined organic layers were washed with water (2 x 10 mL) and brine 
(2 x 10 mL), dried over Na2SO4, filtered and concentrated under reduced pressure and 
purified by silica gel chromatography (cyclohexane/ ethyl acetate 9:1) to furnish 2.14 g of 
the product (75% yield). 
 
6.3.13 Synthesis of compound 55: 
 
O
55  
 
To a suspension of triphenylmethylphosphoniumbromide (0.728 g, 2.04 mmol, 2 equiv) 
in THF (10 mL) at 0 oC, n-butyl lithium solution (2.5 M in hexane solution, 0.82 mL, 
2.04 mmol, 2 equiv) was added dropwise (the color of the solution turned red). After 
stirring at 0oC for 30 minutes compound 53 (0.2 g, 1.02 mmol, dissolved in THF) was 
added dropwise and stirring was continued at 0 oC for 30 mintutes. The reaction was 
quenched with 10 mL of 1M HCl solution and diluted with 30 mL of diethyl ether. The 
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aqueous layer was extracted with diethyl ether (2 x 20 mL) and the combined organic 
layers were washed with water (2 x 10 mL) and brine (2 x 10 mL), dried over Na2SO4, 
filtered and concentrated under reduced pressure and purified by silica gel 
chromatography (cyclohexane/ ethyl acetate 19:1) to furnish 148 mg of the product (75% 
yield). 
1H NMR (400 MHz, CDCl3): δ = 6.59-6.48 (m, 1H), 6.12-6.05 (m, 1H), 5.86-5.78 (m, 
1H), 5.26-5.19 (m, 2H), 5.15-5.07 (m, 3H), 4.16-4.13 (m, 1H), 3.96-3.93 (m, 1H), 3.75-
3.71 (m, 1H), 1.58-1.57 (m, 1H), 1.38-1.34 (m, 1H), 1.28-1.21 (m, 6H), 0.81-0.79 (t, J = 
3.4 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ= 135.4, 133.3, 132.1, 132.0, 119.0, 116.9, 74.4, 69.2, 
35.8, 31.99, 25.1, 22.8, 14.2. 
HR-MS (EI, 70eV): m/z calculated for C13H22O = 194.1671, found = 194.1700 [M]+. 
Rf = 0.5 (cyclohexane/ ethyl acetate 19:1). 
 
6.3.14 Synthesis of compound 56 and 57: 
 
O O O
+
(56:57 = 2:3)
DCM, reflux, 5 min
 70%
3 (10 mol%) 
or 
6 (5 mol%)
55
56 57
 
 
6.3.14.1 Analytical data of compound 56: 
1H NMR (400 MHz, CDCl3): δ = 5.87-5.85 (m, 1H), 5.79-5.77 (m, 1H), 4.83-4.79 (m, 
1H), 4.68-4.63 (m, 1H), 4.62-4.56 (m, 1H), 1.55-1.51 (m, 2H), 1.37-1.25 (m, 6H), 0.90-
0.86 (t, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 130.1, 126.5, 86.4, 75.1, 36.2, 32.2, 25.2, 22.9, 14.2. 
HR-MS (EI, 70eV): m/z calculated for C9H17O = 141.1279, found = 141.1200 [M+H]+. 
Rf = 0.5 (cyclohexane/ ethyl acetate 10:1). 
Yield: 28%. 
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6.3.14.2 Analytical data of compound 57: 
1H NMR (400 MHz, CDCl3): δ = 5.94-5.92 (m, 2H), 5. 92-5.89 (m, 1H), 5.84-5.80 (m, 
1H), 4.43-4.38 (m, 1H), 4.34-4.30 (m, 1H), 4.18-4.16 (m, 1H), 1.60-1.56 (m, 2H), 1.33-
1.28 (m, 6H), 0.91-0.85 (t, J = 6.8 Hz, 3H).  
13C NMR (100 MHz, CDCl3): δ =138.6, 135.85, 125.8, 125.8, 80.0, 70.3, 35.5, 32.00, 
29.9, 25.6, 22.8, 14.3. 
HR-MS (FAB, 70eV): m/z calculated for C11H17O = 165.1279, found = 165.1286 [M-
H]+. 
Rf = 0.7 (cyclohexane/ ethyl acetate 10:1). 
Yield: 42%. 
 
6.3.15 Synthesis of compound 58: 
 
O
HO
58
(1:1 mixture of two isomers)*  
* = isomeric ratio determined by 1H NMR spectroscopy 
 
To a solution of aldehyde 53 (0.2 g, 1.02 mmol) in THF under argon and at 0 oC, vinyl 
magnesium bromide (1.53 mL, 1.53 mmol, 1.5 equiv, 1M solution in THF) was added 
dropwise. The reaction was stirred at room temperature for 2h, quenched with saturated 
ammonium chloride solution and the aqueous layer was extracted with diethyl ether (2 x 
50 mL). The combined organic layers were washed with brine (2 x 20 mL), dried over 
Na2SO4, filtered and concentrated under reduced pressure and purified by silica gel 
chromatography (cyclohexane/ ethyl acetate 9:1) to furnish 160 mg of the product (70% 
yield) as 1:1 inseparable mixture of two isomers. 
1H NMR (400 MHz, CDCl3): δ = 6.66-6.55 (m, 1H), 6.20-6.13 (m, 1H), 5.85-5.76 (m, 
1H), 5.36-5.24 (m, 3H), 5.18-5.16 (m, 2H), 4.29-4.18 (m, 1H), 3.36-3.34 (d, J= 6.04 Hz, 
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1H), 3.15-3.11 (dt, J = 0.8 Hz, 9.2 Hz, 1H), 2.42 (bs, 1H), 1.68-1.63 (m, 1H), 1.47-1.40 
(m, 1H), 1.34-1.28 (m, 6H), 0.89-0.86 (t, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 136.9, 136.8, 132.7, 132.7, 132.3, 132.1, 132.8, 119.5, 
116.5, 76.2, 75.6, 72.6, 72.1, 72.0, 71.6, 35.7, 35.7, 31.9, 31.9, 25.1, 25.1, 22.7, 14.2. 
HR-MS (EI, 70eV): m/z calculated for C14H24O2 = 224.1776, found = 224.1700 [M]+ . 
Rf = 0.5 (cyclohexane/ ethyl acetate 9:1). 
 
6.3.16 Synthesis of compound 59: 
 
(1:1 mixture of two isomers)*
O
HO
59
 
* = isomeric ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, CDCl3): δ = 5.99-5.95 (m, 1H), 5.85-5.76 (m, 1H), 4.21-4.13 (m, 
1H), 4.06-4.03 (m, 1H), 3.98-3.95 (m, 1H), 3.86-3.85 (m, 1H), 3.89-3.85 (m, 1H), 3.69-
3.65 (dd, J = 6.8 Hz, 13 Hz, 1H), 3.44-3.39 (dd, J = 6.8 Hz, 11.2 Hz, 1H), 1.96 (bs, 1H), 
1.56-1.48 (m, 2H), 1.47-1.40 (m, 2H), 1.38-1.29 (m, 4H), 0.89-0.86 (t, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 134.6, 132.9, 128.1, 126.5, 74.6, 73.9, 71.0, 68.6, 
63.2, 62.8, 35.2, 34.3, 32.0, 31.9, 25.2, 24.9, 22.8, 14.2, 14.2.  
HR-MS (FAB, 70eV): m/z calculated for C10H17O2 = 169.1229, found = 169.1247 [M-
H]+. 
Rf = 0.5 (cyclohexane/ ethyl acetate 5:1). 
Yield: 60%. 
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6.3.17 Synthesis of compound 61: 
 
(1:1 mixture of two isomers)*
OHO
61
 
* = isomeric ratio determined by 1H NMR spectroscopy 
 
To a solution of aldehyde 53 (0.2 g, 1.02 mmol) in THF under argon at 0 oC, allyl 
magnesium bromide (1.53 mL, 1.53 mmol, 1.5 equiv, 1M solution in diethyl ether) was 
added dropwise. The reaction was stirred at room temperature for 2h, quenched with 
saturated ammonium chloride solution and the aqueous layer was extracted with diethyl 
ether (2 x 50 mL). The combined organic layers were washed with brine (2 x 20 mL), 
dried over Na2SO4, filtered and concentrated under reduced pressure and purified by silica 
gel chromatography (cyclohexane/ ethyl acetate 9:1) to furnish 170 mg of the product 
(70% yield) as 1:1 inseparable mixture of two isomers. 
1H NMR (400 MHz, CDCl3): δ = 6.66-6.55 (m, 1H), 6.19-6.12 (m, 1H), 5.87-5.77 (m, 
1H), 5.31-5.06 (m, 5H), 4.23-4.15 (m, 1H), 3.84-3.76 (m, 1H), 3.51-3.48 (dd, J = 3.8 Hz, 
9.1 Hz, 1H), 3.37-3.29 (m, 1H), 3.16-3.12 (dd, J = 7.4 Hz, 9.5 Hz, 1H), 2.25-2.21 (m, 
2H), 1.69-1.60 (m, 1H), 1.47-1.39 (m, 1H), 1.30-1.27 (m, 6H), 0.89-0.85 (t, J = 6.8 Hz, 
3H). 
13C NMR (100 MHz, CDCl3): δ = 134.6, 134.6, 132.9, 132.2, 132.1, 131.9, 119.4, 117.7, 
76.2, 75.7, 72.3, 71.9, 70.2, 69.9, 38.2, 38.1, 35.8, 35.8, 32.0, 31.9, 25.2, 25.2, 22.8, 14.2. 
HR-MS (FAB, 70eV): m/z calculated for C15H25O2 = 237.1855, found = 237.1847 [M-
H]+. 
Rf = 0.5 (cyclohexane/ ethyl acetate 9:1). 
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6.3.18 Synthesis of compound 62: 
 
(1:1 mixture of two isomers)*
OTBSO
62
 
* = isomeric ratio determined by 1H NMR spectroscopy 
 
To a solution of compound 61 (0.1 g, 0.42 mmol) in 10 mL DMF imidazole (0.057 g, 
0.84 mmol, 2 equiv) was added and stirred at room temperature for 15 minutes. Then 
TBSCl (0.126 g, 0.84 mmol, 2 equiv) was added and stirred at room temperature for 18h, 
quenched with water and extracted with ethyl acetate (2 x 50 mL). The combined organic 
layers were washed with water (3 x 20 mL), brine (2 x 20 mL), dried over Na2SO4, 
filtered and concentrated under reduced pressure and purified by silica gel 
chromatography (cyclohexane/ ethyl acetate 9.8:0.2) to furnish 110 mg of the product 
(75% yield) as 1:1 inseparable mixture of two isomers. 
1H NMR (400 MHz, CDCl3): δ = 6.66-6.57 (m, 1H), 6.17-6.06 (m, 1H), 5.89-5.76 (m, 
2H), 5.08-4.99 (m, 4H), 4.18-4.11 (m, 1H), 3.82-3.77 (m, 1H), 3.39-3.11 (m, 2H), 2.35-
2.27 (m, 1H), 2.23-2.13 (m, 1H), 1.74-1.56 (m, 2H), 1.31-1.28 (m, 6H), 0.89-0.87 (m, 
12H), 0.07-0.04 (m, 6H). 
13C NMR (100 MHz, CDCl3): δ = 135.4, 135.3, 133.7, 133.7, 132.2, 131.8, 131.6, 119.0, 
118.9, 117.1, 117.1, 75.9, 75.6, 72.5, 72.4, 71.6, 71.5, 39.7, 39.7, 35.9, 35.8, 32.1, 32.0, 
31.8, 31.7, 26.1, 25.2, 25.1, 22.8, 18.4, 18.4, 14.3, -4.2, -4.4.  
HR-MS (FAB, 70eV): m/z calculated for C21H39O2Si = 351.2719, found = 351.2749 [M-
H]+. 
Rf = 0.5 (cyclohexane/ ethyl acetate 9.8: 0.2). 
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6.3.19 Synthesis of compound 63: 
 
(1:1 mixture of two isomers)*
O
TBSO
63
 
* = isomeric ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, CDCl3): δ = 5.69-5.66 (m, 1H), 5.61-5.41 (m, 1H), 4.09-4.03 (m, 
1H), 3.98-3.87 (m, 1H), 3.82-3.73 (m, 1H), 3.71-3.66 (dd, J = 6.0 Hz, 11.7 Hz, 1H), 3.44-
3.39 (dd, J = 9.2 Hz, 11.5 Hz, 1H), 2.72-2.46 (m, 1H), 2.35-2.08 (m, 1H), 1.60-1.38 (m, 
2H), 1.33-1.25 (m, 6H), 0.88-0.87 (m, 12H), 0.05-0.03 (m, 6H). 
13C NMR (100 MHz, CDCl3): δ = 136.7, 134.6, 126.9, 125.2, 80.2, 79.1, 78.1, 75.3, 
71.9, 69.1, 36.9, 36.4, 35.9, 34.4, 32.1, 32.0, 26.0, 25.4, 25.4, 18.4, 18.3, 14.3, 14.3, -4.5, 
-4.6.  
HR-MS (FAB, 70eV): m/z calculated for C17H33O2Si = 297.225, found = 297.2276 [M-
H]+. 
Rf = 0.5 (cyclohexane/ ethyl acetate 9: 1) 
Yield: 65%. 
 
6.3.20 Synthesis of compound 66: 
 
(1:1 mixture of two isomers)*
HO
O
66
 
* = isomeric ratio determined by 1H NMR spectroscopy 
 
Magnesium turnings (18.4 mg, 0.765 mmol, 1.5 equiv) were taken under argon in a two 
neck round bottom flask and activated with a pinch of iodine. 2 mL diethyl ether was 
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added into the flask and cooled to -78 oC. Crotyl bromide (0.07 mL, 0.765 mmol, 1.5 
equiv) was added dropwise and the reaction mixture was stirred for 30 minutes at -78 oC. 
The reaction mixture was allowed to warm at room temperature and stirred until all the 
magnesium metal was dissolved to give a turbid solution. The reaction mixture was 
cooled again at -78 oC and the aldehyde 53 (0.1 gm, 0.51 mmol, dissolved in diethyl 
ether) was added into the flask. The reaction mixture was stirred at room temperature for 
2h. The reaction was quenched with 10 mL saturated ammonium chloride solution and 
the aqueous layer was extracted with diethyl ether (2 x 20 mL). The combined organic 
layers were washed with brine (2 x 10 mL), dried over Na2SO4, filtered and concentrated 
under reduced pressure and purified by silica gel chromatography (cyclohexane/ ethyl 
acetate 9:1) to furnish 51 mg of the product (40% yield). 
1H NMR (400 MHz, CDCl3): δ = 6.63-6.51 (m, 1H), 6.20-6.15 (m, 1H), 5.90-5.87 (m, 
1H), 5.51-5.17 (m, 4H), 4.25-4.10 (m, 1H), 3.86-3.70 (m, 1H), 3.49-3.46 (dd, J = 3.7 Hz, 
7.1 Hz, 1H), 3.39-3.27 (m, 1H), 3.18-3.14 (dd, J = 3.7 Hz, 7.2 Hz, 1H), 2.22-2.20 (m, 
2H), 1.93-1.89 (m, 3H), 1.70-1.65 (m, 1H), 1.48-1.38 (m, 1H), 1.31-1.29 (m, 6H), 0.86-
0.82 (t, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 133.7, 132.6, 131.9, 131.2, 131.1, 130.9, 125.4, 116.7, 
77.2, 76.7, 71.3, 70.9, 70.2, 68.9, 39.2, 38.5, 36.8, 35.8, 32.8, 31.3, 27.2, 26.2, 23.8, 20.5, 
14.5. 
HR-MS (FAB, 70eV): m/z calculated for C16H27O2 = 251.2089, found = 251.2012 [M-
H]+. 
Rf = 0.5 (cyclohexane/ ethyl acetate 9:1). 
 
6.3.21 Synthesis of compound 68: 
 
(1:1 mixture of two isomers)*
HO
O
68
 
* = isomeric ratio determined by 1H NMR spectroscopy 
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To a solution of compound 53 (0.1 gm, 0.51 mmol) in THF at 0 oC 2-methyl-1-
propenylmagnesium bromide (2.04 mL, 1.02 mmol, 2 equiv, 0.5 M solution in THF) was 
added dropwise. The reaction was stirred at room temperature for 8h, quenched with 
saturated ammonium chloride solution and the aqueous layer was extracted with diethyl 
ether (2 x 20 mL). The combined organic layers were washed with brine (2 x 10 mL), 
dried over Na2SO4, filtered and concentrated under reduced pressure and purified by silica 
gel chromatography (cyclohexane/ ethyl acetate 9:1) to furnish 103 mg of the product 
(80% yield) as 1:1 inseparable mixture of two isomers. 
1H NMR (400 MHz, CDCl3): δ = 6.67-6.55 (m, 1H), 6.19-6.12 (m, 1H), 6.19-6.12 (m, 
1H), 5.28-5.27 (m, 1H), 5.24-5.23 (m, 1H), 5.18-5.15 (m, 1H), 5.13-5.08 (m, 1H), 4.53-
4.45 (m, 1H), 4.27-4.19 (m, 1H), 3.44-3.41 (dd, J = 3.1 Hz, 9.6 Hz, 1H), 3.32-3.25 (m, 
1H), 3.12-3.07 (dd, J = 8.9 Hz, 9.6 Hz, 1H), 2.40 (bs, 1H), 1.72-1.71 (d, J = 1.0 Hz, 3H), 
1.69-1.67 (dd, J = 1.4 Hz, 5.4 Hz, 3H), 1.32-1.24 (m, 8H), 0.89-0.86 (t, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 137.5, 137.4, 132.9, 132.9, 132.3, 132.0, 131.9, 131.9, 
123.5, 123.4, 119.4, 76.3, 75.4, 72.7, 72.0, 68.3, 67.6, 35.8, 35.8, 32.0, 31.9, 26.0, 25.2, 
25.1, 22.79, 18.6, 14.2. 
HR-MS (FAB, 70eV): m/z calculated for C16H27O2 = 251.2011, found = 251.2023 [M-
H]+. 
Rf = 0.5 (cyclohexane/ ethyl acetate 9: 1). 
 
6.3.22 Synthesis of compound 69: 
 
(1:1 mixture of two isomers)*
TBSO
O
69
 
* = isomeric ratio determined by 1H NMR spectroscopy 
 
To a solution of compound 68 (0.05 g, 0.35 mmol) in 5 mL DMF, imidazole (0.047 g, 
0.714 mmol, 2 equiv) was added and the solution was stirred at room temperature for 15 
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minutes. Then TBSCl (0.107 g, 0.714 mmol, 2 equiv) was added and after stirring for 18h 
at room temperature, the reaction was quenched with water and the mixture was extracted 
with ethyl acetate (2 x 10 mL). The combined organic layers were washed with water (3 x 
10 mL), brine (2 x 10 mL), dried over Na2SO4, filtered and concentrated under reduced 
pressure and purified by silica gel chromatography (cyclohexane/ ethyl acetate 9.8:0.2) to 
furnish 50 mg of the product (70% yield) as 1:1 inseparable mixture of two isomers. 
1H NMR (400 MHz, CDCl3): δ = 6.69-6.56 (m, 1H), 6.15-6.09 (m, 1H), 5.33-5.26 (m, 
1H), 5.25-5.20 (m, 1H), 5.15-5.12 (m, 1H), 5.10-5.03 (m, 1H), 4.49-4.42 (m, 1H), 4.25-
4.17 (m, 1H), 3.42-3.37 (dd, J = 10.1 Hz, 10.1 Hz, 1H), 3.28-3.25 (dd, J = 10.3 Hz, 10.3 
Hz, 1H), 3.22-3.18 (dd, J = 10.3 Hz, 10.3 Hz, 1H), 3.14-3.10 (dd, J = 10.1 Hz, 9.9 Hz, 
1H), 1.70-1.68 (dd, J = 1.3 Hz, 6.5 Hz, 3H), 1.64-1.62 (dd, J = 1.2 Hz, 7.6 Hz, 3H), 1.31-
1.26 (m, 8H), 0.88-0.86 (m, 12H), 0.06-0.01 (m, 6H). 
13C NMR (100 MHz, CDCl3): δ = 133.9, 133.8, 133.4, 133.3, 132.3, 132.2, 131.54, 
131.4, 126.7, 126.4, 118.7, 118.7, 75.8, 75.5, 73.2, 73.1, 70.1, 69.4, 35.9, 35.8, 32.0, 31.9, 
26.0, 25.9, 25.8, 25.0, 25.0, 22.7, 22.7, 18.6, 18.4, 14.2, -4.3, -4.5. 
HR-MS (FAB, 70eV): m/z calculated for C22H41O2Si = 365.2876, found = 365.2864 [M-
H]+. 
Rf = 0.5 (cyclohexane/ ethyl acetate 9.8: 0.2). 
 
6.3.23 Synthesis of compound 71: 
 
(1:1 mixture of two isomers)*
O
HO
71
 
* = isomeric ratio determined by 1H NMR spectroscopy 
 
Magnesium turning (0.024 g, 1.02 mmmol, 2 equiv) was activated with a pinch of iodine 
crystal under argon atmosphere and was treated with 2-methyl-1-propenyl bromide (0.15 
mL, 1.27 mmol, 2.5 equiv) dissolved in 1 mL THF at 0 oC. The reaction mixture was 
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stirred at room temperature until all the magnesium metal was dissolved. The mixture 
was treated with a solution of aldehyde 53 (0.1 g, 0.51 mmol) in THF at 0 oC and the 
reaction mixture was stirred at room temperature for 3h, quenched with saturated 
ammonium chloride solution and the aqueous layer was extracted with diethyl ether (2 x 
20 mL). The combined organic layers were washed with brine (2 x 10 mL), dried over 
Na2SO4, filtered and concentrated under reduced pressure and purified by silica gel 
chromatography (cyclohexane/ ethyl acetate 9:1) to furnish 88 mg of the product (65% 
yield) as 1:1 inseparable mixture of two isomers. 
1H NMR (400 MHz, CDCl3): δ = 6.61-6.55 (m, 1H), 6.25-6.19 (m, 1H), 5.95-5.88 (m, 
1H), 5.45-5.11 (m, 5H), 4.35-4.19 (m, 1H), 3.87-3.70 (m, 1H), 3.56-3.46 (m, 2H), 3.40-
3.33 (m, 1H), 3.25-3.15 (m, 1H), , 1.70-1.65 (m, 1H), 1.49-1.40 (m, 1H), 1.35-1.29 (m, 
6H), 1.25 (s, 3H), 1.22 (s, 3H), 0.88-0.86 (t, J = 6.7 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 135.6, 134.0, 133.0, 132.8, 132.1, 131.9, 120.4, 108.7, 
78.2, 76.7, 73.4, 72.9, 71.2, 68.9, 37.2, 36.1, 35.9, 34.8, 32.9, 31.5, 25.6, 25.1,23.9, 23.2, 
22.8, 14.5. 
HR-MS (FAB, 70eV): m/z calculated for C17H29O2 = 265.2246, found = 265.2290 [M-
H]+. 
Rf = 0.4 (cyclohexane/ ethyl acetate 9:1). 
 
6.3.24 Synthesis of compound 72: 
 
H
O
SS
72  
 
Compound 53 (0.1 gm, 0.51 mmol) was dissolved in DCM (10 mL), 1,3-propanedithiol 
(0.1 mL, 1.02 mmol, 2 equiv) was added and the reaction mixture was cooled to -30 oC. 
To this solution boron trifluoride dimethyl ether complex (0.06 mL, 0.51 mmol, 1 equiv) 
was added drop wise and the reaction mixture was stirred for 30 min at -30 oC. The 
reaction mixture was quenched with saturated aqueous NaHCO3 (10 mL). The aqueous 
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layer was extracted with ethyl acetate (3 x 10 mL) and the combined organic layer was 
washed with brine (2 x 10 mL), dried over Na2SO4, filtered and concentrated under 
reduced pressure and purified by silica gel chromatography (cyclohexane/ethyl acetate 
9.5: 0.5) to furnish 102 mg of the product in 70% yield. 
1H NMR (400 MHz, CDCl3): δ = 6.66-6.56 (m, 1H), 6.19-6.13 (dt, J = 0.9 Hz, 11.6 Hz, 
1H), 5.34-5.31 (m, 1H), 5.29-5.23 (m, 1H), 5.19-5.15 (m, 1H), 4.24-4.18 (m, 2H), 3.73-
3.65 (m, 1H), 3.54-3.50 (dd, J = 5.86 Hz, 10.7 Hz, 1H), 2.86-2.70 (m, 4H), 2.67-2.60 (m, 
2H), 1.95-1.85 (m, 2H), 1.31-1.26 (m, 6H), 0.90-0.85 (t, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ=132.9, 132.3, 131.9, 119.5, 76.2, 70.7, 46.7, 35.74, 
31.9, 29.5, 26.2, 25.2, 22.8, 14.3. 
HR-MS (FAB, 70eV): m/z calculated for C15H27OS2 = 287.1503, found = 287.1544 
[M+H]+. 
Rf = 0.5 (cyclohexane/ ethyl acetate 9.5: 0.5). 
 
6.3.25 Synthesis of compound 77: 
 
O
OH
77  
 
To a suspension of methoxymethyltriphenyl phosphonium chloride (0.297 g, 0.867 
mmol, 1.7 equiv) in THF at 0 oC, n-butyllithium (0.35 mL, 0.87 mmol, 1.7 equiv, 2.5 M 
in hexane solution) was added dropwise (the color of the solution turned red). After 
stirring at 0 oC for 30 minutes aldehyde 53 (0.1 g, 0.51 mmol, dissolved in THF) was 
added dropwise at 0 oC and stirring was continued at room temperature for 30 minutes. 
After the aldehyde was consumed (monitored by TLC) 1M HCl solution (10 mL) was 
added and the mixture was stirred for 8h at room temperature, followed by addition of 
saturated aqueous NaHCO3 solution (10 mL). The aqueous layer was extracted with ethyl 
acetate (3 x 10 mL) and the combined organic layers were washed with brine (2 x 10 
mL), dried over Na2SO4, filtered and concentrated under reduced pressure and purified by 
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silica gel chromatography (cyclohexane/ethyl acetate 9:1) to furnish 85 mg of the product 
(80% yield). 
1H NMR (400 MHz, CDCl3): δ = 9.77-9.76 (t, J = 1.9 Hz, 1H), 6.68-6.58 (m, 1H), 6.20-
6.14 (dt, J = 0.9 Hz, 11.6 Hz, 1H), 5.31-5.28 (m, 1H), 5.26-5.23 (m, 1H), 5.19-5.16 (m, 
1H), 4.20-4.15 (m, 1H), 3.83-3.77 (m, 1H), 3.63-3.59 (m, 1H), 2.63-2.59 (dt, J = 1.9 Hz, 
7.0 Hz, 2H), 1.63-1.57 (m, 1H), 1.31-1.25 (m, 7H), 0.89-0.85 (t, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 201.7, 132.9, 132.2, 131.9, 119.5, 75.9, 62.3, 44.22, 
35.8, 31.9, 25.1, 22.8, 14.2. 
HR-MS (FAB, 70eV): m/z calculated for C13H21O2 = 209.1542, found = 209.1530 [M-
H]+. 
Rf = 0.5 (cyclohexane/ethyl acetate 9:1). 
 
6.3.26 Synthesis of compound 78: 
 
(1:1 mixture of two isomers)*
O
HO
78
 
* = isomeric ratio determined by 1H NMR spectroscopy 
 
To a solution of compound 77 (0.1 g, 0.47 mmol) in THF at 0 oC, 2-methyl-1-
propenylmagnesium bromide (1.9 mL, 0.95 mmol, 2 equiv, 0.5 M solution in THF) was 
added dropwise at 0 oC. The reaction was stirred at room temperature for 8h, quenched 
with saturated ammonium chloride solution and the aqueous layer was extracted with 
diethyl ether (2 x 20 mL). The combined organic layers were washed with brine (2 x 10 
mL), dried over Na2SO4, filtered and concentrated under reduced pressure and purified by 
silica gel chromatography (cyclohexane/ethyl acetate 5:1) to furnish 76 mg of the product 
(60% yield) as 1:1 inseparable mixture of two isomers. 
1H NMR (400 MHz, CDCl3): δ = 6.66-6.57 (m, 1H), 6.19-6.02 (td, J = 11.1 Hz, 1H), 
5.29-5.27 (m, 1H), 5.22-5.15 (m, 3H), 4.58-4.51 (m, 1H), 4.18-4.13 (m, 1H), 3.71-3.58 
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(m, 1H), 3.54-3.35 (m, 1H), 1.71 (s, 3H), 1.67 (s, 3H), 1.29-1.25 (m, 8H), 0.89-0.85 (t, J 
= 6.8 Hz, 3H).  
13C NMR (100 MHz, CDCl3): δ = 134.7, 134.6, 133.1, 133.0, 132.2, 132.1, 132.0, 132.9, 
130.7, 127.9, 127.9, 119.3, 75.9, 75.8, 68.4, 68.3, 68.2, 67.1, 66.9, 37.6, 37.2, 32.0, 31.9, 
25.9, 25.2, 22.8, 18.4, 14.2. 
HR-MS (EI, 70eV): m/z calculated for C17H30O2 = 266.2246, found = 266.2257 [M]+. 
Rf = 0.5 (cyclohexane/ ethyl acetate 5: 1). 
 
6.3.27 Synthesis of compound 79: 
 
(1:1 mixture of two isomers)*
O
TBSO
79
 
* = isomeric ratio determined by 1H NMR spectroscopy 
 
To a solution of compound 78 (0.07 g, 0.263 mmol) in 5 mL DMF, imidazole (0.035 g, 
0.526 mmol, 2 equiv) was added and stirred at room temperature for 15 minutes. Then 
TBSCl (0.08 g, 0.526 mmol, 2 equiv) was added and the reaction was stirred for 18h at 
room temperature, quenched with water and extracted with ethyl acetate (2 x 10 mL). The 
combined organic layers were washed with water (3 x 10 mL), brine (2 x 10 mL), dried 
over Na2SO4, filtered and concentrated under reduced pressure and purified by silica gel 
chromatography (cyclohexane/ ethyl acetate 9.8:0.2) to furnish 70 mg of the product 
(70% yield) as 1:1 inseparable mixture of two isomers. 
1H NMR (400 MHz, CDCl3): δ = 6.68-6.57 (m, 1H), 6.16-6.10 (dt, J = 0.8 Hz, 11.5 Hz, 
1H), 5.32-5.27 (m, 1H), 5.25-5.20 (m, 1H), 5.15-5.06 (m, 2H), 4.50 (m, 1H), 4.16-4.08 
(m, 1H), 3.53-3.41 (m, 1H), 3.33-3.19 (m, 1H), 1.68-1.67 (dd, J = 1.4 Hz, 4.2 Hz, 3H), 
1.62-1.61 (t, J = 1.6 Hz, 3H), 1.43-1.36 (m, 2H), 1.28-1.25 (m, 8H), 0.89-0.85 (m, 12H), 
0.07 (s, 6H). 
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13C NMR (100 MHz, CDCl3): δ = 133.9, 132.3, 132.2, 131.6, 131.5, 129.5, 129.5, 118.8, 
75.3, 75.2, 67.3, 67.2, 65.2, 39.0, 38.9, 36.0, 35.9, 32.1, 26.2, 25.9, 25.3, 22.8, 18.5, 14.3, 
-3.9, -4.6. 
HR-MS (FAB, 70eV): m/z calculated for C23H43O2Si = 379.3032, found = 379.3045 [M-
H]+. 
Rf = 0.5 (cyclohexane/ethyl acetate 9.8:0.2). 
 
6.3.28 Synthesis of compound 83: 
 
TBSO
O
O
O
83
Ha
Hb
 
 
To a solution of compound 69 (0.02 g, 0.05 mmol) and methyl acrylate (0.007 mL, 0.08 
mmol, 1.5 equiv) in 20 mL degassed DCM (0.002 M) the 2nd generation Gruubs catalyst 
(0.002 g, 0.005 mmol, 10 mol %) was added and the mixture was refluxed until the 
starting material was totally consumed (monitored by TLC). The solvent was evaporated 
under reduced pressure and the crude product was purified by silica gel chromatography 
(cyclohexane/ethyl acetate 9.8:0.2) to furnish 14 mg of the product (60% yield). 
1H NMR (400 MHz, CDCl3): δ = 7.60-7.51 (m, 1H), 6.25-6.20 (t, J = 11.0 Hz, 1H), 
5.92-5.88 (d, JHa-Hb = 15.8 Hz, 1H), 5.08-5.03 (m, 1H), 4.47-4.42 (m, 1H), 4.31-4.27 (m, 
1H), 3.75-3.72 (m, 3H), 3.37-3.11 (m, 2H), 1.70-1.67 (dd, J = 1.2 Hz, 7.9 Hz, 3H), 1.64-
1.62 (dd, J = 1.2 Hz, 9.7 Hz, 3H), 1.30-1.25 (m, 8H), 0.88-0.86 (m, 12H), 0.07-0.02 (m, 
6H). 
13C NMR (100 MHz, CDCl3): δ = 167.9, 142.4, 142.1, 139.3, 133.7, 128.3, 126.3, 122.8, 
119.9, 76.0, 75.6, 69.9, 69.5, 51.8, 35.8, 32.1, 26.1, 26.1, 25.9, 25.9, 25.0, 22.8, 18.6, 
18.5, 14.2, -4.2, -4.4. 
HR-MS (FAB, 70eV): m/z calculated for C24H43O4Si = 423.2931, found 423.2945 [M-
H]+.  
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Rf = 0.5 (cyclohexane/ ethyl acetate 9.8: 0.2). 
 
6.3.29 Synthesis of compound 84: 
 
O
84  
To a suspension of triphenylmethyl phosphonium bromide (0.178 g, 0.5 mmol, 1.5 equiv) 
in THF (10 mL) at 0 oC, n-butyl lithium solution (1.6 M in toluene solution, 0.33 mL, 
0.528 mmol, 1.6 equiv) was added dropwise (the color of the solution turned red). After 
stirring at 0oC for 30 minutes compound 77 (0.07 g, 0.33 mmol, dissolved in THF) was 
added dropwise and stirring was continued at 0 oC for 30 mintutes. The reaction was 
quenched with 10 mL of 1M HCl solution and diluted with 30 mL of diethyl ether. The 
aqueous layer was extracted with diethyl ether (2 x 20 mL) and the combined organic 
layers were washed with water (2 x 10 mL) and brine (2 x 10 mL), dried over Na2SO4, 
filtered and concentrated under reduced pressure and the crude product was treated with 
Grubbs catalysts in ring-closing metathesis reaction conditions. The product was purified 
by silica get chromatography (cyclohexane/ ethyl acetate 9.8:0.2) to furnish 32 mg of the 
product (62% yield). 
1H NMR (400 MHz, CDCl3): δ = 5.29-5.30 (m, 1H), 1.93-1.99 (m, 3H), 1.51-1.60 (m, 
2H), 1.29-1.43 (m, 8H), 0.90-0.86 (t, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 130.1, 126.5, 86.4, 76.9, 75.1, 36.2, 32.2, 25.2, 22.8, 
14.2 
HR-MS (FAB, 70eV): m/z calculated for C10H18O = 154. 1358, found 155. 1391 
[M+H]+. 
Rf = 0.5 (cyclohexane/ ethyl acetate 9.8: 0.2). 
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Solution Phase Synthesis of an Oxepane Library 
using Solid-Supported Reagents 
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1. Introduction: 
As Douglas Adams famously said “Space is big. You just won’t believe how vastly, 
hugely, mind-bogglingly big it is”.1 The same statement is true for the “Chemical Space” 
also. The total number of possible small organic molecules that populates “Chemical 
Space” has been estimated to exceed 1060, which is so vast that so far only a very little 
part has been explored.2 The investigations have been greatly influenced by our 
understanding of biology and directed to the development of many life saving drugs 
nowadays. Not surprisingly the number of chemical compounds used by biological 
systems is smaller than the total possible number of small organic molecules. So in terms 
of numbers of compounds in “biologically relevant chemical space” is a small fraction of 
the complete “chemical space”.3 The mapping of biologically active space using small 
molecules is akin to map the stars in the real space. To search effectively new chemical 
tools to understand biology we need to navigate the “biologically relevant chemical 
space”. Exploring the “biologically relevant chemical space” using small organic 
molecules is an ever-growing strategy nowadays.  
To understand a biological system, we need to perturb it, which is being persuaded in 
“Chemical Genetics” studies and is used to illuminate the molecular mechanisms 
underlying biological processes. Small molecules can alter the functions of proteins by 
binding to them and inhibiting or activating their normal functions. The use of small 
molecules is complementary to gene-based methods to disrupt the protein function. For 
example in the case of deletion mutation all the functions of a protein are lost. Similarly it 
is also possible to find small molecules which can modify the functions of the protein.4 
Small molecules are extensively used both in the “Forward Chemical Genetics” and 
“Reverse Chemical Genetics” which are in direct analogy to “Classical Genetics”. In 
forward chemical genetics, large collections of structurally unbiased compounds are 
screened in whole organisms or cells for those that induce specific phenotypic outcomes. 
However the target identification is an ultimate goal of the forward chemical genetics 
approach. But the reverse chemical genetics approach requires a known protein target, 
which is subjected to binding or functional assays to identify a small molecule partner 
(Fig.1).5 The completion of the Human Genome Project has outlined the map for further 
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exploration towards providing a complete understanding of cellular processes at the 
molecular level and reveal the gene function, i.e., the examination of proteins that are 
encoded within. As an increasing demand of combinatorial chemistry, the chemical 
library approach can be extended to investigate the whole genome/proteome with small 
molecules. Combinatorial chemistry has become the method of choice to undertake this 
herculean task. 
 
 
 
Figure 1. Forward and reverse chemical genetics approach. 
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Natural products have inspired chemists for the last 100 years by their rich structural 
diversity and complexity as well as their therapeutic applications. Natural products are 
viable, biologically validated starting points for combinatorial library design. Such 
natural product inspired libraries should permit hit or lead compounds to be found with 
enhanced probability and quantity which would be determined by their “diversity” and 
“drug likeness” if these libraries are included in high-throughput screening.6 
The emergent enhancement in the number of new drug targets arising from genomics and 
proteomics has steered the synthetic chemist into the need for new methods to rapidly 
assemble pure small molecules (Mr ~250-800) that possess an increasing level of 
structural complexity. Such demands have compelled the development of new techniques 
such as solid-supported reagents. The use of solid-supported reagents and scavengers in 
multistep chemical synthesis has become an important tool for synthesizing complex 
target molecules rapidly. Recently the use of solid-supported reagents and scavengers in 
solution phase chemistry has been developed to meet the demand for diverse compound 
libraries to be tested in biological assays.7  
 
2. Background: 
2.1 Polymer-supported solution phase organic synthesis: 
2.1.1 Introduction: 
In solution phase organic synthesis, purification and isolation of individual compounds 
from unwanted byproducts are important determinats of the overall effectiveness and 
efficiency of a synthesis. After all no reaction is useful if it proceeds quantitatively in the 
flask, but affords the desired product in mediocre yield following chromatographic 
isolation. To meet the mounting demand of synthesizing highly pure small molecules 
with greater level of structural complexity for genomics and proteomics studies, the 
development of novel techniques is needed. One such technology is the use of polymer-
supported reagents used in solution phase organic synthesis. The use of polymer-
supported reagents has been demonstrated to be viable to improve efficiency in 
production of compound collections. This new development is not only important in 
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target oriented synthesis but also very much applied in the field of combinatorial 
chemistry and parallel synthesis. 
  
2.1.2 Solid-supported reagents: 
Immobilization means tethering the reagents to an insoluble polymeric resin, usually 
functionalized divinylbenzene cross-linked polystyrene, although many other polymer 
cores and support materials such as glass beads, silica, cellulose, zeolites and graphite 
have also been used. In all the cases the reagent is completely insoluble, but the bound 
reactive species remains freely accessible within the support matrix to both the solvent 
and to the dissolved reactants. So the reagent can be used in excess to force reaction to 
completion, leading to clean reaction with the isolation of the desired product only by 
simple filtration of the resin and solvent evaporation. 
Supported scavengers can selectively quench or sequester the byproducts of the reaction 
or remove excess or unreacted starting material and can be removed by filtration. The use 
of insoluble polymers and other solid-supported agents to scavenge the byproducts and 
excess starting materials from complex reaction mixtures without the need of liquid-
liquid extractions or the non specific column chromatography is a significant strategy. 
The working principle of the solid-supported reagents and scavengers is shown in 
Scheme 2.1.7 
 
Reagent
+
(excess)
solution phase
+
(excess)
Scavenger
Scavenged
Clean product
Solid-phase bead Reactants
 
 
Scheme 2.1. Basic concept of solid-supported reagents and scavengers. 
 
Using solid-supported reagents and scavengers has advantages over both conventional 
solution phase reactions and substrate-immobilized solid-phase synthesis. The advantages 
over conventional solution phase synthesis are (i) excess reagents can be used to drive the 
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reaction to completion without causing the problem with laborious work up process, (ii) 
toxic, noxious and hazardous reagents and their byproducts can be immobilized and 
thereby removed from the reaction mixture, (iii) automated synthesis can be adopted and 
(iv) allows the simultaneous use of multiple reagents that would otherwise be 
incompatible, for example, oxidizing and reducing reagents. On the other hand, the  
convenience over the substrate-immobilized solid-phase synthesis are (i) as the chemistry 
is carried out in solution, standard analytical techniques for example thin-layer 
chromatography (TLC), gas chromatography-mass spectrometry (GC-MS) can be applied 
to monitor the reactions, allowing rapid optimization, (ii) convergent syntheses are 
possible. Equally problematic, in the conventional solid-phase strategy, is the absence of 
a selective method to cleave the final product from the resin at the end of the sequence; 
any partially or improperly reacted intermediate will be released into the solution at the 
same time as the desired compound.  
Using solid-supported reagents and scavengers has improved the safety profile of the 
hazardous reactions. This approach is advantageous for the elimination of the volatile 
obnoxious sulfur components from Swern oxidation reaction (1 and 2)8 and for the 
preparation of the solid supported version of Lawesson’s reagent 3 (Scheme 2.2).9 
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Scheme 2.2. Solid supported reagents to remove obnoxious byproducts. 
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One of the most important achievements of the solid supported reagent approach over the 
conventional solid phase synthesis is the ease with which the intermediates and reactions 
can be monitored. The optimization in traditional solid phase synthesis is lengthy and can 
be minimized by the chemistry carried out in solution, thereby allowing standard 
analytical techniques to be applied e.g. NMR, GC-MS, LC-MS, TLC and HPLC.  
This solid-supported reagents and scavengers can be used not only in single step 
transformations but also iterative multistep synthesis, convergent or various split and 
recombination strategy (Scheme 2.3),7 which is also another breakthrough over 
traditional solid phase chemistry. Furthermore, as these reagent systems are anchored on 
a solid support; they also allow the simultaneous use of multiple reagents to achieve one 
pot transformations where, because of incompatibility of the reagents, no solution phase 
equivalent exists.  
 
Reagent
+
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a. Linear routes
b. Convergent routes
Reagent
+
+
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+
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+
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Reagent
Reactants
 
 
Scheme 2.3. Applicability of solid supported reagents in synthesis. 
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2.1.3 Solid-supported scavengers: 
Supported scavengers are also known as ‘sequestering agents’ or ‘quenching agents’. 
Two different types of scavengers are commonly used: (i) Those that form ionic 
interactions like acidic or basic resins, termed as ion exchange resins and (ii) those that 
form covalent bonds like electrophilic and nucleophilic species (Scheme 2.4).10 
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Scheme 2.4. Some examples of polymeric scavenger systems. 
 
One complementary approach in scavenging techniques is the “catch-and-release” 
technique. The idea behind the “catch-and-release” approach is to use a suitably 
functionalized solid-support to selectively capture the required product away from any 
contaminating impurities, filter and then release it (catch-and-release) in a pure form 
(scheme 2.5).10 
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Scheme 2.5. Catch and release technique using solid supported reagents. 
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Another attractive variant of this approach is to use a hydrophobic adsorption technique 
for the purification of the intermediates and products. An example of this system is 
shown in Scheme 2.6.11 Attachment of the ‘tag’ to the amino terminus of the resin bound 
peptide, followed by cleavage from the solid phase gives the species with several 
impurities. Treatment with porous graphitized carbon (PGC), which absorbs large 
aromatic moieties with high affinity, allows the washing of the immobilized material and 
thus removes the impurities. Base catalyzed cleavage of the ‘tag’ followed by elution 
provides purified peptide. 
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Scheme 2.6. Affinity binding purification of polypeptides and proteins. 
 
2.1.4 Synthesis of small molecules using solid-supported 
reagents and scavengers:  
As the need of biologically relevant small molecules is increasing for chemical genetics 
and genomics studies, we need to generate small molecule libraries efficiently and rapidly 
for the high throughput screening. 
Using solid-supported reagents and scavengers it is possible by simple chemical 
manipulations to generate cleanly a wide array of structurally complex molecules from 
readily available starting materials (scheme 2.7).12 Using this technique not only diversity 
oriented synthesis can be done. But this approach can be used successfully in the solution 
phase combinatorial library synthesis of the natural product inspired small molecules. 
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Scheme 2.7. Diversity generation from a common intermediate. 
 
2.1.5 Solid-supported reagents and scavengers in total 
synthesis: 
Not only in the synthesis of small molecule libraries, the solid supported reagents and 
scavengers have also been used for the total synthesis of natural products. One of the 
main advantages of using solid-supported reagents and scavengers over traditional solid 
phase synthesis is that both linear and convergent syntheses strategies can be used. Ley 
and co-workers have demonstrated this usefulness brilliantly in the total synthesis of the 
amaryllidaceae alkaloid (+)-plicamine (4) and the anti tumor natural products epothilone 
A and C (5) using solid-supported reagents and scavengers.  
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2.1.5.1 Total synthesis of (+)-plicamine: 
Total synthesis of highly complex alkaloid (+)-plicamine (4) using solid supported 
reagents and scavengers is the elegant example where Ley and co-workers demonstrated 
the strength of this unique technique (Scheme 2.8).13 
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Scheme 2.8. Total synthesis of (+)-plicamine using solid supported reagents and scavengers. 
 
2.1.5.2 Convergent total synthesis of epothilone C: 
The epothilone natural products exhibit extraordinary cytotoxicity by promoting GTP-
independent tubulin polymerization. Mechanistic investigation revealed that the 
epothilones mode of action inhibits the growth of tumors by inducing mitotic arrest 
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followed by cell apoptosis. The Ley group employed immobilized reagents and 
scavengers to synthesize epothilone C (5), in a convergent synthesis, avoiding frequent 
use of conventional work up and purification procedures.14 The synthesis of the 
fragments and the tethering of the fragments in the total synthesis are shown below 
(Schemes 2.9 and 2.10). 
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Scheme 2.9. Fragment synthesis in total synthesis of epothilone C. 
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Scheme 2.10. Total synthesis of epothilone C using solid supported reagents and scavengers. 
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3. Aim of the project: 
Nature is very much efficient in synthesizing different natural products containing seven 
membered cyclic ethers, so called oxepane scaffold (Figure 3). This oxepane containing 
natural products are isolated from different components of nature e.g. from plant leafs, 
from deep sea sponges, corals and marine natural sources. Those oxepane containing 
natural products have vast array of biological activity e.g. allelopathic and phytotoxic 
activity which are significant for the plant biology and plant physiology, antifertility 
activity which can be used as a contraceptive, cytotoxic activity which can be used for the 
treatment against human cancer cells as an anti tumor agent as well as protein synthesis 
inhibitors. 
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Figure 3. Natural products containing oxepane scaffold having broad range of bioactivity. 
 
 
 84
Hence those biologically active oxepane containing natural products can be regarded as 
chemical entities that were evolutionary selected and validated for binding to particular 
protein domain. As they are already biologically validated, the underlying structural 
architechture of such natural products may provide powerfull guiding principles for 
oxepane based library development.  
In one hand the main aim of this project is to develop a competent synthetic strategy to 
produce oxepane library. As the library generation needs to be efficient and realistic, a 
solution phase combinatorial strategy was intended to develop where different building 
blocks can be used in parallel to generate a large number of compounds. After developing 
a solution phase parallel synthetic approach, it is particularly important to mould this 
synthetic plan in useful and rapid technique. For this reason, on the other hand, the aim of 
this project is the extensive and convenient use of solid-supported reagents and 
scavengers in the solution phase parallel synthetic strategy. At the end a one pot synthetic 
strategy has been endeavored to develop using solid-supported reagents and scavengers 
without any purification steps in between to generate an oxepane library in a convenient 
and practical way. Finally the synthesized oxepane library is destined to the high-
throughput screening in both forward and reverse chemical genomics studies for their 
biological validations.     
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4. Results and discussions: 
The focused oxepane scaffold was synthesized by ring closing enyne metathesis as one of 
the key steps. The starting point of the oxepane library synthesis was different 
commercially available substituted propargyl alcohol building blocks.  
 
4.1 Retrosynthetic analysis: 
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Scheme 4.1. Retrosynthetic analysis of focused oxepane scaffold 6. 
 
The oxepane diene core 6 can be retrosynthetically disconnected by the ring-closing 
enyne metathesis reaction which is the key transformation to generate the oxepane moiety 
from the open chain ene-yne precursor 7 (Scheme 4.1). The ene-yne precursor 7 contains 
a homoallyl alcohol moiety. The precursor 7 can be prepared in diastereomerically pure 
form by the asymmetric Brown allylation from the aldehyde precursor 8 which can be 
prepared from the corresponding ethyl ester 9 by controlled reduction. The ethyl ester 9 
can be easily envisioned to be prepared by the coupling of two building blocks: 
substituted α-bromo ethyl acetate 10 and substituted propargyl alcohol 11. This is the 
starting point of the forward synthetic strategy. 
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4.2 Diversification of the oxepane core: 
After synthesizing the oxepane core, further diversification can be achieved on the 
oxepane core 6 (Scheme 4.2). The alcohol group in 6 can be derivatized and the diene 
moiety can be diversified using the Diels-Alder reaction to generate library 12. The 
alcohol in 6 can be oxidized to the ketone and after Diels-Alder reaction the library 13 
can be obtained. The functionalization of ketone in 13 can give rise to the library 14. The 
diene moiety in 6 can be derivatized using cross metathesis and the free alcohol can be 
derivatized to synthesize the library 15. 
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Scheme 4.2. Diversification of oxepane core 6. 
 
4.3 Synthesis of the substituted propargyl alcohol 18: 
The substituted propargyl alcohol 18 was prepared in enantiomerically pure form from 
the commercially available racemic alcohol 16 by means of a oxidation-reduction 
protocol. First the racemic alcohol 16 was oxidized with pyridinium chlorochromate 
(PCC) in DCM to obtain the ketone 17. The black residue resulted from the chromium 
metal from PCC was filtered through a Celite pad and washed thoroughly with DCM to 
afford the ketone 17 in 98% GC purity. This low molecular weight ketone 17 is volatile. 
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So the care was taken while evaporating the solvent. The ketone 17 was then treated 
further without any chromatographic purification. Then the ketone 17 was reduced 
enantioselectively by using borane-dimethyl sulphide (BMS) complex in the presence of 
(+)-(R)-methyl oxazaborolidine catalyst (CBS catalyst) in THF at -30 oC to -10 oC to 
afford the alcohol 18 in 60% overall yield after 2 steps in 99% enantiomeric excess (ee) 
(Scheme 4.2).15 The determined optical rotation value of 18 showed perfect matching 
with the commercially available (+)-(R)-oct-1-yne-3-ol.16 
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Scheme 4.3. Synthesis of enantiopure propargylic alcohol 18. 
 
In this reduction procedure 6.0 mol% of the CBS catalyst (Corey-Bakshi-Shibata 
catalyst) and 0.6 equiv of the BMS complex were used. It was noted that using more than 
1.0 equiv of the BMS complex lead to the reduction of the alkyne to alkene and a 1:1 
mixture (determined by GC-MS spectroscopy) of unwanted over reduced allyl alcohol 
formed along with compound 18. All possible attempts to purify compound 18 from the 
unwanted over reduced product were in vain. So it is prudent to use 0.6 equiv of BMS 
complex for this reduction.  
 
4.4 Synthesis of the substituted α-chloro ethyl acetate: 
After preparing the substituted propargyl alcohol building block 18 in enantiomerically 
pure form, the synthesis of the second building block α-halo ethyl acetate in 
enantiomerically pure form was endeavored from both antipode of alanine. The amino 
acids 19 and ent-19 were diazotized with sodium nitrite and 48% hydrobromic acid to 
obtain the corresponding bromopropionic acid 20 and ent-20 respectively in quantitative 
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yield and 98% GC purity. The next step was carried out without any chromatographic 
purification. Both 20 and ent-20 were esterified with ethanol in presence of catalytic 
amount of DOWEX® 50X8-200 acid resin to furnish the desired ethyl ester of α-bromo 
propionic acid 21 and ent-21 in 80% and 78% yield respectively (Scheme 4.4).17 
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Scheme 4.4. Synthesis of enantiomerically pure 21 and ent-21. 
 
4.5 Coupling of building blocks: 
The coupling of the two building blocks was achieved using sodium hydride in THF. 
When the substituted propargyl alcohol 18 was treated with 95% sodium hydride at 0 oC 
and coupled with α-bromoethyl acetate 22, the coupled product 23 was formed in 70% 
isolated yield (Scheme 4.5).18 
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Scheme 4.5. Synthesis of coupling product 23. 
 
Keeping in mind that this coupling reaction needs to be done to generate a library of 
oxepanes, many other bases (Table 4.1) were employed which has solid supported 
analogues. None of them was successful. In all the cases only the starting material 18 was 
recovered without any trace of product 23 detected. It appeared that triethyl amine (Entry 
1), pyridine (Entry 3), imidazole (Entry 4) and polymer supported pyridine (Entry 6) are 
not enough basic to deprotonate the alcohol 18. When stronger base DBU (Entry 2) and 
its polymer supported analogue TBD-methyl polystyrene (Entry 6) were used as base, no 
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trace of product was detected. In these last two cases, the bases are stronger but they are 
sterically hindered, hence can not deprotonate the secondary alcohol 18. It materialized 
that sodium hydride is the best choice for this reaction because it is enough basic and 
sterically least hindered to deprotonate the secondary alcohol 18. Hence it was used 
further for the library generation. 
 
Table 4.1. Base used for the coupling reaction. 
 
Entry Base Product 
1 Et3N (2 equiv) Starting material recovered 
2 N
N  
1,8-Diazabicyclo[5.4.0]undec-7-en 
(DBU, 2 equiv) 
Starting material recovered 
3 Pyridine (2 equiv) Starting material recovered 
4 Imidazole (2 equiv) Starting material recovered 
5 N
N
N
 
TBD-methyl polystyrene 
(3 equiv) 
Starting material recovered 
6 
N
 
(3 equiv) 
Starting material recovered 
 
4.6 Construction of the oxepane core by ring-closing 
enyne metathesis: 
Having the coupled product in hand the ester functionality in 23 was reduced to the 
aldehyde 24 directly using diisobutylaluminiumhydride (DIBAL-H) in diethyl ether in 
75% yield. The reaction was carried out by slow addition of DIBAL-H (1M solution in 
hexane or toluene) in diethyl ether solution of 23 at -78 oC temperature. It was interesting 
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to observe that, if the reaction was carried out using DIBAL-H (1M solution in DCM or 
THF) in any other solvent system like DCM or THF even at -78 oC, a mixture of the 
aldehyde 24 and unexpected over reduced alcohol was formed. So the perfect system for 
the controlled reduction of ester to aldehyde was optimized using DIBAL-H in hexane or 
toluene and the reaction must be carried out in diethyl ether solution. The aldehyde 24 
was allylated using allylmagnesiumchloride in THF to obtain homoallyl alcohol 25 as the 
1:1 inseparable mixture of two diastereomers in 80% yield. The diastereomeric ratio was 
determined by 1H NMR spectroscopy. When the ring-closing metathesis precursor 25 
was treated with commercially available Grubbs 1st generation ruthenium carbene 
complex 26 (20 mol%) or 2nd generation N-heterocyclic carbene complex 27 (10 mol%) 
in refluxing DCM, the expected seven-membered oxepane diene 28 was formed as the 
1:1 inseparable mixture of two diastereomers in 65% and 70% yield respectively 
(Scheme 4.6).19 In this case also the diastereomeric ratio was determined by 1H NMR 
spectroscopy. 
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Scheme 4.6. Synthesis of the oxepane 28 by ring-closing enyne metathesis. 
 
It was noteworthy that slightly better yield was obtained using the 2nd generation Grubbs 
catalyst 27 than the 1st generation Grubbs catalyst 26 (70% vs 65%). Also a less catalyst 
loading was needed for 27 than 26 (10 mol% vs 20 mol%). Despite the lower yield and 
higher catalyst loading, the 1st generation Grubbs catalyst 26 was chosen as the viable 
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catalyst for library generation because of its lower cost than the 2nd generation Grubbs 
catalyst 27. 
 
4.7 Asymmetric Brown allylation: 
As the decisive enyne ring-closing metathesis reaction smoothly offered the oxepane 
scaffold, the focus was then turned toward the diastereoselective synthesis of the oxepane 
system. The diastereo-pure oxepane can be obtained by the asymmetric allylation of the 
aldehyde 24 to get diastereomerically enriched homoallyl alcohol 29 or 30. To synthesize 
diastereomerically pure enyne precursor for the metathesis reaction, Brown’s asymmetric 
allylation reaction was chosen. Aldehyde 24 was treated with either (+) or (-)-
diisopinocamphenylallylborane prepared in situ by (+) or (-)-diisopinocamphenylboron 
chloride (DIPCl) and allylmagnesiumchloride, in THF to afford homoallyl alcohol 29 and 
30 in 76% and 70% yield respectively after hydrolysis of the intermediate alkoxy borane 
using sodium hydroxide and 30% hydrogen peroxide (Scheme 4.7).20  
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Scheme 4.7. Asymmetric Brown allylation of aldehyde 24. 
 
In case of the (+)-DIPCl the diastereomeric ratio was found to be 8:1 in favor of the 
desired isomer. But in case of the (-)-DIPCl the diastereomeric ratio was 2.5:1 in favor of 
the desired isomer. The diastereomeric ratio was determined by 1H NMR spectroscopy. 
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From the diastereomeric ratio it is clear that the chiral allyl borane formed from (+)-
DIPCl is “matched” case for the aldehyde 24. On the other hand the chiral allyl borane 
reagent formed from (-)-DIPCl is “mismatched” case. This asymmetric allylation reaction 
of aldehyde proceeds through a chair like transition state where the larger group on 
aldehyde occupies an equatorial position and the aldehyde facial selectivity is determined 
by minimization of steric interaction between the axial “Ipc” ligand and the allyl group. 
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Figure 4.1a. Chair like transition state of the (+)-Ipc2B-allyl addition to the aldehyde 24. 
 
When aldehyde 24 was treated with (+)-DIPCl and allylmagnesiumchloride the reaction 
could proceed through two possible chair like transitions states (TS) 29a and 30a (Figure 
4.1a). In TS 30a, the axial bulky “Ipc” group is experiencing a steric interaction with the 
allyl group on “B” atom which makes this TS less favoured. On the other hand in the 
more favourable TS 29a, the axial bulky “Ipc” ligand is totally on the other side of the 
allyl group on “B” atom and not experiencing any steric hindrance with any other bulky 
group. So the reaction proceeded through the more favourable transition state 29a. This 
transition state model explains the stereoselectivity of the major product 29. 
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Figure 4.1b. Chair like transition state of the (-)-Ipc2B-allyl addition to the aldehyde 24. 
 
Similarly when aldehyde 24 was tretated with (-)-DIPCl and allylmagnesiumchloride the 
reaction could proceed through the chair like transition states (TS) 29b and 30b (Figure 
4.1b). In the less favoured TS 29b the methyl group of the axial “Ipc” ligand on “B” is 
experiencing a steric interference with the allyl group because both of them are in the 
same side of the chair TS. But in the more favourable TS 30b, the methyl group on the 
axial “Ipc” ligand is projected in the opposite direction of the allyl group, hence there is 
no steric hindrance beween them. So obviously the reaction proceeds through the more 
favourable TS 30b. The chair like transition state model explains the stereoselectivity of 
the major product 30. 
After the Brown’s asymmetric allylation of aldehyde 24, further reactions were carried 
out without any separation of the diastereomers. When both enyne 29 (8:1 diastereomeric 
mixture) and 30 (2.5:1 diastereomeric mixture) were treated separately with 20 mol% of 
the 1st generation Grubbs catalyst 26 in refluxing DCM, the oxepane 31 and 32 were 
obtained as 8:1 and 2.5:1 inseparable diastereomeric mixture respectively (determined by 
1H NMR spectroscopy) in 60% yield (Scheme 4.8). As the main aim of this project is to 
develop a synthetic strategy which can be mould into a one pot protocol, the next steps 
were carried out without any separation of the diastereomers. 
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Scheme 4.8. Enyne metathesis of 29 and 30 to afford 31 and 32. 
 
4.8 Attempted coupling of alcohol and carboxylic 
acids:21 
At this point the oxepane scaffold is ready for diversification. First the alcohol 31 (8:1 
inseparable mixture of two diastereomers) was attempted to functionalize into ester 34 
using different acids 33 (Scheme 4.9). 
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Scheme 4.9. Attempted synthesis of esters 34 by coupling of alcohol and carboxylic acids. 
 
Alcohol 31 was treated with the carboxylic acid 33 in presence of dicyclohexyl-
carbodiimide (DCC) or its solid supported analogue, N-cyclohexyl-carbodiimide, N´-
methyl polystyrene, dimethyl amino pyridine (DMAP) as catalyst, in DCM at room 
temperature. But in none of the cases ester 34 was observed and the unreacted starting 
material was recovered in all the cases (Scheme 4.9). 
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4.9 Synthesis of ester and carbamate:22 
From the above coupling attempts it was evident that the carboxylic acids were not the 
best coupling partner with the alcohol 31. Also the alcohol 31 is a secondary alcohol 
which is hence less reactive. So a more reactive coupling partner was necessary to 
esterify the alcohol in 31. Acid chlorides were chosen for this purpose. The alcohol in 31 
was also derivatized to carbamates using isocyanates as the other coupling partner 
(Scheme 4.10). 
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(d.r. = 8:1)
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Scheme 4.10. Synthesis of ester 37 and carbamates 38 and 39. 
 
When alcohol 31 (8:1 inseparable mixture of two diastereomers) was treated with 3,4-
dichloro benzoyl chloride 35 or isocyanate 36 (either 4-chlorophenyl isocyanate or 
phenyl isocyanate) in the presence of pyridine as base, ester 38, carbamate 39 and 40 
were formed in 57%, 65% and 40% yield respectively. The ester 38 and carbamates 39 
and 40 were formed as 8:1 inseparable mixture of two diastereomers (diastereomeric ratio 
was determined by 1H NMR spectroscopy), which showed that the diastereomeric ratio of 
the starting material was relayed to the products. Further reaction was carried out without 
any separation of the diastereomers. To avoid the workup procedure, this coupling 
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reactions were carried out in presence of poly(4-vinylpyridine) 37 (25% cross-linked) in 
THF at room temperature for 20h. But all the attemps were unsuccessfull and in all the 
cases starting alcohol 31 was recovered. It was materialized that the polymer supported 
pyridine is not suitable for this coupling reactions.  
 
4.10 Diels-Alder reaction: 
The conjugated diene of the oxepane scaffold was then diversified by Diels-Alder 
reaction. Ester 38 (8:1 inseparable mixture of two diastereomers) was treated with the 
electron-poor dienophile p-benzoquinone in toluene at 70 oC to obtain the Diels-Alder 
adduct which was aromatized under the reaction condition to afford 41 as the single 
diastereoisomer isolated by silica gel flash chromatography in 60% yield (Scheme 
4.11).23, 19a-c 
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Scheme 4.11. Diels-Alder reaction with 41. 
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4.11 Use of polymer-sulfonic acid scavengers in the 
Brown allylation: 
After achieving the fully functionalized oxepane in solution phase, the next task ahead 
was to reduce the extensive workup and purifications to produce the oxepane library in a 
fast and efficient way. In this context the effectiveness of the solid supported reagents and 
scavengers was taken into account. In the whole strategy, the first reaction where the 
solid supported scavenger was used was the Brown allylation.  
The aldehyde 24 was treated with both (+) - and (-) -DIPCl and allylmagnesiumchloride 
separately in THF. After 4h, when the reactions were complete (determined by TLC), 
DOWEX® 50WX8-200-ion exchange resin14b (8% cross linking, 200-400 mesh) was 
used to scavenge the excess allylmagnesium chloride. Then the resin was filtered to 
obtain the homoallyl alcohol 29 and 30 respectively in the same diastereomeric ratio 
obtained before (Scheme 4.12). The diastereomeric ratio was determined by 1H NMR 
spectroscopy of the crude products. The excess allylmagnesiumchloride can also be 
scavenged by polymer supported sulfonic acid resin 42 (macroporous copoly[styrene-
DBV], 70-90 mesh, loading = 3.20 mmol/g) using same method. 
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Scheme 4.12. Use of polymer-supported scavengers in the Brown allylation. 
 
Both DOWEX® 50WX8-200 and 42 were effectively well to scavenge the excess 
Grignard reagent, but the commercially available DOWEX® 50WX8-200 resin contains 
some unwanted impurities which could come to the reaction mixture. So using DOWEX® 
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50WX8-200 as the scavenger the product obtained after evaporation of the solvent 
contains impurities from the resin which can not be removed without chromatography. 
But on the other hand commercially available sulfonic acid resin 42 does not contain 
impurities which can create problem in the later stage of the synthesis and the product 
obtained after filtration of the resin and evaporation of the solvent devoid of any 
impurities from the scavenging resin. The scavenging resin 42 was chosen for the further 
library generation. 
 
4.12 Scavenging Ru-metal from the RCM reaction: 
One of the serious experimental drawbacks of using Grubbs Ru-carbene complex in ring-
closing metathesis reactions is the removal of the dark-colored, metal containing by-
products upon completion of the reaction, since it might effect unwanted synthetic 
reactions and result in misleading biological screening results. Several research groups 
have developed different tehniques to solve this problem.24 One of those strategies is to 
use polymer bound olefin metathesis catalysts which can be removed very easily from the 
reaction mixture by filtration. Hence, when enyne 29 (used from the previous reaction 
without any further purification) was treated with the commercially available solid 
supported 1st generation Grubbs catalyst 43 (2 x 40 mol%) developed by Barrett,25 the 
ring-closed product 31 was obtained (Scheme 4.13).  
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Scheme 4.13. Solid supported 1st generation Grubbs catalyst 43 used for enyne metathesis. 
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After filtration of the resin from the reaction mixture, a clear, colorless, crude reaction 
mixture was obtained. The identity of the product 31 was confirmed by GC-MS and 1H 
NMR spectra of the crude sample. The oxepane 31 was formed in the same 8:1 
inseparable mixture of two diastereomers as the open chain starting alcohol 29. The 
diastereomeric ratio was also determined by 1H NMR spectroscopy.  
The main problem faced in this strategy was twofold. First, the polymer supported 1st 
generation Grubbs catalyst 43 is very costly and second, it has only low loading (0.11 
mmol/g). Hence a large catalyst loading (2 x 40 mol %) of the polymer supported 1st 
generation Grubbs catalyst 43 was needed for each set of reactions. Based on those points 
this strategy was not compatible with the synthesis of a large library. So to scavenge the 
ruthenium metal after the reaction, Breinbauer’s26 method was adopted. 
 
NH2 H H
O PH
+ + N
P
P
Toluene, 105 oC
16 h
44
 
 
Scheme 4.14. Synthesis of the polymer bound phosphine ligand 49. 
 
This strategy is inexpensive and efficient. In this technique, the resin bound phosphine 44 
was used as a readily accessible P-ligand to chelate the ruthenium metal from the reaction 
mixture. The resin bound phosphine 44 was synthesized by heating the commercially 
available amino methylated polystyrene (loading = 1.1 mmol/g), with paraformaldehyde 
and diphenyl phosphine in toluene at 105 oC (Scheme 4.14).27 
After the ring-closing enyne metathesis reaction was completed (monitored by TLC) with 
29 (8:1 mixture of two diastereomers) using the 1st generation Grubbs catalyst 26 (20 
mol%), the polymer bound phosphine ligand 44 (20 equiv relative to the catalyst used) 
was added and the reaction mixture was stirred for 10h at room temperature. The resin 
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was filtered through a silica gel plug. After removing the solvent, colorless product 31 
(8:1 mixture of two diastereomers) was obtained (Scheme 4.15). 
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O
O
HO
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1. 26 (20 mol%), 
DCM, reflux
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2. 44 (20 equiv), 
rt, 10h
(d.r. = 8:1) (d.r. = 8:1)  
 
Scheme 4.15. Use of the polymer bound scavenger 44 in enyne metathesis of 29. 
 
4.13 Use of scavengers in carbamate formation: 
The next aim was to use polymer bound scavenger for the carbamate formation reaction 
from the alcohol and isocyanate. In this step the commercially available aminomethylated 
polystyrene 45 was used as the scavenger for the excess isocyanate. Compound 32 (2.5:1 
mixture of two diastereomers) was treated with either 1-naphthyl isocyanate or phenyl 
isocyanate to obtain the carbamate 46 and 47 respectively in the presence of pyridine as 
base in THF (Scheme 4.16).  
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Scheme 4.16. Use of aminomethyl polystyrene 45 as scavenger of isocyanate. 
 
When the reaction was complete after 16h (monitored by TLC), 3 equiv (relative to the 
excess isocyanate used) of aminomethylated polystyrene 45 (loading = 3.0 mmol/g) was 
added and the reaction mixture was stirred for 4 h at room temperature. After filtration 
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and evaporation of solvent, carbamate 46 and 47 were obtained as 2.5:1 inseparable 
mixture of two diastereomers. The identity and the diastereomeric ratio of the products 
formed were determined by GC-MS and the 1H NMR spectra. These crude products were 
used for the next Diels-Alder reaction without further purification. 
 
4.14 Diels-Alder reaction with N-phenylmaleimide: 
The crude carbamates 46 and 47 (2.5:1 mixture of two diastereomers) were then heated 
with N-phenyl maleimide as the dienophile in the Diels-Alder reaction in toluene at 70 oC 
to obtain the tricyclic Diels-Alder adduct 48 and 49 in 56% and 60% overall yield 
respectively after 2 steps (Scheme 4.17). The pure products were obtained by silica gel 
flash chromatography as single diastereomer (determined by 1H NMR spectroscopy).  
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Scheme 4.17. Diels-Alder reaction to synthesize 48 and 49. 
 
4.15 Development of a one pot synthetic strategy: 
At this stage the path was laid down to generate an oxepane library in solution using solid 
supported reagents and scavengers. The library generation will be practical and quick 
only if it is performed without any purification of the intermediates. In other words the 
synthetic strategy must dwell on the use of solid supported reagents and scavengers and 
all the reactions must be accomplished in one pot. 
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Keeping those two points in mind, one pot synthesis was commenced from the DIBAL-H 
reduction of ester 23 to aldehyde 24 (Scheme 4.18). After workup and evaporation of the 
solvent the crude aldehyde 24 (without any further purification) was treated separately 
with either (+) - or (-) - DIPCl and allylmagnesium chloride in THF to obtain both 
homoallyl alcohol 29 and 30.  
After the completion of the reaction after 4h (TLC monitoring), polymer supported 
sulfonic acid resin 42 (5 equiv relative to the excess allylmagnesium chloride) was added 
to scavenge the excess allylmagnesium chloride. The resin was filtered and after removal 
of the solvent both crude 29 and 30 was treated separately by 20 mol% 1st generation 
Grubbs catalyst 26 in refluxing DCM to obtain both oxepane 31 and 32 respectively. As 
soon as the reaction was over after 10h (TLC monitoring), the polymer supported 
chelating phosphine ligand 44 (20 equiv relative to the catalyst added) was added to 
scavenge the ruthenium metal. After filtration, the solvent was evaporated to afford 
colorless crude 31 and 32.  
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Scheme 4.18. Synthesis of oxepane 52 and 53 using solid-supported scavengers. 
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Both oxepane 31 and 32 were treated separately with different commercially available 
acid chlorides and isocyanates in the presence of pyridine as base in THF to obtain esters 
and carbamates 50 and 51 respectively. When all the starting material was consumed 
after 16h (monitored by TLC), aminomethylated polystyrene 45 (3 equiv relative to the 
excess isocyanate/ 6 equiv relative to the excess acid chlorides added) was added to 
scavenge the excess isocyanates and acid chlorides. After filtering and removal of 
solvent, crude 50 and 51 were separately treated with the electron poor dienophiles in 
toluene at 70 oC for 3h to 18h (depending on the dienophiles used). After the Diels-Alder 
reaction the crude products were purified by flash chromatography to yield pure 52 and 
53 in 16% to 60% overall yields after 5 steps.  
The fully functionalized oxepane 52 and 53 were found to be varying inseparable 
mixtures of two diastereomers (see experimental part for the diastereomeric ratio of the 
individual compounds). The diastereomeric ratio was detemined by 1H NMR 
spectroscopy.Using the above one pot synthetic strategy using solid-supported scavengers 
17 diverse fully functionalized oxepanes were synthesized in 16% to 60% overall yield 
after 5 steps. Three different electron poor dienophiles: p-benzoquinone, N-
phenylmaleimide and dimethyl acetylenedicarboxylate were used in the Diels-Alder 
reaction. The p-benzoquinone gave the hydroquinone moiety after aromatization under 
the reaction conditions. The electron donating groups (eg. 4-methyl and 4-methoxy 
groups) on the aromatic acid chlorides and isocyanates gave poor overall yield (~ 20% 
after 5 steps). On the other hand the electron withdrawing groups (eg. 4-chloro and 3,4-
dichloro groups) on the aromatic acid chlorides and isocyanates gave better overall yield 
(~ 60% after 5 steps). It was observed that the tertiary butyl isocyanate and tertiary butyl 
isothiocanate were totally unreactive in the carbamate formation condition. This result 
can be realized because of their bulky nature and the other reacting partner is secondary 
alcohol on oxepane moiety. Among the 17 oxepane compounds 12 were found to be 
single diastereomers, 2 were found to be the 4:1 inseparable mixture of two diastereomers 
and the rest 3 were 8:1 inseparable mixture of two diastereomers. In all the cases the 
diastereomeric ratio was determined by 1H NMR spectroscopy. At this point it was 
assumed that the Diels-Alder reaction with the electron poor dienophiles proceeded 
exclusively through an endo-selective transition state where the dienophile is approaching 
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from the opposite phase of the bulky pentyl group near the diene moiety (Scheme 4.26). 
This assumption will be proved correct later by nOe study of a particular library member 
(Figure 4.2). 
Hence a solution phase one pot synthetic scheme was developed using extractive work up 
and polymer bound scavenging reagents excluding the purification steps in between. This 
synthetic strategy was used to generate the combinatorial oxepane library in a practical 
and efficient way in solution phase where the reactions can be monitored by thin-layer 
chromatography (TLC) and GC-MS technique. 
 
4.16 Diversification of the oxepane library: 
4.16.1 Keto-oxepane library synthesis: 
As the one pot strategy was successfully accomplished, the oxepane scaffold was further 
diversified to produce diverse molecules. When compound 28, a 1:1 mixture of two 
diastereomers was oxidized by PCC, ketone 54 was formed. The chromium metal 
containing residue was filtered from the reaction mixture by a Celite pad and after 
evaporation of the solvent, crude 54 was obtained which was further treated without any 
purification. Crude ketone 54 was treated with different dienophiles like N-phenyl 
maleimide, p-benzoquinone, maleic anhydride and dimethyl acetylenedicarboxylate 
separately in toluene at 70 oC to yield the Diels-Alder adducts 55 (25% overall yield after 
5 steps), 56 (14% overall yield after 5 steps), 57 (25% overall yield after 5 steps) and 58 
(30% overall yield after 5 steps) respectively as single diastereomers (determined by 1H 
NMR spectroscopy) after 5 steps (Scheme 4.19). N-phenylmaleimide and maleic 
anhydride reacted quickly (3h), but p-benzouinone and dimethyl acetylenedicarboxylate 
took longer time (16h and 10h respectively). As before the Diels-Alder adduct with p-
benzoquinone aromatized under the reaction condition to give rise to catechol moiety. It 
was also assumed that the Diels-Alder reaction proceeded exclusively through an endo-
selective transition state where the electron poor dienophiles approached from the 
opposite phase of the bulky pentyl group near the diene moiety.  
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Scheme 4.19. Synthesis of keto-oxepane library. 
 
4.16.2 Tandem ring-closing metathesis/cross-metathesis: 
To create a new scaffold based on the oxepane core structure, the tandem ring-closing 
metathesis/cross-metathesis (RCM/CM) reaction was chosen. When the enyne 25 (1:1 
mixture of two diastereomers) was treated with the 2nd generation Hoveyda-Grubbs 
catalyst 59 and either methyl acrylate or methyl vinyl ketone separately in refluxing 
DCM, instead of the expected products 60 and 61 respectively, the only product isolated 
in both the cases was 28 as 1:1 inseparable mixture of two diastereomers in 60% yield 
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(Scheme 4.20).28 The diastereomeric ratio was determined by GC-MS and 1H NMR 
spectroscopy.  
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Scheme 4.20. Attempted tandem ring-closing metathesis/ cross-metathesis (RCM/CM) reaction. 
 
4.16.3 Stepwise ring-closing metathesis/ cross metathesis: 
When the attempts of tandem RCM/CM were failed, stepwise RCM/CM reaction was 
endeavored as the bypass remedy. Compound 30 (2.5:1 mixture of two diastereomers) 
was treated with 1st generation Grubbs catalyst 26 (20 mol%) in refluxing DCM to obtain 
the oxepane 32 as 2.5:1 inseparable mixture of two diastereomers. As soon as all the 
starting material was consumed after 20h (monitored by TLC), the 2nd generation Grubbs 
catalyst 27 (15 mol%) and methyl acrylate were added to the reaction mixture and the 
refluxing was continued for 10h to obtain the E- cross metathesis product 62 as 2.5:1 
inseparable mixture of two diastereomers (determined by 1H NMR spectroscopy) in 65% 
overall yield29 after scavenging the ruthenium metal by the scavenging resin 44 (Scheme 
4.21). 
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Scheme 4.21. Stepwise ring-closing metathesis/ cross-metathesis to synthesize 62. 
 
The E-geometry of the newly formed olefin was determined by the higher coupling 
constant value (JHa-Hb = 16.0 Hz) between Ha and Hb in product 65 by the 1H NMR 
spectroscopy. 
The RCM/CM product 62 (2.5:1 mixture of two diastereomers) was functionalized using 
isocyanates and acid chlorides in presence of pyridine as base to obtain carbamates and 
ester 63, 64, 65 and 66 respectively in 40% to 75% yield after scavenging the excess 
isocyanates and acid chloride by the commercially available aminomethylated 
polystyrene resin 45 (Scheme 4.22).  
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Scheme 4.22. Formation of carbamate 63, 64, 65 and ester 66. 
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The carbamates and ester were obtained exclusively as single diastereomers (determined 
by 1H NMR spectroscopy) after purification by the silica gel flash chromatography. The 
cabamate 65 from 4-chlorophenyl isocyanate gave a good yield (75% after 5 steps), 
which again showed that the isocyanate having electron withdrawing group (4-Cl group) 
on the aromatic ring gives better result than the other products 63 (40% after 5 steps), 64 
(47% after 5 steps) and 66 (47% after 5 steps). The E-geometry of the starting alcohol 
remained intact in the product (JHa-Hb ~ 16.0 Hz).  
 
4.16.4 Diacid synthesis: 
Further diversification on the oxepane scaffold was accomplished after the Diels-Alder 
reaction with maleic anhydride. The diene was heated with maleic anhydride at 70 oC in 
toluene for 3h. The anhydride formed after the Diels-Alder reaction was hydrolyzed in 
situ using 20% water in THF at room temperature for 10h. After the reaction was over, 
the solvent was evaporated and the crude product was purified by silica gel 
chromatography as mixtures of two diastereomers (determined by 1H NMR spectroscopy) 
in 20% to 41% yield after 6 steps (Scheme 4.23).30  
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Scheme 4.23. Synthesis of diacids. 
 
Irrespective of the carbamates and esters, the overall yield of the diacids obtained was 
moderate. The diastereomeric ratio of the products reflected the isomeric ratio of the 
starting material. It was also assumed that the Diels-Alder reaction with maleic anhydride 
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was proceeded through an endo-selective transition state where the dienophile 
approached the diene from the opposite phase of the bulky pentyl moiety near diene. 
 
4.16.5 Two step synthesis of carbamate: 
To introduce more diversity in the oxepane library, a different two step procedure was 
adopted to synthesize the carbamates from the secondary alcohol. In this strategy the 
alcohol 32 (2.5:1 mixture of two diastereomers) was treated with 1,1/-carbonyl 
diimidazole 72 in DCM to obtain the crude product 73 in 2.5:1 diastereomeric mixture 
(Scheme 4.24). The diastereomeric ratio was determined by GC-MS of the crude product 
73. 
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Scheme 4.24. Two Step synthesis of carbamate 74. 
 
In the next step crude 73 was heated in a sealed tube at 40 oC with triethylamine as base, 
a catalytic amount of N,N-dimethyl amino pyridine (DMAP) and benzyl amine to obtain 
the carbamate 74 as the same diastereomeric ratio of the starting material in 60% yield 
after 2 steps.31 
From the above scheme it was evident that triethylamine was not enough basic to 
deprotonate the benzyl amine and the reaction required a long time (48h). Hence to 
synthesize the carbamate in two steps the stronger base potassium carbonate (K2CO3) was 
employed (Scheme 4.25). 
When compound 31 (8:1 mixture of two diastereomers) was treated with 72 in DCM, 
crude 75 was obtained as 8:1 diastereomeric mixture (ratio determined by GC-MS). Then 
compound 75 was treated with K2CO3 in THF: DMF (4:1) solvent mixture with different 
primary or secondary amines at room temperature. 
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Scheme 4.25. Two step synthesis of carbamate and diacid 77, 78 and 79 synthesis. 
 
When the reaction was complete after 6h (determined by TLC), polymer supported 
sulfonic acid resin 42 (6 equiv relative to the total amount of K2CO3 and excess amine) 
was added to scavenge the excess K2CO3 and excess amine at room temperature for 5h. 
After filtering the resin and evaporating the solvent carbamates 76 (8:1 diastereomeric 
mixture) were obtained. The ratio was determined by GC-MS. The carbamates 76 were 
then treated without any purification with maleimide in toluene at 70 oC for 3h to obain 
the Diels-Alder adducts in 16% to 24% yield after 6 steps. Two primary amines 
(piperonylamine and dodecyl amine) and one secondary amine (piperidine) were used for 
the carbamate synthesis. From the overall yield it was evident that there was no big 
difference between the reactivity and yield between them. Diels-Alder adducts were 
purified by silica gel flash chromatography as exclusively single diastereomers, which 
was determined by 1H NMR spectroscopy and nOe study. The final products 77, 78 and 
79 were obtained in 16%, 24% and 20% overall yield respectively after 6 steps. 
The endo-transition state in Diels-Alder reaction could give rise to two possible diastereo 
isomers for the product 77. The two possible endo-isomers are 77a and 77b (Figure 4.2).  
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Figure 4.2. nOe study of compound 77. 
 
The Nuclear Overhauser Effect (nOe) study of compound 77 (Table 4.2) showed that 
when H2 was irradiated in its resonance frequency the intensity of H8 was increased 
which could be possible in both 77a and 77b isomers. But when H6 was irradiated then 
only the intensity of the H4 was increased, which suggested that H6 and H4 are close in 
space which could be possible in the 77b isomer, not in the 77a isomer. Moreover when 
H4 was irradiated in its resonance frequency the intensity of both H6 and H11 were 
increased suggested that H4 is closer in space with both H6 and H11. This results show that 
the compound 77 and 77b are identical, rules out the possibility of the 77a isomer.  
 
Table 4.2. nOe irradiation and intensity of the protons. 
 
Irradiation Intensity 
H6 H4 (5.0%), H5 (3.0 %) 
H4 H6 (6.0%), H11 (3.0%), H5 (3.0%) 
H2 H8 (4.0%), H7 (2.0%) 
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From the above nOe experiment it was evident that the Brown asymmetric allylation 
proceeded with the exactly expected stereochemistry. The Diels-Alder reaction was also 
proceeded through endo- selective manner. Based on this experiment the configuration of 
the other library members have assigned by analogy. The transition state for the Diels-
Alder reaction to obtain compound 77 is predicted in the Scheme 4.26.  
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Scheme 4.26. Endo-transition state for the Diels-Alder reaction to synthesize 77. 
 
The Diels-Alder reaction with maleimide to synthesize compound 77 could proceed 
through two possible endo-transition states. When the maleimide dienophile approaches 
to the diene from the same phase of the bulky pentyl group in transition state 77B, it 
experiences a steric hindrance which destabilizes the transition state and makes it less 
fovoured. So the reaction does not proceed through this transition state leading to the 
endo-product 77a. But on the other hand, when the dienophile approaches from the 
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opposite or anti-phase of the bulky pentayl group, it does not experience any steric 
hindrance which makes the transition state 77A stable to lead to the product 77. On the 
basis of this assumption we envisaged the absolute stereochemistry of all the members of 
the oxepane library. 
 
4.17 Solution phase parallel synthesis of oxepane library 
using solid-supported reagents: 
As dercribed above a synthetic strategy to produce an oxepane library in very fast and 
efficient way in one pot using polymer bound scavenging resins has been developed 
successfully. In this strategy different building blocks were used to produce the diverse 
library members. The generalized synthetic strategy is shown in Scheme 4.27 
The synthesis was initiated with coupling of the substituted propargyl alcohol 11 and the 
substituted α-bromo ethyl acetate 10 to synthesize the ether 9. Then the ethyl ester group 
in 9 was reduced in a controlled way using diisobutylaluminiumhydride in diethyl ether at 
-78 oC to afford the aldehyde 8. After the extractive work up and evaporation of the 
solvent the crude aldehyde 8 was obtained. The crude aldehyde 8 was then allylated using 
Brown’s aymmetric allylation protocol using both (+)- and (-)-DIPCl as chiral auxiliary 
to synthesize enantio- or diastereo-pure enyne metathesis precursor 7 after scavenging the 
excess allyl Grignard reagent by polymer bound sulfonic acid resin 42. After filtering the 
resin and evaporation of the solvent crude product 7 was obtained, this was used further 
for the next reaction without any purification. The enyne ring-closing metathesis reaction 
was carried out with 1st generation Grubbs catalyst 26 (20 mol%) to afford the oxepane 
scaffold 6 after scavenging the ruthenium metal using the polymer supported resin 44. 
After filtering the resin and evaporation of the solvent, crude oxepane 6 was obtained. 
The free alcohol in crude product 6 was then diversified to afford carbamate 81 by a two 
step protocol. First a half carbamate was formed using 1,1/-carbonyl diimidazole (CDI, 
72), then in the presence of K2CO3 as base, using primary or secondary amines in parallel 
carbamate 81 was synthesized. The polymer bound sulfonic acid resin 42 was used to 
scavenge excess amines and potassium carbonate. The crude carbamate 81 was obtained 
after filtering the resin and evaporation of the solvent. Finally the diene in crude 81 was 
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diversified using different dienophiles in parallel to afford the fully functionalized 
oxepane library 83 in 15% to 50% yield after 6 steps.  
 
HO
R1 R
2
O
R1 R
2O
O
R3
O
O
Br
R3
NaH, THF, 0 oC to rt, 
10h, 70-80% O
R1 R
2
H
O
R3
DIBAL-H, Et2O, -78 oC
20 min
MgCl
(+) DIPCl or (-) DIPCl
THF, -78 oC to rt
    4h
O
R1 R
2
HO
R3O R1
R2
R3
HO
CH2Cl2, reflux, 
3h-18h
O R1
R2
R3
O
O
X
R4
R5
2. K2CO3, THF: DMF (4:1)
     R5R4NH, rt, 5h
O R1
R2
R3
O
O
N
R4
R5
Toluene, 70 oC, 3h-10h
15% to 50% after 5 or 6 steps
N
PPh2
PPh2
11
10
9 8
7
6
26
Y
O
O
Y
O
O
42
then
42
rt, 4h
44
then 44
rt, 10h
then 42, rt, 4h
80: X = -CH2-
81: X = -NH-
Ru
Ph
PCy3
PCy3
Cl
Cl
26
HH
H
1. CDI (72), CH2Cl2, 10h
R4 N C O or R4
O
Cl
Py, THF, rt, 6h
then 45, rt, 6h
45
82: X = -CH2-
83: X = -NH-
Oxepane Library 1
SO3H
NH2
 
 
Scheme 4.27. General strategy to synthesize oxepane library using solid-supported scavengers.  
 
In this strategy 53 oxepanes were synthesiszed. The final products were purified by silica 
gel column chromatography and also by preparative thin layer chromatography (PTLC). 
Some of the oxepane molecules synthesized in this one pot synthetic strategy was formed 
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as single diastereomers and some were formed as mixtures of the two diastereomers. The 
diastereomeric ratios of the individual products are shown in the experimental part. The 
diastereomeric ratios of the individual products are determined by 1H NMR spectroscopy. 
It was assumed that the products obtained by the endo-selective Diels-Alder reactions, 
which was determined by the nOe experiment and the transiton state model shown 
before. The building blocks used in this strategy is shown in Figure 4.3. When p-
benzoquinone was used as the dienophile, the products were formed as hydroquinone 
after aromatization afer the Diels-Alder reaction under the reaction conditions. When 
maleic anhydride was used as the dienophile, the anhydride formed after the Diels-Alder 
reaction was hydrolyzed by 20% water in THF to synthesize diacids. The isolated overall 
yields and the structures of the oxepane molecules synthesized in this strategy are shown 
in Table 6.1.  
The oxepane scaffold 6 was treated in parallel either with isocyanates or acid chlorides to 
generate esters 80 or carbamates 81 in one step. The excess isocyanates or acid chlorides 
were scavenged by the amimomethylated polystyrene 45. The crude ester 80 and crude 
carbamate 81 were used for the next reactions. After the Diels-Alder reaction with 
dienophiles the fully functionalized oxepanes 82 and 83 were formed in 15% to 50% 
overall yield after 5 steps. In this strategy 22 more oxepanes were synthesized. The 
overall yields and the structures are shown in Table 6.1. The diastereomeric ratios of 
individual compounds are determined by 1H NMR spectroscopy and are shown in the 
experimental part. It was also assumed that the final oxepane molecules are formed as 
endo-selective way. The acid chlorides and the isocyanates building blocks used in this 
strategy are shown in Figure 4.3. 
Further diversification was introduced in the oxepane moiety by cross-metathesis 
reaction. Cross-metathesis reaction was carried out on oxepane 6 using 2nd generation 
Grubbs catalyst 27 (15 mol%) to generate 84. The ruthenium metal was scavenged by 
polymer bound chelating ligand 44. The resin was filtered and the solvent was evaporated 
to obtain crude cross-metathesis product 84. The free alcohol in crude 84 was then 
diversified to carbamates and esters by the same protocol used before to afford the 
oxepanes 85 and 86 (Scheme 4.28). The free alcohol in compound 84 was also 
derivatized to carbamate 86 using the previously mensioned two step protocol using CDI 
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(72) in the first step and then treating the half carbamate with K2CO3 as a base and 
primary and secondary amines as the coupling partners. The overall yield in this two step 
protocol was the same as the single step carbamate formation. The products were isolated 
by silica gel column chromatography. Using this stategies 12 more oxepanes were 
synthesized. All the products were formed in moderate to good yields (30% to 50%) after 
5 steps. All the compounds formed with E-selectivity after cross-metathesis and the same 
geometry was found in the final products. The E-geometry in the final products was 
confirmed by the higher coupling constant value (JHa-Hb ~ 16.0 Hz) between Ha and Hb 
protons by 1H NMR spectroscopy. The final oxepanes 85 and 86 were formed as single 
isomers as well as mixture of two diastereomers. The diastereomeric ratios are 
determined by 1H NMR spectroscopy and are showed in the experimental part for 
individual compounds. The oxepanes were purified by silica gel column chromatography. 
The overall isolated yields and the structures of the individual compounds are shown in 
Table 6.3. The acid chlorides and isocyanates building blocks used in this strategy are 
shown in Figure 4.3. 
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Scheme 4.28. Synthesis of oxepanes 85 and 86 from 6. 
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A keto oxepane library 91 was synthesized in a one pot synthetic strategy and from 
library 91 a small collection of O-substituted oximes 92 was synthesized by O-substituted 
hydroxyl amine hydrochloride addition reaction (Scheme 4.29). The aldehyde 87 was 
treated with allylmagnesiumchloride in THF to obtain the enyne metathesis precursor 88 
in 1:1 mixture of two isomers. The excess allylmagnesiumchloride was scavenged by 
polymer supported sulfonic acid resin 42. The resin was filtered and the solvent was 
evaporated to aobtain crude product 88. Crude 88 (1:1 mixture of two isomers) was 
treated with the 1st generation Grubbs catalyst 26 (20 mol%) in refluxing DCM to obtain 
oxepane 89 in 1:1 mixture of two isomers. After treatment of the reaction mixture with 
the ruthenium scavenging resin 44, colorless product 89 was afforded. Without any 
further purification 89 was treated with pyridinium chlorochromate (PCC) in CH2Cl2 to 
obtain the keto oxepane 90. After the reaction was over (after 10h), chromium residue 
was filtered through a Celite pad and solvent was evaporated to obtain colorless crude 
ketone 90. Crude ketone 90 was heated at 70 oC in toluene with dienophiles to afford the 
Diels-Alder adduct 91.  
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Scheme 4.29. General procedure to synthesize keto oxepanes 91 and oximes 92. 
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Half of the crude product was purified by silica gel column chromatography to obtain 
pure 91 in 10% to 25% overall yield after 5 steps. The other half of the crude 91 was 
further treated with either O-methylhydroxylamine hydrochloride salt or O-
benzylhydroxylamine hydrochloride salt in ethanol:water (2:1) mixture at room 
temperature for 10h to obtain the addition product 92. Crude 92 was purified by 
preparative thin layer chromatography (PTLC) to obtain pure 92 in 10% to 15% overall 
yield (after 6 steps).32 
Using this synthetic strategy 9 more keto oxepane molecules and 6 more oxime 
molecules were synthesized. It was assumed that the Diels-Alder adducts formed in an 
endo-selective fashion. The Diels-Alder adduct with p-benzoquinone gave the 
hydroquinone moiety after aromatizaion under the reaction conditions. It was noted in the 
addition reaction of the keto moiety with the O-substituted hydroxyl amine, the O-
benzylhydroxyl amine gave a better yield and reactivity than the O-methylhydroxyl 
amine. The oxepanes 91 and 92 formed as the diastereomeric mixture of two isomers and 
the ratios were determined by 1H NMR spectroscopy. The isomeric ratios of the 
individual compounds are shown in the experimental part. The isolated overall yields and 
structure of the compounds are shown in the Table 6.2. The best yield (overall yield 30% 
after 5 steps) in the keto oxepane library 91 was obtained using dimethylacetylene 
diacarboxylate as dienophile and pentyl group as R1. The lowest overall yield (10% after 
5 steps) was obtained using N-phenyl maleimide as dienophile and R1 = R2 = -(CH2)5- 
(Table 6.2). In the hydroxyl amine addition reaction the best overall yield (15% after 6 
steps) was obtained using O-bezylhydroxyl amine and maleimide as dienophile with R1 = 
R2 = -CH3 (Table 6.2). 
 
4.18 Building blocks used in the library synthesis: 
Six different types of building blocks were use to synthesize the oxepane library. They 
are (1) substituted propargyl alcohols, (2) substituted α-bromo ethyl acetates, (3) 
isocyanates, (4) acid chlorides, (5) dienophiles and (6) primary and secondary amines 
(Figure 4.3). 
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Figure 4.3. Building blocks used in the library synthesis 
 
Among the substituted propargyl alcohol building blocks, all the propargyl alcohols gave 
moderate to good yields except propargyl alcohol itself. It was noted that the propargyl 
alcohol is difficult to handle due to its volatility and that reflected in the low yields of the 
oxepane molecules using this building block. Bromo ethyl acetate showed the best 
reactivity and yields than the other two building blocks among the substituted α-bromo 
ethyl acetates. Among the isocyanate building blocks, the 2,4-dimethoxy phenyl 
isocyante showed the least reactivity and yield due to its electron donating property as 
well as the bulkiness ortho-substituent. The naphthyl and phenyl isocyante showed 
moderate reativity. The best reactivity was observed with p-chloro phenylisocyanate due 
to its electron withdrawing property. It was noted that the aliphatic acid chlorides are 
more reactive then the aromatic acid chlorides. Among the aromatic acid chlorides 2-
fluoro benzoylchloride and 3,4-dichloro benzoylchloride are most reactive due to their 
 
 
 120
electron withdrawing character. On the other hand p-methoxy and p-methyl 
benzoylchlorides are least reactive due to their electron donating property. It was 
observed that all the primary and secondary amines reacted equally well with similar 
reactivity. It was experienced that among the dienophiles N-phenyl maleimide, maleimide 
and maleic anhydride showed the best reactivity. p-benzoquinone and diemthyl acetylene 
diacarboxylate are sluggish reactors among the dienophiles.  
 
5. Summary and outlook: 
A solution phase parallel synthetic strategy has been developed to synthesize a fully 
functionalized oxepane library. In this synthetic strategy the ring-closing enyne 
metathesis reaction was used as the key reaction to synthesize the oxepane scaffold. The 
oxepane scaffold was then functionalized to generate an oxepane libaray. This solution 
phase synthetic strategy was extended to the use of the solid-supported scavenging 
technique which leads to the development of a one pot synthetic strategy to produce the 
oxepane library in a rapid and practical way excluding the extensive separation and 
purification e.g. chromatography, distillation, extraction and crystallization protocol after 
each reaction.  
At the end a small oxepane library containing 110 molecules (Table 6.1, Table 6.2 and 
Table 6.3), was synthesized using the advantages of the polymer supported scavenging 
procedure. The synthesized oxepane molecules will be used in chemical genomics studies 
to identify the target of interest and also in cell based assays to detect inhibitors or 
activators in signaling pathways. 
 
6. The compound library: 
All the oxepane molecules in the library are shown below in Table 6.1, Table 6.2 and 
Table 6.3. All the compounds are purified by either silica gel column chromatograpy or 
preparative thin layer chromatography. The yields shown in the tables are isolated yields. 
The amounts of individual compounds (in mg) are shown in the experimental part. 
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6.1 Oxepane library 1: 
O R1
R2
R3
R4
HH
H
Y
 
 
Table 6.1. Oxepane library 1. 
 
Compound  
No.  
R1 R2 R3 R4 Y Isolated  
Yield 
94 -(CH2)5- -(CH2)5- -H 
O
O
N
 
COOH
COOH
H
H  
34 % 
(after 7 steps) 
95 -(CH2)5- -(CH2)5- -H O
O
H
N
5  N
O
O
Ph
H
H
 
32% 
(after 6 steps) 
96 -(CH2)5- -(CH2)5- -H O
O
H
NPh
 N
O
O
Ph
H
H
 
40% 
(after 6 steps) 
97 -(CH2)5- -(CH2)5- -H 
O
O
HN
Cl
 
COOH
COOH
H
H  
15% 
(after 7 steps) 
98 -(CH2)5- -(CH2)5- -H 
O
O
N
 
N
O
O
Ph
H
H
 
32% 
(after 6 steps) 
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99 -(CH2)5- -(CH2)5- -H 
O
O
H
N
O
O
N
O
O
Ph
H
H
 
32% 
(after 6 steps) 
100 -(CH2)5- -(CH2)5- -H 
O
O
N
O
 
N
O
O
Ph
H
H
 
34% 
(after 6 steps) 
101 -(CH2)5- -(CH2)5- -H 
O
O
HN
Cl
 
N
O
O
Ph
H
H
 
32% 
(after 7 steps) 
102 -(CH2)5- -(CH2)5- -H O
O
H
NPh
 
COOH
COOH
H
H  
20% 
(after 7 steps) 
103 -(CH2)5- -(CH2)5- -H O
O
H
N
5  
COOH
COOH
H
H  
15% 
(after 7 steps) 
104 -CH3 -CH3 -H 
O
O
N
O
 
NH
O
O
H
H  
30% 
(after 6 steps) 
105 -CH3 -CH3 -H 
O
O
N
 
NH
O
O
H
H  
22% 
(after 6 steps) 
106 -CH3 -CH3 -H O
O
H
NPh
 NH
O
O
H
H  
20% 
(after 6 steps) 
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107 -CH3 -CH3 -H 
O
O
HN
Cl
NH
O
O
H
H  
16% 
(after 6 steps) 
108 -CH3 -CH3 -H O
O
H
N
5  NH
O
O
H
H  
31% 
(after 6 steps) 
109 -(CH2)5- -(CH2)5- -H O
O
H
NPh
 
N
O
O
Ph
H
H  
29% 
(after 6 steps) 
110 -CH3 -CH3 -H 
O
O
HN
Cl
 
NH
O
O
H
H  
22% 
(after 6 steps) 
111 -CH3 -CH3 -H 
O
O
N
O
 
NH
O
O
H
H  
15% 
(after 6 steps) 
112 -CH3 -CH3 -H 
O
O
N
 
NH
O
O
H
H  
15% 
(after 6 steps) 
113 -CH3 -CH3 -H 
O
O
H
N
O
O
NH
O
O
H
H  
30% 
(after 6 steps) 
114 -CH3 -CH3 -H O
O
H
N
 
COOH
COOH
H
H  
16% 
(after 7 steps) 
115 -H -H -H 
O
O
N
 
NH
O
O
H
H  
20% 
(after 6 steps) 
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116 -H -H -H O
O
H
N
 NH
O
O
H
H  
26% 
(after 6 steps) 
117 -H -H -H 
O
O
N
O
 
NH
O
O
H
H  
30% 
(after 6 steps) 
118 -H -H -H 
O
O
H
N
5  NH
O
O
H
H  
20% 
(after 6 steps) 
119 (CH2)4CH3  -H -H 
O
O
N
O
 
NH
O
O
H
H  
16% 
(after 6 steps) 
120 (CH2)4CH3  -H -H 
O
O
HN
F
 
OH
OH  
15% 
(after 6 steps) 
77 (CH2)4CH3  -H -H 
O
O
H
N
O
O
NH
O
O
H
H  
16% 
(after 6 steps) 
122 (CH2)4CH3  -H -H O
O
H
N
5  
OH
OH  
15% 
(after 6 steps) 
123 (CH2)4CH3  -H -H 
O
O
HN
Cl
 
OH
OH
 
15% 
(after 6 steps) 
 
 
 125
124 (CH2)4CH3  -H -H O
O
H
N
 NH
O
O
H
H  
16% 
(after 6 steps) 
125 (CH2)4CH3  -H -H 
O
O
HN
Cl
 
OH
OH  
20% 
(after 6 steps) 
130 (CH2)4CH3  -H -H 
O
O
HN
Cl
 
COOH
COOH
H
H  
15% 
(after 6 steps) 
121 (CH2)4CH3  -H -H 
O
O
HN
F
 
COOH
COOH
H
H  
20% 
(after 6 steps) 
126 (CH2)4CH3  -H -H O
O
H
N
10  NH
O
O
H
H  
23% 
(after 6 steps) 
93 (CH2)4CH3  -H -H O
O
H
NPh
 
COOH
COOH
H
H  
41% 
(after 7 steps) 
127 -CH3 -CH3 -H 
O
O
N
N
F
COOH
COOH
H
H  
25% 
(after 7 steps) 
128 (CH2)4CH3  -H -H O
O
H
N
5  NH
O
O
H
H  
29% 
(after 6 steps) 
 
 
 126
129 (CH2)4CH3  -H -H O
O
H
N
 
NH
O
O
H
H  
31% 
(after 6 steps) 
78 (CH2)4CH3  -H -H O
O
H
N
11  NH
O
O
H
H  
24% 
(after 6 steps) 
131 (CH2)4CH3  -H -H 
O
O
H
N
O
O
 
COOH
COOH
H
H  
15% 
(after 7 steps) 
79 (CH2)4CH3  -H -H 
O
O
N
 
NH
O
O
H
H  
20% 
(after 6 steps) 
132 (CH2)4CH3  -H -H 
O
O
Cl
Cl
 
OH
OH  
30% 
(after 5 steps) 
133 (CH2)4CH3  -H -H O
O
H
N
 
OH
OH  
20% 
(after 5 steps) 
134 (CH2)4CH3  -H -H O
O
12
 
O
O
O
O
 
44% 
(after 5 steps) 
135 (CH2)4CH3  -H CH3
 
OH  
N
O
O
Ph
H
H  
52% 
(after 4 steps) 
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136 (CH2)4CH3  -H CH3
 
O
O
HN
 
O
O
O
O
 
32% 
(after 5 steps) 
137 (CH2)4CH3  -H CH3
 O
O
H
N
O
O
N
O
O
Ph
H
H  
50% 
(after 5 steps) 
138 (CH2)4CH3  -H CH3
 
O
O
HN
 
N
O
O
Ph
H
H  
60% 
(after 5 steps) 
139 (CH2)4CH3  -H CH3
O
O  
O
O
O
O
 
26% 
(after 5 steps) 
41 (CH2)4CH3  -H -H 
O
O
Cl
Cl
 
OH
OH  
60% 
(after 5 steps) 
70 (CH2)4CH3  -H -H 
O
O
F
 
COOH
COOH
H
H  
21% 
(after 6 steps) 
67 (CH2)4CH3  -H -H O
O
12
 
COOH
COOH
H
H  
25% 
(after 6 steps) 
69 (CH2)4CH3  -H -H 
O
O
Cl
Cl
 
COOH
COOH
H
H  
24% 
(after 6 steps) 
68 (CH2)4CH3  -H -H 
O
O  
COOH
COOH
H
H  
20% 
(after 6 steps) 
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140 (CH2)4CH3  -H -H O
O
12
 
O
O
O
O
 
28% 
(after 5 steps) 
141 (CH2)4CH3  -H -H 
O
O
HN
 
O
O
O
O
 
16% 
(after 5 steps) 
 
142 (CH2)4CH3  -H -H 
O
O  
O
O
O
O
 
32% 
(after 5 steps) 
143 (CH2)4CH3  -H -H O
O  
O
O
O
O
 
25% 
(after 5 steps) 
144 (CH2)4CH3  -H -H O
O  
O
O
O
O
 
25% 
(after 5 steps) 
71 (CH2)4CH3  -H -H O
O
H
N
Cl  
COOH
COOH
H
H  
26% 
(after 6 steps) 
49 (CH2)4CH3  -H -H O
O
H
N
 
N
O
O
Ph
H
H  
32% 
(after 5 steps) 
48 (CH2)4CH3  -H -H 
O
O
HN
 
N
O
O
Ph
H
H  
30% 
(after 5 steps) 
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145 (CH2)4CH3  -H -H 
O
O
O
 
OH
OH  
17% 
(after 5 steps) 
146 (CH2)4CH3  -H CH3 OH  
N
O
O
Ph
H
H  
60% 
(after 4 steps) 
147 (CH2)4CH3  -H CH3 OH  
N
O
O
Ph
H
H  
70% 
(after 4 steps) 
148 (CH2)4CH3  -H -H O
O
12
 
OH
OH  
23% 
(after 5 steps) 
149 (CH2)4CH3  -H -H OH  
N
O
O
Ph
H
H  
65% 
(after 4 steps) 
150 (CH2)4CH3  -H CH3 OH  
N
O
O
Ph
H
H  
50% 
(after 4 steps) 
151 (CH2)4CH3  -H CH3 OH  
O
O
O
O
 
55% 
(after 4 steps) 
152 (CH2)4CH3  -H -H O
O
H
N
5  
COOH
COOH
H
H  
27% 
(after 7 steps) 
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6.2 Oxepane library 2: 
 
O R1
R2
X
HH
H
Y
 
Table 6.2. Oxepane library 2. 
 
Compound  
No. 
R1 R2 X Y Yield 
58 (CH2)4CH3  
-H O O
O
O
O
 
30% 
(after 5 steps) 
57 (CH2)4CH3  
-H O 
O
O
O
H
H  
25% 
(after 5 steps) 
55 (CH2)4CH3  
-H O 
N
O
O
Ph
H
H  
25% 
(after 5 steps) 
153 -(CH2)5- -(CH2)5- OBn
N  N
O
O
Ph
H
H  
10%  
(after 6 steps) 
154 -(CH2)5- -(CH2)5- OBn
N  
NH
O
O
H
H  
12% 
(after 6 steps) 
155 -(CH2)5- -(CH2)5- O 
NH
O
O
H
H  
15% 
(after 5 steps) 
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156 -(CH2)5- -(CH2)5- O 
N
O
O
Ph
H
H  
10% 
(after 5 steps) 
157 -(CH2)5- -(CH2)5- O O
O
O
O
 
15% 
(after 5 steps) 
158 -(CH2)5- -(CH2)5- OMe
N  
OH
OH  
10% 
(after 6 steps) 
159 -CH3 -CH3 O 
N
O
O
Ph
H
H  
12% 
(after 5 steps) 
160 -CH3 -CH3 O 
NH
O
O
H
H  
15% 
(after 5 steps) 
161 -CH3 -CH3 OBn
N  
NH
O
O
H
H  
15% 
(after 6 steps) 
162 -CH3 -CH3 OBn
N  N
O
O
Ph
H
H  
13% 
(after 6 steps) 
163 (CH2)4CH3  
-H OBn
N  N
O
O
Ph
H
H  
10% 
(after 6 steps) 
56 (CH2)4CH3  
-H O OH
OH  
14% 
(after 5 steps) 
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6.3 Oxepane library 3: 
 
O R1
R2
R3
R4
 
 
Table 6.3. Oxepane library 3. 
 
Compound  
No. 
R1 R2 R3 R4 Yield 
164 -CH3 -CH3 -H 
O
O
N
N
F
 
40% 
(after 5 steps) 
165 -CH3 -CH3 -H O
O
H
N
5  
25% 
(after 5 steps) 
166 -CH3 -CH3 -H 
O
O
N
 
29% 
(after 5 steps) 
167 -CH3 -CH3 -H 
O
O
N
O
 
40% 
(after 5 steps) 
168 -CH3 -CH3 -H O
O
H
N
 
45% 
(after 5 steps) 
 
169 -CH3 -CH3 
O
O
 
O
O
H
N
 
35% 
(after 6 steps) 
170 -CH3 -CH3 
O
O
 
O
O
N
O
 
36% 
(after 6 steps) 
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171 -CH3 -CH3 
O
O
 
O
O
N
N
F
 
38% 
(after 6 steps) 
172 -CH3 -CH3 
O
O
 
O
O
H
N
 
35% 
(after 6 steps) 
173 -CH3 -CH3 
O
O
 
O
O
H
N
5  
35% 
(after 6 steps) 
174 -CH3 -CH3 
O
O
 
O
O
N
 
30% 
(after 6 steps) 
66 (CH2)4CH3  -H 
O
O
 
O
O
12
 
47% 
(after 5 steps) 
175 (CH2)4CH3  -H 
O
O
 
O
 
30% 
(after 5 steps) 
65 (CH2)4CH3  -H 
O
O
 
O
O
H
N
Cl  
75% 
(after 5 steps) 
64 (CH2)4CH3  -H 
O
O
 
O
O
H
N
 
47% 
(after 5 steps) 
63 (CH2)4CH3  -H 
O
O
 
O
O
HN
 
40% 
(after 5 steps) 
31 (CH2)4CH3  -H -H OH  
60% 
(after 3 steps) 
32 (CH2)4CH3  -H -H OH  
60% 
(after 3 steps) 
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38 (CH2)4CH3  -H -H 
O
O
Cl
Cl
 
57% 
(after 4 steps) 
39 (CH2)4CH3  -H -H O
O
H
N
Cl  
65% 
(after 4 steps) 
40 (CH2)4CH3  -H -H O
O
H
N
 
40% 
(after 4 steps) 
62 (CH2)4CH3  -H 
O
O
 
OH  
65% 
(after 4 steps) 
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8. Experimental part: 
8.1 General experimental procedures: 
1H and 13C-NMR spectra were recoreded on a Varian Mercury 400 spectrometer at room 
temperature. Chemical shifts are expressed in part per million (ppm) and the spectra’s are 
afterwards calibrated to the solvent signals of CDCl3 (7.26 ppm and 77.16 ppm). 
Coupling constants are given in Hertz (Hz) and the following notations indicate the 
multiplicity of the signals: s (singlet), d (doublet), t (triplet), dd (double of doublet), m 
(multiplet), dt (doublet of triplet), td (triplet of doublet, br (broad signal). Gass 
chromatography-mass spectrometry (GC-MS) were measured from a Hewlett Packard 
6890 GC system coupled to a Hewlett Packard 5973 Mass Selective Detector. A HP 5TA 
capillary column (0.33 μm x 25 m x 0.2 mm) and helium flow rate of 2 mL/ min were 
used. High resolution mass spectra (HR-MS, 70 eV) were measured on a Jeol SX 102A 
spectrometer by using electron impact (EI), fast atom bombardment (FAB) techniques. 
The matrix used for FAB was 3-nitrobenzylalcohol (3-NBA). Thin layer chromatography 
(TLC) was carried out on Merck precoated silica gel plate (60F-254) using ultra violet 
light irradiation 254 nm or the KMnO4 solution (1 gm KMnO4, 6.6 gm K2CO3, 1.67 mL 
of 5% NaOH solution, 100 mL water) as staining reagent. Purifications were performed 
using silica gel from J.T. Baker or Merck (particle size 40-60 μm) under approximately 
0.5 bar pressure. All reactions were performed under argon atmosphere with freshly 
distilled and dried solvents. All solvents were distilled using standard procedures. Unless 
otherwise stated all the reagents were obtained from Aldrich, Acros Chimica, Fluka, 
Advance Chemtech, Avocado, J.T. Baker, Novabiochem, Riedel de Haen, Roth, Sigma or 
Lancaster and used without further purification. 
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8.1.1 Synthesis of compound 18: 
 
HO O HOPCC, DCM, 10h, rt
N
B
O
Me
Ph
Ph
H
BH3.Me2S, THF, 
-30 oC to -10 oC
       1h, 60% after 2 steps
rac (R)
(R)
1716 18
 
 
Pyridinium chlorochromate (PCC) (25 g, 3 equiv, 119 mmol) was suspended in DCM and 
stirred at room temperature for 30 min. Racemic oct-1-yn-3-ol 16 (5 g, 39.7 mmol, 
dissolved in DCM) was added dropwise into the PCC suspension and the mixture was 
stirred for 10h at room temperature. The solution was filtered through a silica gel pad, 
which was washed thoroughly with DCM. The solvent was evaporated to afford the crude 
oct-1-yn-3-one 17.  
Crude oct-1-yn-3-one 17 and (R)-Me oxazaborolidine (CBS) (1M solution in toluene) 
(0.06 equiv., 2.5 mmol, 2.5 mL) were dissolved in THF in a two neck round bottom flask 
and cooled to -30 oC. 94% Borane-dimethyl sulfide (BMS) complex (0.6 equiv., 24.19 
mmol, 2.3 mL) was added dropwise with a syringe pump into the reaction mixture. The 
reaction temperature was raised to -10 oC for 1h. The mixture was quenched by dropwise 
addition of methanol at room temperature and 50 mL NaOH and Na2CO3 (2:1) solution 
was added. The aqueous layer was extracted with diethyl ether (2 x 50 mL). The 
combined organic layers were washed thoroughly with water (3 x 50 mL) and brine (2 x 
10 mL) and dried over Na2SO4, concentrated under reduced pressure. The residue was 
purified by silica gel chromatography (cyclohexane/ethyl acetate 4:1) to furnish 3 g of the 
product 18. 
1H NMR (400 MHz, CDCl3): δ = 4.37-4.33 (dt, J = 2.1 Hz, 8.0 Hz, 1H), 2.45-2.44 (d, J 
= 2.2 Hz, 1H), 2.00 (bs, 1H), 1.73-1.67 (m, 2H), 1.49-1.41 (m, 2H), 1.32-1.25 (m, 4H), 
0.90-0.87 (t, J = 7.0 Hz, 3H).  
13C NMR (100 MHz, CDCl3): δ = 85.3, 72.9, 62.5, 37.83, 31.6, 24.9, 22.7, 14.2 
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HR-MS (FAB, 70 eV): m/z calculated for C8H13O = 125.1045, found = 125.1029 [M-
H]+. 
Rf = 0.3 (cylohexane: ethyl acetate = 4:1). 
[ ]20Dα : + 6.0o (c = 2, CH2Cl2).16 
Yield: 3 gm (60% after 2 steps). 
 
8.1.2 Synthesis of compound 23: 
 
O
O
O
23  
 
A 250 mL two necked flask was charged with sodium hydride (95%) (1.5 g, 59.5 mmol, 
1.5 equiv), 50 mL of THF was added and the suspension was stirred and cooled to 0 oC. 
To the suspension was added dropwise over 20 minutes a solution of the (R)- oct-1-yn-3-
ol 18 (5 g, 39.68 mmol) in THF (20 mL). The mixture was warmed to 25 oC and stirred 
for 15 minutes. The mixture was cooled to 0 oC and a solution of ethyl bromoacetate 
(6.58 mL, 59.52 mmol, 1.5 equiv) in THF (10 mL) was added dropwise over 30 minutes. 
The mixture was warmed to 25 oC, stirred for 6h and quenched with water (20 mL). The 
mixture was diluted with water (100 mL) and diethyl ether (100 mL) and separated. The 
aqueous layer was washed with diethyl ether (2 x 200 mL). The combined ether layers 
were washed with brine (2 x 20 mL), dried over Na2SO4, filtered and concentrated under 
reduced pressure. The residue was purified by silica gel chromatography 
(cyclohexane/ethyl acetate 9:1) to furnish 6.7 g of the product 23. 
1H NMR (400 MHz, CDCl3): δ = 4.28-4.18 (m, 5H), 2.45-2.44 (d, J = 2.2 Hz, 1H), 1.85-
1.69 (m, 2H), 1.52-1.44 (m, 2H), 1.32-1.30 (m, 4H), 1.30-1.26 (t, J = 7.2 Hz, 3H), 0.90-
0.87 (t, J = 7.0 Hz, 3H).  
13C NMR (100 MHz, CDCl3): δ = 170.4, 82.1, 74.7, 70.0, 65.7, 61.0, 35.6, 31.6, 24.9, 
22.7, 14.4, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C12H20O3 = 212.1412, found = 212.1400 [M]+. 
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Rf = 0.5 (cylohexane: ethyl acetate = 9:1). 
[ ]20Dα : + 77.0o (c = 2, CHCl3). 
Yield: 5.8 g (70%). 
 
8.1.3 Analytical data of compound 23a: 
 
O
O
O
23a  
 
1H NMR (400 MHz, CDCl3): δ = 4.39-4.34 (q, J = 6.8 Hz, 1H), 4.23-4.14 (m, 3H), 2.41-
2.40 (d, J = 2.1 Hz, 1H), 1.82-1.66 (m, 2H), 1.50-1.45 (m, 2H), 1.42-1.41 (d, J = 7.0 Hz, 
3H), 1.31-1.26 (m, 7H), 0.90-0.87 (t, J = 7.0 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 173.4, 82.8, 74.1, 72.3, 68.9, 60.9, 35.9, 31.7, 24.9, 
22.7, 19.2, 14.4, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C13H22O3 = 226.1569, found = 226.1566 [M]+. 
Rf = 0.6 (cylohexane: ethyl acetate = 9:1). 
[ ]20Dα : + 55.25o (c = 2, CHCl3). 
Yield: 1.4 g (35%). 
 
8.1.4 Analytical data of compound 23b: 
 
O
O
O
23b  
 
1H NMR (400 MHz, CDCl3): δ = 4.22-4.13 (m, 4H), 2.41-2.40 (d, J = 1.9 Hz, 1H), 1.80-
1.66 (m, 2H), 1.46-1.43 (m, 2H), 1.39-1.38 (d, J = 6.8 Hz, 3H), 1.30-1.26 (m, 7H), 0.89-
0.86 (t, J = 6.8 Hz, 3H). 
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13C NMR (100 MHz, CDCl3): δ = 173.3, 82.6, 74.3, 73.7, 69.4, 61.0, 35.7, 31.6, 25.0, 
22.7, 18.4, 14.3, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C13H22O3 = 226.1569, found = 226.1566 [M]+. 
Rf = 0.4 (cylohexane: ethyl acetate = 9:1). 
[ ]20Dα : + 6.75o (c = 2, CHCl3). 
Yield: 1.4 g (35%). 
 
8.1.5 Synthesis of compound 24: 
 
O
H
O
24  
 
To a solution of compound 23 (1.7 g, 8.02 mmol) in diethyl ether (200 mL) at -78 oC, 
diisobutylaluminumhydride (1M solution in hexane, 12.02 mL, 12.02 mmol, 1.5 equiv) 
was added slowly by a syringe pumpe over 30 minutes. The solution was stirred at -78 oC 
for 20 minutes, quenched with 1M HCl solution and stirred for 1h. The solution was 
diluted with diethyl ether (50 mL). The aqueous layer was extracted with diethyl ether (2 
x 20 mL) and the combined organic layers were washed with water (2 x 10 mL) and brine 
(2 x 10 mL), dried over Na2SO4, filtered and concentrated under reduced pressure. The 
residue was purified by silica gel chromatography (cyclohexane/ethyl acetate 9:1) to 
furnish 1 g of the product 24. 
1H NMR (400 MHz, CDCl3): δ = 9.75-9.74 (t, J = 0.98 Hz, 1H), 4.29-4.24 (dd, J = 0.96 
Hz, 17.7 Hz, 1H), 4.19-4.15 (dt, J = 2.2 Hz, 7.6 Hz, 1H), 4.14- 4.09 (dd, J = 0.96 Hz, 
17.7 Hz, 1H), 2.48-2.47 (d, J = 2.2 Hz, 1H), 1.79-1.70 (m, 2H), 1.52-1.41 (m, 2H), 1.33-
1.29 (m, 4H), 0.91-0.87 (t, J = 7.0 Hz, 3H).  
13C NMR (100 MHz, CDCl3): δ = 200.9, 81.9, 75.2, 74.1, 70.7, 35.6, 31.6, 24.9, 22.7, 
14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C10H16O2 = 168.115, found = 168.1133 [M]+. 
Rf = 0.5 (cylohexane: ethyl acetate = 4:1). 
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[ ]20Dα : + 33.5o (c = 2, CHCl3). 
Yield: 1.0 g (75%). 
 
8.1.6 Analytical data of compound 24a: 
 
H
O
O
24a  
 
1H NMR (400 MHz, CDCl3): δ = 9.64-9.63 (d, J = 1.6 Hz, 1H), 4.22-4.20 (m, 1H), 4.19-
4.18 (m, 1H), 2.43-2.42 (d, J = 2.2 Hz, 1H), 1.85-1.67 (m, 2H), 1.53-1.46 (m, 2H), 1.34-
1.23 (m, 7H), 0.91-0.87 (t, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 203.4, 82.6, 78.1, 74.5, 69.3, 35.9, 31.6, 25.0, 22.7, 
16.0, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C11H18O2 = 182.1307, found = 182.1311 [M]+. 
Rf = 0.6 (cylohexane: ethyl acetate = 4:1). 
[ ]20Dα : + 58.5o (c = 2, CHCl3). 
Yield: 64%. 
 
8.1.7 Analytical data of compound 24b: 
 
H
O
O
24b  
 
1H NMR (400 MHz, CDCl3): δ = 9.75-9.74 (d, J = 1.8 Hz, 1H), 4.20-4.16 (dt, J = 2.2 
Hz, 7.6 Hz, 1H), 4.07-4.01 (dq, J = 1.8 Hz, 6.8 Hz, 1H), 2.45-2.44 (d, J = 2.2 Hz, 1H), 
1.82-1.71 (m, 2H), 1.51-1.44 (m, 2H), 1.33-1.28 (m, 4H), 1.26-1.25 (d, J = 7.0 Hz, 3H), 
0.91-0.88 (t, J = 7.0 Hz, 3H). 
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13C NMR (100 MHz, CDCl3): δ = 204.2, 82.8, 79.1, 75.0, 69.3, 35.9, 31.6, 25.0, 22.7, 
15.4, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C11H18O2 = 182.1307, found = 182.1311 [M]+. 
Rf = 0.4 (cylohexane: ethyl acetate = 4:1). 
[ ]20Dα : + 12.5o (c = 2, CHCl3). 
Yield: 64%. 
 
8.1.8 Synthesis of compound 25: 
 
O
25
OH
(d.r. = 1:1)*  
* = isomeric ratio was determined by 1H NMR spectroscopy 
 
To a solution of aldehyde 24 (0.1 g, 0.59 mmol) in THF under argon at 0 oC, allyl 
magnesium chloride (0.45 mL, 0.89 mmol, 1.5 equiv, 2M solution in THF) was added 
dropwise. The mixture was stirred at room temperature for 2h, quenched with saturated 
ammonium chloride solution and the aqueous layer was extracted with diethyl ether (2 x 
50 mL). The combined organic layers were washed with brine (2 x 20 mL), dried over 
Na2SO4, filtered and concentrated under reduced pressure. The residue was purified by 
silica gel chromatography (cyclohexane/ethyl acetate 9:1) to furnish 100 mg of the 
product as 1:1 inseparable mixture of two diastereomers. 
1H NMR (400 MHz, CDCl3): δ = 5.89-5.79 (m, 1H), 5.15-5.08 (m, 2H), 4.08-4.02 (dq, J 
= 1.9 Hz, 6.6 Hz, 1H), 3.90-3.85 (m, 1H), 3.78-3.74 (dd, J = 3.3 Hz, 9.36 Hz, 1H), 3.64-
3.60 (dd, J = 7.2 Hz, 8.5 Hz, 1H), 3.46-3.43 (dd, J = 3.5 Hz, 9.5 Hz, 1H), 3.28-3.24 (dd, J 
= 7.6 Hz, 9.4 Hz, 1H), 2.43-2.42 (dd, J = 1.6 Hz, 2.0 Hz, 1H), 2.29-2.25 (m, 2H), 1.77-
1.65 (m, 2H), 1.48-1.41 (m, 2H), 1.34-1.24 (m, 4H), 0.90-0.87 (t, J = 7.0 Hz, 3H).  
13C NMR (100 MHz, CDCl3): δ = 134.5, 117.9, 83.1, 83.0, 74.1, 74.0, 72.8, 72.4, 70.4, 
70.1, 69.9, 69.8, 38.1, 38.0, 35.7, 35.6, 31.6, 25.1, 22.7, 14.2. 
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HR-MS (FAB, 70 eV): m/z calculated for C13H23O2 = 211.162, found = 211.1653 
[M+H]+. 
Rf = 0.5 (cylohexane: ethyl acetate = 4:1). 
Yield: 100 mg (80%). 
 
8.2 General procedure for the asymmetric Brown 
allylation: 
(+) or (-)-Diisopinocamphyl boron chloride (DIPCl) (1.4 equiv) was dissolved in THF in 
a two neck round bottom flask and cooled to -78 oC. Allylmagnesiumchloride (2M 
solution in THF, 1.5 equiv.) was added dropwise into the flask and the solution was 
stirred at -78 oC for 1h. Then the reaction mixture was brought to room temperature and 
stirred another 1h at room temperature to allow forming the diisopinocamphyl allyl 
borane complex. Then the mixture was cooled again to -78 oC and the aldehyde 
(dissolved in THF) was added dropwise into the reaction mixture and the reaction was 
stirred at -78 oC for 1h. Then the reaction mixture was allowed to warm to room 
temperature and stirred for another 1h. The reaction was quenched with 50 mL mixture of 
sodium hydroxide and saturated sodium hydrogen carbonate solution (2:1). The 
combined organic layers were washed with brine (2 x 20 mL), dried over Na2SO4, filtered 
and concentrated under reduced pressure. The residue was purified by silica gel 
chromatography (cyclohexane/ethyl acetate 9:1) to furnish the product as 8:1 and 2.5:1 
inseparable mixture of two diastereomers respectively. Further reaction was carried out 
without the separation of the diastereomers. 
 
8.2.1 Analytical data of compound 29: 
 
(d.r. = 8:1)*
O
OH
29
 
* = isomeric ratio determined by 1H NMR spectroscopy 
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1H NMR (400 MHz, CDCl3): δ = 5.89-5.79 (m, 1H), 5.15-5.08 (m, 2H), 4.08-4.02 (m, 
1H), 3.90-3.83 (m, 1H), 3.78-3.74 (dd, J = 3.4 Hz, 9.5 Hz, 1H, major diastereomer), 3.64-
3.60 (dd, J = 7.2 Hz, 9.6 Hz, 1H, minor diastereomer), 3.46-3.42 (dd, J = 3.5 Hz, 9.4 Hz, 
1H, minor diastereomer), 3.28-3.24 (dd, J = 7.4 Hz, 9.5 Hz, 1H, major diastereomer), 
2.43-2.42 (d, J = 1.9 Hz, 1H), 2.28-2.24 (m, 2H), 2.03 (bs, 1H), 1.77-1.66 (m, 2H), 1.48-
1.41 (m, 2H), 1.32-1.27 (m, 4H), 0.90-0.87 (t, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 134.4, 117.9, 83.1, 74.0, 72.8, 72.4, 70.4, 70.0, 38.1, 
35.7, 31.6, 25.1, 22.7, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C13H23O2 = 211.162, found = 211.1653 
[M+H]+. 
Rf = 0.5 (cylohexane: ethyl acetate = 4:1). 
Yield: 70 %. 
 
8.2.2 Analytical data of compound 30: 
 
O
OH
30
(d.r. = 2.5:1)*  
* = isomeric ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, CDCl3): δ = 5.89-5.79 (m, 1H), 5.15-5.08 (m, 2H), 4.07-4.03 (m, 
1H), 3.87-3.83 (m, 1H), 3.78-3.74 (dd, J = 3.3 Hz, 9.4 Hz, 1H, minor diastereomer), 3.64-
3.60 (dd, J = 7.0 Hz, 9.6 Hz, 1H, major diastereomer), 3.46-3.43 (dd, J = 3.5 Hz, 9.5 Hz, 
1H, major diastereomer), 3.28-3.24 (dd, J = 7.4 Hz, 9.4 Hz, 1H, minor diastereomer), 
2.43-2.42 (d, J = 1.9 Hz, 1H), 2.29-2.24 (m, 2H), 1.77-1.65 (m, 2H), 1.48-1.41 (m, 2H), 
1.31-1.28 (m, 4H), 0.91-0.87 (t, J = 7 Hz, 3H).  
13C NMR (100 MHz, CDCl3): δ = 134.5, 117.9, 83.0, 74.1, 72.8, 72.4, 70.1, 69.8, 38.1, 
35.7, 31.7, 25.1, 22.7, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C13H23O2 = 211.162, found = 211.1653 
[M+H]+. 
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Rf = 0.5 (cylohexane: ethyl acetate = 4:1). 
Yield: 70 %. 
 
8.3 General procedure for the enyne metathesis: 
The enyne was dissolved in DCM (0.002 M) in a two neck round bottom flask containing 
a refluxing condenser attached. Argon gas was bubbled through the solution by a needle 
for 30 minutes. The Grubbs catalyst was added and the reaction mixture was refluxed for 
18h. The solvent was evaporated and the residue was purified by silica gel 
chromatography.  
 
8.3.1 Analytical data of compound 31: 
 
(d.r. = 8:1)*
O
HO
31
 
* = isomeric ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, CDCl3): δ = 6.23-6.17 (dd, J = 11.1 Hz, 17.7 Hz, 1H), 5.71-5.68 
(dd, J = 4.9 Hz, 8.4 Hz, 1H), 5.04-4.92 (m, 2H), 4.57-4.54 (m, 1H), 4.16-4.12 (m, 1H), 
4.07-4.03 (dd, J = 5.5 Hz, 11.4 Hz, 1H), 3.41-3.37 (dd, J = 6.9 Hz, 12.4 Hz,  1H), 2.85-
2.81 (m, 1H), 2.36-2.29 (m, 1H), 1.74-, 1.67 (m, 1H), 1.65-1.58 (m, 1H), 1.49-1.39 (m, 
2H), 1.32-1.25 (m, 4H), 0.91-0.87 (t, J = 6.9 Hz, 3H).  
13C NMR (100 MHz, CDCl3): δ = 142.9, 138.7, 126.2, 111.9, 80.6, 70.5, 69.9, 33.2, 
31.9, 25.5, 22.9, 14.3. 
HR-MS (FAB, 70 eV): m/z calculated for C13H22O2 = 210.162, found = 210.1600 [M]+. 
Rf = 0.5 (cylohexane: ethyl acetate = 3:2). 
Yield: 60%. 
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8.3.2 Analytical data of compound 32: 
 
(d.r. = 2.5:1)*
O
HO
32
 
* = isomeric ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, CDCl3): δ = 6.14-6.09 (dd, J = 11.0 Hz, 17.5 Hz, 1H), 5.70-5.66 
(dd, J = 5.0 Hz, 8.3 Hz, 1H), 5.02-4.90 (m, 2H), 4.44-4.41 (m, 1H), 4.17-4.11 (m, 1H), 
4.12-3.98 (m, 1H), 3.88-3.75 (m, 1H), 2.83-2.75 (m, 1H), 2.30-2.25 (m, 1H), 1.70-, 1.65 
(m, 1H), 1.60-1.55 (m, 1H), 1.45-1.35 (m, 2H), 1.30-1.22 (m, 4H), 0.87-0.84 (t, J = 6.8 
Hz, 3H).  
13C NMR (100 MHz, CDCl3): δ = 142.9, 138.7, 126.2, 111.9, 80.6, 70.5, 69.9, 33.2, 
32.1, 25.4, 22.9, 14.3. 
HR-MS (FAB, 70 eV): m/z calculated for C13H22O2 = 210.162, found = 210.1600 [M]+. 
Rf = 0.5 (cylohexane: ethyl acetate = 3:2). 
Yield: 60%. 
 
8.4 General procedure to synthesize ester and 
carbamates: 
To a solution of alcohol 31 (8:1 mixture of two diastereomers) in THF, pyridine (1.5 
equiv) and either acid chloride or isocyanate (1.5 equiv) were added and the mixture was 
stirred at room temperature for 16h. The solvent was evaporated and the rasidue was 
purified by silica gel chromatography. The products were formed in the same 
diastereomeric ration of the starting alcohol 31. 
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8.4.1 Analytical data of compound 38: 
 
(d.r. = 8:1)*
O
O
O
Cl
Cl
38
 
* = isomeric ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, CDCl3): δ = 7.86-7.48 (m, 3H), 6.26-6.12 (m, 1H), 5.78-5.69 (m, 
1H), 5.46-5.29 (m, 1H), 5.07-4.98 (m, 2H), 4.58-4.45 (m, 1H), 4.29-4.25 (dd, J = 7.2 Hz, 
12.5 Hz, 1H), 3.51-3.46 (dd, J = 8.0 Hz, 12.4 Hz, 1H), 3.10-3.06 (m, 1H), 2.41-2.34 (m, 
1H), 1.78-1.67 (m, 2H), 1.58-1.43 (m, 2H), 1.34-1.28 (m, 4H), 0.91-0.87 (t, J = 6.3 Hz, 
3H). 
13C NMR (100 MHz, CDCl3): δ = 164.5, 142.6, 138.0, 137.8, 133.1, 131.8, 130.7, 130.2, 
129.0, 125.6, 112.8, 82.5, 75.6, 70.7, 67.5, 34.7, 32.1, 28.6, 25.3, 22.9, 14.3. 
HR-MS (FAB, 70 eV): m/z calculated for C20H24Cl2O3 = 382.1103, found = 384.1073 
[M+2H]+. 
Rf = 0.5 (cylohexane: ethyl acetate = 9:1). 
Yield: 57% (after 4 steps). 
 
8.4.2 Analytical data of compound 39: 
 
(d.r. = 8:1)*
O
O
O
H
N
Cl
39
 
* = isomeric ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, CDCl3): δ = 7.31-7.23 (m, 4H), 6.68 (bs, 1H), 6.23-6.11 (m, 1H), 
5.73-5.67 (m, 1H), 5.23-5.21 (m, 1H), 5.08-4.97 (m, 2H), 4.56-4.44 (m, 1H), 4.23-4.18 
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(dd, J = 7.2 Hz, 12.5 Hz, 1H), 3.43-3.38 (dd, J = 8.0 Hz, 12.5 Hz, 1H), 3.02-2.97 (m, 
1H), 2.41-2.27 (m, 1H), 1.76-1.66 (m, 2H), 1.56-1.45 (m, 2H), 1.33-1.25 (m, 4H), 0.91-
0.87 (t, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 153.0, 142.5, 138.3, 129.3, 125.9, 120.0, 112.8, 82.4, 
70.7, 67.7, 34.7, 32.1, 28.9, 27.8, 25.4, 22.8, 14.3. 
HR-MS (FAB, 70 eV): m/z calculated for C20H26ClNO3 = 363.1601, found = 365.1572 
[M+2H]+. 
Rf = 0.5 (cylohexane: ethyl acetate = 9:1). 
Yield: 65 % (after 4 steps). 
 
8.4.3 Analytical data of compound 40: 
 
(d.r. = 8:1)*
O
O
O
40
H
N
 
* = isomeric ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, CDCl3): δ = 7.36-7.27 (m, 5H), 5.68 (bs, 1H), 6.24-6.11 (m, 1H), 
5.75-5.68 (m, 1H), 5.25-5.23 (m, 1H), 5.08-5.04 (m, 1H), 5.01-4.97 (m, 1H), 4.56-4.45 
(m, 1H), 4.25-4.20 (dd, J = 7.0 Hz, 11.8 Hz, 1H), 3.44-3.39 (dd, J = 8.0 Hz, 12.3 Hz, 
1H), 3.01-2.97 (m, 1H), 2.41-2.32 (m, 1H), 1.77-1.67 (m, 2H), 1.60-1.40 (m, 2H), 1.34-
1.26 (m, 4H), 0.91-0.87 (t, J = 6.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 153.1, 142.4, 141.8, 138.3, 138.1, 135.2, 129.3, 126.1, 
125.3, 123.6, 118.8, 112.7, 82.3, 70.8, 67.8, 34.6, 32.1, 28.9, 27.8, 25.4, 22.8, 14.3. 
HR-MS (FAB, 70 eV): m/z calculated for C20H27NO3 = 329.1991, found = 330.2011 
[M+H]+. 
Rf = 0.5 (cylohexane: ethyl acetate = 9:1). 
Yield: 40 % (after 4 steps). 
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8.5 General procedure for the Diels-Alder reaction: 
The diene and the dienophile (1.5 equiv) were dissolved in a minimum volume of toluene 
and the mixture was heated to 70 oC until all the starting material was totally consumed 
(monitored by TLC). The solvent was removed in vacuo and the crude product was 
purified by silica gel chromatograpy. 
 
8.5.1 Analytical data of compound 41: 
 
41
O
O
O
Cl
Cl HO
OH
H
 
 
1H NMR (400 MHz, CDCl3): δ = 8.07-7.92 (m, 1H), 7.79-7.71 (m, 1H), 7.53-7.45 (m, 
1H), 6.90-6.83 (dd, J = 10.2 Hz, 18.4 Hz,  1H), 6.75-6.75 (d, J = 1.9 Hz, 1H), 6.53-6.52 
(d, J = 1.2 Hz, 1H), 5.74-5.73 (dd, J = 1.6 Hz, 5.8 Hz, 1H), 5.30-5.20 (m, 1H), 4.92-4.88 
(dd, J = 4.4 Hz, 8.5 Hz,  1H), 4.33-4.28 (dd, J = 6.4 Hz, 12.1 Hz,  1H), 4.24-4.13 (m, 
1H), 4.03-3.95 (m, 2H), 3.77-3.73 (m, 1H), 3.63-3.55 (m, 1H), 3.52-3.46 (m, 1H), 2.38-
2.19 (m, 1H), 2.03-1.86 (m, 1H), 1.65-1.59 (m, 2H), 1.35-1.24 (m, 6H), 0.88-0.84 (t, J = 
6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 186.8, 185.9, 164.1, 163.6, 149.7, 143.5, 141.3, 140.8, 
136.4, 131.7, 130.7, 128.9, 120.8, 113.3, 84.61, 72.5, 69.1, 54.0, 39.9, 35.8, 31.9, 31.8, 
29.5, 28.6, 25.9, 25.6, 22.8, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C26H30Cl2O5 = 492.1314, found = 492.1300 
[M+2H]+. 
[ ]20Dα : + 5.6o (c = 2, CHCl3).  
Rf = 0.5 (cyclohexane: ethyl acetate = 4:1). 
Yield: 60 % (after 5 steps). 
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8.6 General procedure for the one pot synthesis of the 
oxepane library starting from DIBAL-H reduction: 
To a solution of the ethyl ester in diethyl ether at -78 oC, diisobutylaluminumhydride (1M 
solution in hexane, 1.5 equiv) was added slowly by a syringe pumpe over 30 minutes. 
The solution was stirred at -78 oC for 20 minutes, quenched with 1M HCl solution and 
stirred for 1h. The solution was diluted with diethyl ether (50 mL). The aqueous layer 
was extracted with diethyl ether (2 x 20 mL) and the combined organic layers were 
washed with water (2 x 10 mL) and brine (2 x 10 mL), dried over Na2SO4, filtered and 
concentrated under reduced pressure.  
(+) or (-)-Diisopinocamphyl boron chloride (DIPCl) was dissolved in THF in a two neck 
round bottom flask and cooled to -78 oC. Allylmagnesiumchloride (2M solution in THF, 
1.5 equiv.) was added dropwise into the flask and the solution was stirred at -78 oC for 
1h. Then the reaction mixture was brought to room temperature and stirred another 1h at 
room temperature to allow for formation of the diisopinocamphyl allyl borane complex. 
Then the mixture was cooled again to -78 oC and the solution of the crude aldehyde in 5 
mL THF was added dropwise into the reaction mixture and the mixture was stirred at -78 
oC for 1h. Then the reaction mixture was allowed to warm to room temperature and 
stirred another hour. The mixture was diluted with methanol (10 mL) and DOWEX® 
50WX-200 or sulfonic acid resin 42 was added. The reaction mixture was shaken at room 
temperature for 6h and then filtered. The resin was washed with methanol and DCM, and 
the solvent was evaporated to afford the crude homoallyl alcohol.  
The crude homoallyl alcohol was dissolved in DCM (0.002 M) in a two neck round 
bottom flask containing a refluxing condenser attached. Argon gas was bubbled through 
the solution by a needle for 30 minutes. The Grubbs catalyst was added and the reaction 
mixture was refluxed for 18h. The polymer bound ruthenium metal scavenger resin 44 
(20 equiv relative to the catalyst added) was added and the mixture was shaken at room 
temperature for 10h and then filtered. The resin was washed with DCM, the solvent was 
evaporated and the crude pale yellow diene product was dissolved in THF in a two neck 
round bottom flask and pyridine (1.5 equiv). Either acid chloride or isocyanate (1.5 
equiv) was added and the mixture was stirred at room temperature for 16h. The 
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aminomethylated polystyrene resin 45 (3 equiv. relative to the excess isocyanate or acid 
chloride) was added and the mixture was shaken for 5h and filtered. The resin was 
washed with DCM, the solvent was evaporated and the crude product was again 
dissolved in a minimum amount of toluene. The dienophile (1.5 equiv.) was added and 
the mixture was heated to 70 oC for 6-10h. The solvent was removed in vacuo and the 
crude product was purified as their major isomers by silica gel chromatography. 
 
8.6.1 Analytical data of compound 48: 
 
O
O
O
HN
N
O
O
48
H
HH
Ph
 
 
1H NMR (400 MHz, CDCl3): δ = 7.92-7.82 (m, 3H), 7.67-7.65 (d, J = 8.2 Hz, 1H), 7.52-
7.43 (m, 6H), 7.39-7.36 (m, 1H), 7.25-7.21 (m, 2H), 5.83-5.80 (t, J = 4.8 Hz, 1H), 5.08-
5.07 (m, 1H), 4.23-4.19 (m, 1H), 3.92-3.91 (m, 1H), 3.29-3.26 (m, 1H), 3.22-3.18 (m, 
1H), 2.73-2.69 (m, 1H), 2.54-2.49 (m, 1H), 2.30-2.29 (m, 2H), 1.67-1.59 (m, 1H), 1.56-
1.45 (m, 1H), 1.32-1.26 (m, 8H), 0.92-0.88 (t, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 179.1, 177.7, 154.4, 144.3, 134.3, 132.7, 131.9, 129.4, 
128.9, 126.6, 126.5, 125.9, 125.3, 123.1, 82.4, 73.4, 72.8, 45.0, 39.9, 33.0, 32.0, 29.5, 
27.1, 25.9, 22.8, 14.3. 
HR-MS (FAB, 70 eV): m/z calculated for C34H36N2O5 = 552.2624 found = 552.2600 
[M]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 4:1). 
[ ]20Dα : - 26.5o (c = 2, CHCl3). 
Yield: 40 mg (30 % after 5 steps). 
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8.6.2 Analytical data of compound 49: 
 
49
O
O
O
HN
N
O
O
H
HH
Ph
 
 
1H NMR (400 MHz, CDCl3): δ = 7.47-7.43 (m, 2H), 7.39-7.35 (m, 3H), 7.30-7.27 (m, 
3H), 7.23-7.19 (m, 2H), 7.07-7.03 (m, 1H), 5.83-5.80 (t, J = 4.9 Hz, 1H), 4.17-4.09 (m, 
1H), 3.91-3.88 (t, J = 6.4 Hz, 1H), 3.31-3.27 (m, 1H), 3.21-3.17 (m, 1H), 2.73-2.68 (m, 
1H), 2.56-2.53 (m, 1H), 2.24-2.23 (m, 1H), 1.67-1.65 (m, 1H), 1.57-1.52 (m, 1H), 1.30-
1.23 (m, 8H), 0.90-0.87 (t, J = 6.6 Hz, 3H).  
13C NMR (100 MHz, CDCl3): δ = 179.1, 177.7, 152.9, 144.3, 143.8, 138.0, 131.9, 129.4, 
128.9, 126.5, 123.7, 122.3, 120.7, 82.15, 72.4, 71.1, 45.0, 39.8, 33.3, 33.0, 32.0, 31.9, 
29.5, 27.1, 25.9, 23.7, 22.7, 14.3. 
HR-MS (FAB, 70 eV): m/z calculated for C30H35N2O5 = 503.2468, found = 503.2401 
[M+H]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 4: 1). 
[ ]20Dα : - 19.8o (c = 1, CHCl3). 
Yield: 34 mg (32% after 5 steps). 
 
8.7 General procedure for PCC oxidation: 
To the suspension of pyridinium chlorochromate (3 equiv) in DCM, a solution of the 
secondary alcohol (1 equiv) in DCM was added. The reaction mixture was stirred for 10h 
at room temperature and filtered through a Celite pad. The Celite pad was washed 
thoroughly with DCM. The solvent was evaporated and the residue was purified by silica 
gel chromatography to afford the pure ketone. 
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8.7.1 Analytical data of compound 54: 
 
O
O
54  
 
1H NMR (400 MHz, CDCl3): δ = 6.20-6.13 (dd, J = 11.6 Hz, 17.8 Hz, 9.2 Hz, 1H), 
5.62-5.58 (dd, J = 4.7 Hz, 1H), 5.09-5.01 (m, 2H), 4.49-4.46 (m, 1H), 4.21-4.16 (d, J = 
18.2 Hz, 1H), 4.14-4.09 (m, 1H), 4.05-4.00 (d, J = 18.2 Hz, 1H), 2.78-2.72 (dd, J = 9.2 
Hz, 13.1 Hz, 1H), 1.87-1.80 (m, 1H), 1.77-1.67 (m, 1H), 1.54-1.45 (m, 2H), 1.34-1.24 
(m, 4H), 0.91-0.87 (t, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 209.3, 141.3, 137.6, 120.7, 113.6, 82.7, 74.1, 41.1, 
34.9, 31.9, 25.1, 22.8, 14.3. 
HR-MS (FAB, 70 eV): m/z calculated for C13H20O2 = 208.1463, found = 208.1458 [M]+. 
Rf = 0.5 (cylohexane: ethyl acetate = 9:1). 
[ ]20Dα : + 9.0o (c = 1, CHCl3).   
Yield: 20 mg (30% after 5 steps). 
 
8.8 General procedure for the cross metathesis: 
The diene (1 equiv) and methyl acrylate (1.5 equiv) were dissolved in DCM in a two neck 
round bottom flask under argon. The solution was degassed by bubbling argon for 30 
minutes. The 2nd generation Grubbs catalyst (20 mol %) was added and the reaction 
mixture was refluxed for 10h. The solvent was evaporated and the crude product was 
purified by silica gel chromatography. 
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8.8.1 Analytical data of compound 62: 
 
O
HO
O
O
62
Ha
Hb
(d.r. = 2.5:1)*  
* = isomeric ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, CDCl3): δ = 7.13-7.09 (d, JHa-Hb = 16.2 Hz, 1H), 6.08-6.05 (dd, J = 
5.9 Hz, 8.9 Hz, 1H), 5.07-5.66 (d, JHa-Hb = 16.4 Hz, 1H), 4.41-4.37 (m, 1H), 3.88-3.85 
(m, 1H), 3.73 (s, 3H), 2.88-2.81 (m, 1H), 2.44-2.37 (m, 1H), 2.04 (bs, 1H), 1.71-1.63 (m, 
2H), 1.51-1.43 (m, 2H), 1.31-1.24 (m, 4H), 0.89-0.86 (t, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 167.7, 146.4, 140.9, 135.3, 116.2, 81.4, 73.4, 71.4, 
51.8, 34.3, 32.7, 32.0, 25.3, 22.8, 14.3 
HR-MS (FAB, 70 eV): m/z calculated for C15H24O4 = 268.1675, found = 269.1648 
[M+H]+. 
Rf = 0.3 (cylohexane: ethyl acetate = 3:2). 
Yield: 65 % (after 4 steps). 
 
8.9 General procedure for the synthesis of diacids: 
The functionalized diene (1 equiv) and maleic anhydride (1.5 equiv) were dissolved in 
the minimum volume of toluene and heated at 70 oC for 3h. Then into the reaction 
mixture 20 % water in THF (5 mL) was added and the mixture was stirred at room 
temperature for 6h. Water was removed by azeotropic distillation with ethanol and the 
crude product was purified by silica gel chromatography.  
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8.10 General procedure for the two step synthesis of 
carbamate: 
The secondary alcohol 31 was dissolved in DCM and 1, 1´-carbonyldiimidazole (1.5 
equiv) was added. The mixture was stirred for 10h untill the starting material was totally 
consumed. The solvent was evaporated to afford the imidazole carbamate 75 which was 
dissolved in THF/DMF (4:1). Anhydrous potassium carbonate (2 equiv) and the primary 
or the secondary amines were added and the mixture was stirred at room temperature for 
6h. The mixture was quenched with the polymer supported sulfonic acid resin 42 (3 equiv 
relative to the excess amine and K2CO3 used) or the DOWEX®-50WX-200 resin and 
stirred at room temperature for 4h. The resin was filtered and washed with DCM and the 
solvent was evaporated to afford the crude carbamate 76 which was used without any 
further purification. 
 
8.11 Analytical data of the members of the oxepane 
library: 
8.11.1 Analytical data of compound 55: 
 
O
O
N
O
O
HH
H
55
Ph
 
 
1H NMR (400 MHz, CDCl3): δ = 7.47-7.38 (m, 3H), 7.26-7.24 (m, 2H), 5.90-5.87 (t, J = 
6.0 Hz, 1H), 4.31-4.09 (m, 1H), 4.13-4.09 (d, J = 17.7 Hz, 1H), 3.93-3.88 (d, J = 17.9 Hz, 
1H), 3.71-3.64 (t, J = 13.2 Hz, 1H), 3.29-3.27 (m, 1H), 2.96-2.93 (m, 1H), 2.80-2.74 (m, 
1H), 2.67-2.62 (dd, J = 4.7 Hz, 13.5 Hz,  1H), 2.38-2.31 (m, 1H), 1.75-1.67 (m, 1H), 
1.75-1.67 (m, 1H), 1.56-1.54 (m, 1H), 1.47-1.42 (m, 2H), 1.33-1.20 (m, 6H), 0.87-0.84 (t, 
J = 6.9 Hz, 3H).  
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13C NMR (100 MHz, CDCl3): δ = 212.4, 178.4, 176.7, 143.4, 131.8, 129.3, 128.9, 126.4, 
124.7, 110.8, 82.8, 73.1, 44.9, 41.9, 39.9, 36.8, 35.8, 31.8, 25.8, 24.5, 22.7, 14.2 
HR-MS (FAB, 70 eV): m/z calculated for C23H28NO4 = 382.1940, found = 382.1974 
[M+H]+. 
Rf = 0.5 (cyclohexane: ethyl acetate = 9: 1). 
[ ]20Dα : + 23.2o (c = 1, CHCl3).  
Yield: 14 mg (25% after 5 steps). 
 
8.11.2 Analytical data of compound 56: 
 
O
O
HO
OH
56
H
 
 
1H NMR (400 MHz, CDCl3): δ = 6.99-6.76 (m, 2H), 5.90-5.88 (dd, J = 2.5 Hz, 4.3 Hz, 
1H), 4.16-4.11 (m, 2H), 4.07-4.00 (m, 1H), 3.81-3.76 (d, J = 17.7 Hz, 1H), 3.60-3.54 (dd, 
J = 10.9 Hz, 14.3 Hz, 1H), 3.22-3.14 (m, 1H), 3.0-2.9 (m, 1H), 2.09-2.04 (m, 1H), 1.86-
1.79 (m, 1H), 1.60-1.51 (m, 2H), 1.33-1.22 (m, 6H), 0.89-0.86 (t, J = 6.7 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 203.9, 186.9, 186.6, 147.6, 142.7, 141.5, 138.8, 136.8, 
133.4, 132.9, 123.9, 86.6, 75.4, 48.2, 39.5, 34.1, 31.9, 30.0, 25.8, 22.8, 14.3. 
HR-MS (FAB, 70 eV): m/z calculated for C19H24O4 = 316.1675, found 317.1669 
[M+H]+. 
Rf = 0.4 (cylohexane: ethyl acetate = 4:1). 
[ ]20Dα : + 10.2o (c = 1, CHCl3). 
Yield: 8 mg (14 % after 5 steps). 
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8.11.3 Analytical data of compound 57: 
 
O
O
O
O
O
57
H
H
H
 
 
1H NMR (400 MHz, CDCl3): δ = 5.89-5.86 (t, J = 5.3 Hz, 1H), 4.16-4.11 (d, J = 18.2 
Hz, 1H), 3.91-3.86 (d, J = 18.0 Hz, 1H), 3.69-3.62 (t, J = 13.1 Hz, 1H), 3.43-3.41 (dd, J = 
3.0 Hz, 7.3 Hz, 1H), 3.38-3.34 (dd, J = 5.8 Hz, 9.9 Hz, 1H), 2.82-2.76 (m, 1H), 2.75-2.72 
(dd, J = 3.0 Hz, 6.4 Hz, 1H), 2.56-2.52 (dd, J = 4.5 Hz, 13.1 Hz, 1H), 2.33-2.26 (m, 1H), 
1.73-1.69 (m,1H), 1.47-1.42 (m, 1H), 1.32-1.25 (m, 6H), 0.91-0.87 (t, J = 6.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 211.7, 173.5, 171.6, 143.2, 136.7, 124.9, 82.9, 73.3, 
45.9, 41.7, 40.5, 36.5, 35.5, 31.7, 25.6, 24.3, 22.8, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C17H22O5 = 306.1467, found = 306.1411 [M]+. 
Rf = 0.3 (cyclohexane: ethyl acetate = 1: 1). 
[ ]20Dα : + 30.8o (c = 2, CHCl3). 
Yield: 13.4 mg (25 % after 5 steps). 
 
8.11.4 Analytical data of compound 58: 
 
O
O
CO2MeMeO2C
58
H
 
 
1H NMR (400 MHz, CDCl3): δ = 5.84-5.77 (t, J = 3.1 Hz, 1H), 4.17-4.10 (d, J = 17.9 
Hz, 1H), 4.01-3.98 (m, 1H), 3.91-3.87 (m, 1H), 3.81 (s, 3H), 3.78 (s, 3H), 3.48-3.39 (m, 
1H), 3.07-3.05 (m, 2H), 2.91-2.86 (dd, J = 4.5 Hz, 13.5 Hz, 1H), 2.66-2.60 (dd, J = 9.5 
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Hz, 13.6 Hz, 1H), 1.78-1.66 (m, 1H), 1.56-1.55 (m, 1H), 1.34-1.25 (m, 6H), 0.92-0.88 (t, 
J = 6.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 212.4, 168.1, 167.6, 137.9, 135.7, 133.7, 123.2, 119.4, 
86.1, 83.3, 75.1, 52.7, 47.7, 36.8, 34.2, 31.9, 31.8, 30.9, 28.4, 25.7, 22.8, 14.2 
HR-MS (FAB, 70 eV): m/z calculated for C19H26O6 = 350.1729, found = 351.1700 
[M+H]+. 
Rf = 0.3 (cylohexane: ethyl acetate = 4:1). 
[ ]20Dα : - 27.2o (c = 2, CHCl3). 
Yield: 10.3 mg (30 % after 5 steps). 
 
8.11.5 Analytical data of compound 63: 
 
63
O
O
O
O
HN
O
Ha
Hb
 
 
1H NMR (400 MHz, CDCl3): δ = 7.87-7.84 (m, 3H), 7.66-7.65 (m, 1H), 7.53-7.44 (m, 
3H), 7.17-7.13 (d, JHa-Hb = 16.4 Hz, 1H), 7.03 (bs, 1H), 6.12-6.08 (dd, J = 5.8 Hz, 8.9 Hz, 
1H), 5.75-5.71 (d, JHa-Hb = 16.2 Hz, 1H), 5.17-5.13 (m, 1H), 4.45-4.44 (m, 1H), 4.09-4.06 
(d, J = 14.1 Hz, 1H), 3.88-3.83 (dd, J = 4.7 Hz, 14.3 Hz, 1H), 3.76 (s, 3H), 3.12-3.06 (m, 
1H), 2.57-2.51 (m, 1H), 1.75-1.70 (m, 2H), 1.54-1.52 (m, 2H), 1.34-1.26 (m, 4H), 0.92-
0.89 (t, J = 7.0 Hz, 3H),  
13C NMR (100 MHz, CDCl3): δ = 167.6, 145.9, 141.2, 134.3, 134.1, 132.6, 129.0, 126.5, 
126.2, 126.0, 116.7, 82.2, 74.7, 70.9, 51.9, 34.6, 32.0, 28.5, 27.1, 25.3, 22.9, 14.3. 
HR-MS (FAB, 70 eV): m/z calculated for C26H31NO5 = 437.2202, found = 437.2259 
[M]+. 
Rf = 0.5 (cylohexane: ethyl acetate = 9:1). 
[ ]20Dα : - 22.2o (c = 1, CHCl3). 
Yield: 30 mg (40 % after 5 steps). 
 
 
 161
8.11.6 Analytical data of compound 64: 
 
O
O
O
O
HN
O
64
Ha
Hb
 
 
1H NMR (400 MHz, CDCl3): δ = 7.36-7.25 (m, 4H), 7.15-7.11 (d, JHa-Hb = 16.2 Hz, 1H), 
7.07-7.03 (m, 1H), 6.70 (bs, 1H), 6.11-6.07 (dd, J = 5.8 Hz, 8.9 Hz, 1H), 5.73-5.69 (d, 
JHa-Hb = 16.2 Hz, 1H), 5.10-5.04 (m, 1H), 4.44-4.41 (m, 1H), 4.02-3.98 (d, J = 14.2 Hz, 
1H), 3.84-3.79 (dd, J = 4.7 Hz, 14.2 Hz, 1H), 3.75 (s, 3H), 3.07-2.99 (m, 1H), 2.51-2.44 
(m, 1H), 1.74-1.65 (m, 2H), 1.54-1.46 (m, 2H), 1.33-1.25 (m, 4H), 0.91-0.87 (t, J = 6.9 
Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 167.6, 152.9, 145.9, 141.1, 137.9, 134.0, 129.3, 123.9, 
118.86, 116.7, 82.1, 74.4, 70.8, 51.9, 34.6, 32.0, 28.4, 25.3, 22.9, 14.3. 
HR-MS (FAB, 70 eV): m/z calculated for C22H29NO5 = 387.2046, found = 387.2046 
[M+H]+. 
Rf = 0.5 (cyclohexane: ethyl acetate = 9: 1). 
[ ]20Dα : - 7.2o (c = 1, CHCl3). 
Yield: 35.5 mg (47% after 5 steps). 
 
8.11.7 Analytical data of compound 65: 
 
65
O
O
O
O
H
N
O
Cl
Ha
Hb
 
 
1H NMR (400 MHz, CDCl3): δ = 7.31-7.23 (m, 4H), 7.14-7.11 (d, JHa-Hb = 16.2 Hz, 1H), 
6.74 (bs, 1H), 6.09-6.05 (dd, J = 5.8 Hz, 8.9 Hz, 1H), 5.73-5.69 (d, JHa-Hb = 16.2 Hz, 1H), 
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5.08-5.03 (m, 1H), 4.41-4.37 (m, 1H), 4.00-3.97 (d, J = 14.1 Hz, 1H), 3.83-3.78 (dd, J = 
4.7 Hz, 14.3 Hz, 1H), 3.75 (s, 3H), 3.06-2.99 (m, 1H), 2.50-2.43 (m, 1H), 1.71-1.65 (m, 
2H), 1.52-1.47 (m, 2H), 1.32-1.25 (m, 4H), 0.90-0.87 (t, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 167.5, 152.9, 145.9, 141.2, 136.6, 133.8, 129.3, 120.0, 
116.8, 82.1, 74.6, 70.7, 51.9, 34.6, 32.0, 28.4, 27.1, 25.3, 22.8, 14.3. 
HR-MS (FAB, 70 eV): m/z calculated for C22H28ClNO5 = 421.1656, found = 423.1666 
[M+2H]+. 
Rf = 0.4 (cylohexane: ethyl acetate = 9:1). 
[ ]20Dα : - 30.5o (c = 1, CHCl3). 
Yield: 50 mg (75 % after 5 steps). 
 
8.11.8 Analytical data of compound 66: 
 
O
O
O
O
O
66
Ha
Hb
 
 
1H NMR (400 MHz, CDCl3): δ = 7.14-7.09 (d, JHa-Hb = 16.2 Hz, 1H), 6.08-6.04 (dd, J = 
5.8 Hz, 9.2 Hz, 1H), 5.72-5.68 (d, JHa-Hb = 16.4 Hz, 1H), 5.05-5.01 (m, 1H), 4.41-4.38 
(m, 1H), 3.90-3.86 (d, J = 14 Hz, 1H), 3.74 (s, 3H), 3.00-2.97 (m, 1H), 2.40-2.33 (m, 
1H), 2.30-2.26 (t, J = 7.5 Hz, 2H), 1.70-1.67 (m, 2H), 1.61-1.57 (m, 2H), 1.52-1.46 (m, 
2H), 1.28-1.24 (m, 24H), 0.89-0.85 (m, 6H). 
13C NMR (100 MHz, CDCl3): δ = 173.6, 167.5, 145.9, 141.1, 134.1, 116.6, 82.1, 73.2, 
70.9, 51.8, 34.6, 34.5, 32.1, 32.0, 29.9, 29.8, 29.7, 29.5, 29.4, 29.3, 28.1, 25.2, 25.1, 22.9, 
22.8, 14.3, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C29H51O5 = 479.3658, found = 479.3692 
[M+H]+. 
Rf = 0.5 (cyclohexane: ethyl acetate = 9: 1). 
[ ]20Dα : - 16.3o (c = 1, CHCl3). 
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Yield: 25 mg (47% after 5 steps). 
 
8.11.9 Analytical data of compound 67: 
 
O
COOHHOOC
O
O
HH
H
67
(d.r. = 9:1)*  
* = isomeric ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, DMSO-d6): δ = 5.42-5.40 (t, J = 3.0 Hz, 1H), 4.59-4.56 (m, 1H), 
4.00-3.98 (m, 1H), 3.67-3.64 (m, 1H), 3.13-3.07 (t, J = 10.5 Hz, 1H), 2.83-2.75 (m, 1H), 
2.72-2.62 (m, 2H), 2.28-2.24 (t, J = 7.3 Hz, 2H), 2.04-1.94 (m, 1H), 1.83-1.80 (m, 1H), 
1.52-1.43 (m, 2H), 1.33-1.27 (m, 30H), 0.90-0.86 (m, 6H). 
13C NMR (100 MHz, DMSO-d6): δ = 179.0, 178.5, 170.9, 140.4, 119.3, 79.6, 75.2, 72.9, 
54.9, 45.2, 33.5, 32.5, 32.2, 31.7, 30.6, 30.2, 30.1, 29.5, 29.1, 28.5, 27.9, 26.1, 23.7, 23.3, 
14.9, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C31H52O7 = 536.3713, found = 536.3766 [M]+. 
Rf = 0.5 (ethyl acetate: methanol = 9:1). 
Yield: 12 mg (25 % after 6 steps). 
 
8.11.10 Analytical data of compound 68: 
 
(d.r. = 6:1)*
O
COOHHOOC
O
O
HH
H
68
 
* = isomeric ratio determined by 1H NMR spectroscopy 
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1H NMR (400 MHz, DMSO-d6): δ = 7.92-7.90 (d, J = 8.2 Hz, 1H), 7.83-7.81 (m, 1H), 
7.38-7.34 (t, J = 7.3 Hz, 2H), 5.45-5.43 (t, J = 3.5 Hz, 1H), 4.05-4.00 (m, 1H), 3.85-3.14 
(m, 2H), 2.42 (s, 3H), 2.06-2.00 (m, 2H), 1.78-1.72 (m, 1H), 1.53-1.48 (m, 2H), 1.33-1.22 
(m, 8H), 0.90-0.87 (t, J = 6.7 Hz, 3H). 
13C NMR (100 MHz, DMSO-d6): δ = 179.3, 178.8, 170.4, 145.3, 140.9, 130.4, 129.5, 
126.9, 121.3, 78.3, 75.9, 73.1, 53.0, 45.2, 36.6, 34.2, 30.4, 28.5, 27.2,  26.0, 21.0, 14.1. 
HR-MS (FAB, 70 eV): m/z calculated for C25H31O7 = 443.2148, found = 443.2156 [M-
H]+. 
Rf = 0.5 (ethyl acetate: methanol = 9:1). 
Yield: 27 mg (30 % after 6 steps). 
 
8.11.11 Analytical data of compound 69: 
 
(d.r. = 6.5:1)*
O
COOHHOOC
O
O
HH
H
Cl
Cl
69
 
* = isomeric ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, DMSO-d6): δ = 8.12-8.04 (m, 1H), 7.96-7.93 (m, 1H), 7.88-7.83 
(m, 1H), 5.41-5.39 (t, J = 4.0 Hz, 1H), 4.05-4.02 (m, 1H), 3.45-3.29 (m, 3H), 2.84-2.70 
(m, 3H), 2.02-1.89 (m, 2H), 1.57-1.45 (m, 2H), 1.34-1.26 (m, 8H), 0.90-0.85 (t, J = 6.8 
Hz, 3H). 
13C NMR (100 MHz, DMSO-d6): δ = 180.5, 178.2, 165.4, 140.7, 138.9, 133.9, 130.4, 
129.5, 129.2, 120.9, 80.9, 75.3, 73.1, 53.8, 45.9, 33.5, 32.2, 31.7, 30.6, 29.5, 28.5, 26.1, 
23.7, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C24H27Cl2O7 = 497.1212, found = 497.1296 
[M-H]+. 
Rf = 0.4 (ethyl acetate: methanol = 9:1). 
Yield: 25 mg (24 % after 6 steps). 
 
 
 165
8.11.12 Analytical data of compound 70: 
 
(d.r. = 8:1)*
O
COOHHOOC
O
O
HH
H
F
70
 
* = isomeric ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, DMSO-d6): δ = 7.86-7.82 (dt, J = 1.7 Hz, 8.5 Hz, 1H), 7.73-7.67 
(m, 1H), 7.37-7.33 (m, 2H), 5.45-5.44 (t, J = 3.5 Hz, 1H), 4.85-4.79 (m, 1H), 4.06-4.02 
(m, 1H), 3.86-3.83 (m, 1H), 3.36-3.25 (m, 2H), 2.85-2.77 (m, 1H), 2.72-2.71 (m, 1H), 
2.02-1.99 (m, 2H), 1.59-1.50 (m, 2H), 1.39-1.24 (m, 8H), 0.91-0.87 (t, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, DMSO-d6): δ = 179.3, 178.8, 169.7, 159.4, 135.3, 130.9, 126.6, 
120.4, 115.9, 80.5, 75.9, 73.1, 54.9, 41.5, 34.9, 31.9, 31.2, 30.0, 29.1, 28.9, 27.1, 24.7, 
14.2. 
19F NMR (338.6 MHz, DMSO-d6 ): -121.1.  
HR-MS (FAB, 70 eV): m/z calculated for C24H29FO7 = 448.1897, found = 448.1811 
[M]+. 
Rf = 0.3 (ethyl acetate: methanol = 9:1). 
Yield: 20 mg (21 % after 6 steps). 
 
8.11.13 Analytical data of compound 71: 
 
(d.r. = 6:1)*
O
COOHHOOC
O
O
H
N
HH
H
71
Cl
 
* = isomeric ratio determined by 1H NMR spectroscopy 
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1H NMR (400 MHz, DMSO-d6): δ = 9.88 (bs, 1H), 7.58-7.56 (d, J = 8.6 Hz, 1H), 7.50-
7.47 (d, J = 9.0 Hz, 1H), 7.35-7.32 (m, 2H), 5.43-5.41 (t, J = 4.0 Hz, 1H), 4.02-3.91 (m, 
1H), 3.40-3.33 (m, 3H), 2.83-2.67 (m, 2H), 2.01-1.87 (m, 2H), 1.71-1.70 (m, 1H), 1.56-
1.49 (m, 1H), 1.33-1.28 (m, 9H), 0.91-0.87 (t, J = 6.6 Hz, 3H). 
13C NMR (100 MHz, DMSO-d6): δ = 180.3, 179.8, 154.9, 140.9, 133.3, 130.9, 129.5, 
124.5, 123.9, 120.6, 80.9, 75.7, 73.1, 54.3, 45.2, 35.2, 33.4, 25.3, 22.0, 14.9. 
HR-MS (FAB, 70 eV): m/z calculated for C24H30ClNO7 = 479.1711, found = 479.1795 
[M]+. 
Rf = 0.4 (ethyl acetate: methanol = 9:1). 
Yield: 14.2 mg (26 % after 6 steps). 
 
8.11.14 Analytical data of compound 77: 
 
O
O
H
N
O
O
H
HH
O
HN
O
O
77  
 
1H NMR (400 MHz, CDCl3): δ = 8.54 (bs, 1H), 6.74-6.70 (m, 3H), 5.92 (s, 2H), 5.74-
5.72 (t, J = 4.7 Hz, 1H), 4.74-4.67 (m, 1H), 4.25-4.20 (m, 2H), 3.92-3.88 (m, 1H), 3.86-
3.82 (t, J = 6.2 Hz, 1H), 3.32-3.27 (t, J = 11.0 Hz, 1H), 3.16-3.10 (m, 1H), 3.06-3.02 (dd, 
J = 6.1 Hz, 9.6 Hz, 1H), 2.57-2.52 (m, 1H), 2.10-2.07 (m, 1H), 1.57-1.53 (m, 1H), 1.48-
1.45 (m, 2H), 1.28-1.24 (m, 6H), 0.88-0.85 (t, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 180.3, 178.5, 155.5, 148.1, 143.9, 132.5, 122.8, 121.1, 
108.5, 101.3, 82.5, 72.8, 69.8, 54.1, 46.1, 45.1, 34.1, 33.2, 31.9, 29.5, 27.1, 25.7, 22.8, 
14.3. 
HR-MS (FAB, 70 eV): m/z calculated for C26H31N2O7 = 483.221, found = 483.2279 [M-
H]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 3: 2). 
[ ]20Dα : + 19.3o (c = 1, CHCl3). 
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Yield: 26 mg (16 % after 6 steps). 
 
8.11.15 Analytical data of compound 78: 
 
O
O
O
HN
H
H
N
O O
HH
78  
 
1H NMR (400 MHz, CDCl3): δ = 8.5 (bs, 1H), 5.76-5.73 (t, J = 5.0 Hz, 1H), 4.71-4.65 
(m, 1H), 3.92-3.82 (m, 2H), 3.15-3.04 (m, 4H), 2.83-2.79 (m, 1H), 2.61-2.54 (m, 1H), 
2.45-2.37 (m, 1H), 2.10-2.08 (m, 1H), 1.85-1.73 (m, 1H), 1.61-1.40 (m, 3H), 1.28-1.24 
(m, 26H), 0.88-0.85 (m, 6H). 
13C NMR (100 MHz, CDCl3): δ = 180.5, 178.8, 158.9, 155.8, 144.3, 123.0, 82.7, 72.8, 
71.6, 53.2, 46.5, 41.6, 41.3, 40.9, 34.5, 33.5, 32.5, 30.7, 30.4, 30.2, 30.1, 29.9, 29.8, 27.5, 
27.3, 26.1, 23.2, 23.1, 14.7, 14.6. 
HR-MS (FAB, 70 eV): m/z calculated for C30H49N2O5 = 517.372, found = 517.3759 [M-
H]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 3: 2). 
[ ]20Dα : + 6.1o (c = 1, CHCl3). 
Yield: 55 mg (24 % after 6 steps). 
 
8.11.16 Analytical data of compound 79: 
 
O
O
O
N
HH
H
H
N
O
O
79  
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1H NMR (400 MHz, CDCl3): δ = 8.44 (bs, 1H), 5.74-5.72 (t, J = 3.5 Hz, 1H), 3.93-3.91 
(m, 1H), 3.85-3.83 (m, 1H), 3.40-3.33 (m, 4H), 3.20-3.14 (m, 1H), 3.07-3.04 (m, 1H), 
2.85-2.79 (m, 1H), 2.62-2.56 (m, 1H), 2.45-2.40 (m, 1H), 2.12-2.09 (m, 1H), 1.90-1.87 
(m, 1H), 1.54-1.49 (m, 10H), 1.26-1.24 (m, 6H), 0.88-0.84 (t, J = 6.5 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 180.4, 178.7, 162.4, 160.3, 157.1, 154.5, 144.1, 135.3, 
122.5, 117.2, 82.5, 73.0, 64.3, 45.0, 33.0, 31.9, 29.5, 25.7, 24.5, 23.0, 22.8, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C23H33N2O5 = 418.2468, found = 418.2491 
[M-H]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 3: 2). 
[ ]20Dα : + 26.9o (c = 1, CHCl3). 
Yield: 22 mg (16 % after 6 steps). 
 
8.11.17 Analytical data of compound 93: 
 
(d.r. = 3:2)*
O
COOHHOOC
O
O
H
N
HH
H
93
 
* = isomeric ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, DMSO-d6): δ = 7.76-7.68 (m, 1H), 7.36-7.24 (m, 5H), 5.41-5.39 (t, 
J = 3.5 Hz, 1H), 4.20-4.18 (m, 2H), 4.00-3.98 (m, 1H), 3.35-3.30 (m, 5H), 2.83-2.69 (m, 
3H), 2.23-1.92 (m, 1H), 1.87-1.82 (m, 1H), 1.40-1.25 (m, 9H), 0.90-0.87 (t, J = 7.0 Hz, 
3H). 
13C NMR (100 MHz, DMSO-d6): δ = 180.6, 178.9, 160.3, 142.6, 140.0, 129.4, 128.3 
127.5, 126.8, 125.4, 120.3, 79.3, 75.2, 71.9, 54.2, 46.9, 42.1, 35.6, 33.2, 32.4, 29.5, 28.2,  
27.0, 20.0, 14.5. 
HR-MS (FAB, 70 eV): m/z calculated for C25H33NO7 = 459.2257, found = 459.2278 [M-
H]+. 
Rf = 0.5 (ethyl acetate: methanol = 9:1). 
 
 
 169
Yield: 11 mg (41 % after 7 steps). 
 
8.11.18 Analytical data of compound 94: 
 
O
O
O
N
HH
H
COOHHOOC
94
(d.r. = 4:1)*  
* = isomeric ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, DMSO-d6): δ = 5.48-5.46 (t, J = 3.5 Hz, 1H), 4.48-4.45 (m, 1H), 
3.71-3.63 (m, 2H), 3.51-3.30 (m, 4H), 3.08-3.03 (m, 1H), 2.81-2.77 (m, 2H), 2.65-2.63 
(m, 1H), 2.65-2.63 (t, J = 4.0 Hz, 1H), 1.90-1.77 (m, 5H), 1.73-1.69 (m, 5H), 1.58-1.43 
(m, 6H), 1.22-1.17 (m, 2H). 
13C NMR (100 MHz, DMSO-d6): δ = 184.1, 177.4, 168.3, 154.7, 148.3, 137.0, 121.6, 
79.8, 73.2, 66.8, 65.6, 60.7, 51.2, 50.3, 45.2, 37.6, 36.6, 35.1, 32.5, 30.5, 28.6, 27.3, 27.2, 
26.7, 26.2, 24.9, 24.7, 22.3, 21.7. 
HR-MS (FAB, 70 eV): m/z calculated for C23H32NO7 = 434.2257, found = 434.2296 [M-
H]+. 
Rf = 0.5 (ethyl acetate: methanol = 9:1). 
Yield: 70 mg (34 % after 7 steps). 
 
8.11.19 Analytical data of compound 95: 
 
O
O
H
NO O
H H
O
H
N
(d.r. = 8:1)*
95
Ph
 
* = inseparable mixture, ratio determined by 1H NMR spectroscopy 
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1H NMR (400 MHz, CDCl3): δ = 7.50-7.45 (m, 2H), 7.41-7.39 (m, 1H), 7.31-7.27 (m, 
2H), 5.82-5.78 (m, 1H), 4.77-4.73 (m, 1H), 3.61-3.58 (m, 1H), 3.26-3.19 (m, 2H), 3.16-
3.09 (m, 2H), 2.80-2.74 (m, 1H), 2.53-2.44 (m, 1H), 2.07-1.82 (m, 2H), 1.71-1.57 (m, 
6H), 1.48-1.43 (m, 4H), 1.30-1.25 (m, 8H), 0.89-0.86 (t, J = 6.0 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 179.4, 177.4, 156.2, 155.5, 149.4, 148.7, 132.0, 129.4, 
129.3, 128.7, 126.6, 126.5, 121.5, 120.6, 78.5, 72.1, 69.7, 64.4, 54.1, 53.7, 44.9, 44.7, 
41.2, 38.7, 31.9, 31.6, 31.4, 26.6, 26.0, 22.7, 21.9, 21.6, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C30H41N2O5 = 509.2937, found = 509.2971 
[M+H]+. 
Rf = 0.3 (cyclohexane: ethyl acetate = 4: 1). 
Yield: 78 mg (32% after 6 steps). 
 
8.11.20 Analytical data of compound 96: 
 
O
O
H
O
HN
NO O
HH
(d.r. = 7.5:1)*
96
Ph
 
* = inseparable mixture, ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, CDCl3): δ = 7.48-7.45 (m, 3H), 7.41-7.39 (m, 1H), 7.31-7.27 (m, 
3H), 7.23-7.17 (m, 3H), 7.13 (bs, 1H), 5.84-5.81 (dd, J = 2.7 Hz, 6.8 Hz, 1H), 4.81-4.76 
(m, 1H), 4.31-4.28 (m, 2H), 3.83-3.63 (m, 1H), 3.26-3.16 (m, 1H), 3.14-3.09 (dd, J = 6.6 
Hz, 9.9 Hz, 1H), 2.79-2.72 (m, 1H), 2.52-2.45 (m 1H), 2.07-2.00 (m, 1H), 1.93-1.86 (m, 
2H), 1.71-1.58 (, 6H), 1.28-1.14 (m, 6H). 
13C NMR (100 MHz, CDCl3): δ = 179.4, 177.4, 155.6, 148.6, 140.8, 134.6, 131.9, 130.2, 
129.4, 128.8, 127.7, 126.5, 125.7, 121.6, 79.5, 71.4, 69.7, 54.1, 47.6, 44.9, 43.8, 41.2, 
38.7, 35.7, 31.9, 29.5, 27.1, 25.9, 21.9, 21.6. 
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HR-MS (FAB, 70 eV): m/z calculated for C31H34N2O5 = 514.2468, found = 514.2445 
[M]+. 
Rf = 0.3 (cyclohexane: ethyl acetate = 4: 1). 
Yield: 99 mg (40% after 6 steps). 
 
8.11.21 Analytical data of compound 97: 
 
(d.r. = 5:1)*
O
O
O
H
N
H
COOHHOOC
HH
97
Cl
 
* = inseparable mixture, ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, DMSO-d6): δ = 7.37-7.23 (m, 5H), 5.48-5.50 (t, J = 4.8 Hz, 1H), 
4.52-4.49 (m, 3H), 4.38-4.19 (m, 2H), 2.99-2.93 (m, 3H), 2.81-2.78 (m, 2H), 1.89-1.09 
(m, 14H). 
13C NMR (100 MHz, DMSO-d6): δ = 178.2, 177.1, 156.8, 145.5, 143.2, 133.9, 131.1, 
127.8, 127.6, 127.5, 126.7, 79.8, 69.4, 56.7, 35.1, 34.5, 33.0, 30.5, 28.6, 27.3, 26.7. 
HR-MS (FAB, 70 eV): m/z calculated for C25H29ClNO7 = 490.1711, found = 490.1759 
[M-H]+. 
Rf = 0.4 (ethyl acetate: methanol = 9:1). 
Yield: 32 mg (15 % after 7 steps). 
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8.11.22 Analytical data of compound 98: 
 
O
O
O
N
H
NO O
H H
(d.r. = 8:1)*
98
Ph
 
* = inseparable mixture, ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, CDCl3): δ = 7.46-7.43 (m, 2H), 7.40-7.35 (m, 1H), 7.29-7.26 (m, 
2H), 5.81-5.78 (dd, J = 2.6 Hz, 6.9 Hz, 1H, major isomer), 5.77-5.75 (dd, J = 2.4 Hz, 7.2 
Hz, 1H, minor isomer), 4.79-4.72 (m, 1H), 3.78-3.71 (m, 1H), 3.59-3.56 (m, 1H), 3.41-
3.31 (m, 4H), 3.24-3.07 (m 2H), 2.79-2.72 (m, 1H), 2.53-2.43 (m, 1H), 2.05-2.01 (m, 
1H), 1.91-1.87 (m, 1H), 1.71-1.42 (m, 16H). 
13C NMR (100 MHz, CDCl3): δ = 179.5, 177.6, 177.4, 155.0, 154.5, 149.4, 148.8, 132.0, 
129.4, 129.3, 128.8, 128.7, 126.6, 126.5, 121.4, 120.6, 71.1, 69.7, 64.5, 63.5, 54.1, 53.6, 
45.0, 44.8, 38.7, 36.6, 33.4, 31.9, 29.5, 27.1, 26.0, 24.5, 21.9, 21.6. 
HR-MS (FAB, 70 eV): m/z calculated for C29H35N2O5 = 491.2624, found = 491.2600 
[M-H]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 4: 1). 
Yield: 75 mg (32% after 6 steps). 
 
8.11.23 Analytical data of compound 99: 
 
O
O
O
HN
HH
H
N
O
O
O
O
(d.r. = 8:1)*
99
Ph
 
* = inseparable isomers, determined by 1H NMR spectroscopy 
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1H NMR (400 MHz, CDCl3): δ = 7.49-7.45 (m, 2H), 7.42-7.38 (m, 1H), 7.30-7.28 (m, 
2H), 6.78-6.71 (m, 3H), 5.92 (s, 2H), 5.83-5.81 (dd, J = 2.6 Hz, 6.8 Hz, 1H), 4.80-4.75 
(m, 1H), 4.24-4.21 (m, 2H), 3.63-3.59 (m, 1H), 3.26-3.16 (m, 2H), 3.14-3.09 (m, 1H), 
2.78-2.74 (m, 1H), 2.52-2.44 (m, 1H), 2.09-2.06 (m 1H), 1.92-1.86 (m, 2H), 1.71-1.57 
(m, 5H), 1.28-1.16 (m, 5H). 
13C NMR (100 MHz, CDCl3): δ = 179.4, 177.4, 148.7, 148.1, 147.1, 132.6, 131.9, 129.4, 
129.3, 128.8, 128.6, 126.6, 126.5, 121.6, 121.0, 120.6, 108.4, 101.2, 78.5, 72.5, 71.2, 
69.7, 64.4, 54.1, 53.7, 45.1, 44.7, 38.7, 31.9, 31.1, 29.5, 27.1, 26.0, 22.1, 21.9, 21.6. 
HR-MS (FAB, 70 eV): m/z calculated for C32H34N2O7 = 558.2366, found = 558.2300 
[M]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 4: 1). 
Yield: 87 mg (32 % after 6 steps). 
 
8.11.24 Analytical data of compound 100: 
 
O
O
O
N
HH
H
N
O
O
O
Ph
(d.r. = 8:1)*
100
 
*= inseparable mixture, determined by 1H NMR 
 
1H NMR (400 MHz, CDCl3): δ = 7.50-7.46 (m, 2H), 7.41-7.39 (m, 1H), 7.32-7.29 (m, 
2H), 5.84-5.82 (dd, J = 2.6 Hz, 6.9 Hz, 1H), 4.84-4.77 (m, 1H), 3.68-3.66 (m, 1H), 3.62-
3.59 (m, 4H), 3.48-3.36 (m, 4H), 3.27-3.20 (m, 1H), 3.16-3.10 (m, 1H), 2.84-2.76 (m, 
1H), 2.53-2.39 (m, 1H), 2.09-2.05 (m, 1H), 1.92-1.89 (m, 1H), 1.75-1.58 (m, 6H), 1.30-
1.25 (m, 4H). 
13C NMR (100 MHz, CDCl3): δ = 179.3, 179.2, 177.5, 177.3, 154.9, 154.4, 149.2, 148.7, 
131.9, 129.4, 128.7, 126.6, 126.4, 121.5, 120.7, 78.5, 71.7, 69.6, 66.7, 64.3, 63.3, 54.0, 
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53.6, 44.9, 44.2, 38.7, 38.6, 36.6, 35.9, 33.3, 31.9, 29.4, 27.1, 25.9, 22.2, 22.0, 21.9, 21.6, 
21.5. 
HR-MS (FAB, 70 eV): m/z calculated for C28H34N2O6 = 494.2417, found = 494.2477 
[M]+. 
Rf = 0.3 (cyclohexane: ethyl acetate = 4: 1). 
Yield: 80 mg (34 % after 6 steps). 
 
8.11.25 Analytical data of compound 101: 
 
O
N
O
O
O
O
HN
Cl
H
HH
101
(d.r. = 6:1)*
Ph
 
*= inseparable mixture, determined by 1H NMR 
 
1H NMR (400 MHz, CDCl3): δ = 7.48-7.45 (m, 2H), 7.41-7.39 (m, 1H), 7.31-7.28 (m, 
3H), 7.23-7.18 (m, 3H), 7.13 (bs, 1H), 5.84-5.81 (dd, J = 2.7 Hz, 6.8 Hz, 1H), 4.81-4.76 
(m, 1H), 4.31-4.29 (m, 2H), 3.83-3.60 (m, 1H), 3.26-3.16 (m, 1H), 3.14-3.09 (dd, J = 6.6 
Hz, 9.9 Hz, 1H), 2.79-2.72 (m, 1H), 2.52-2.45 (m, 1H), 2.07-2.06 (m, 1H), 1.93-1.86 (m, 
1H), 1.71-1.58 (m, 6H), 1.28-1.14 (m, 6H). 
13C NMR (100 MHz, CDCl3): δ = 179.4, 177.4, 156.3, 155.6, 148.6, 140.8, 134.6, 131.9, 
130.2, 129.4, 128.8, 127.8, 126.6, 125.8, 121.7, 120.7, 79.5, 71.4, 69.7, 54.1, 47.6, 44.9, 
43.9, 38.7, 36.5, 35.7, 31.9, 29.5, 27.1, 25.9, 21.9, 21.6. 
HR-MS (FAB, 70 eV): m/z calculated for C31H33ClN2O5 = 548.2078, found = 548.2094 
[M]+. 
Rf = 0.4(cyclohexane: ethyl acetate = 4: 1). 
Yield: 83 mg (32 % after 7 steps).  
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8.11.26 Analytical data of compound 102: 
 
O
O
O
HN
H
HOOC COOH
HH
(d.r. = 4:1)*
102
 
* = inseparable mixture, ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, DMSO-d6): δ =  7.75-7.72 (t, J = 6.1 Hz, 1H), 7.36-7.24 (m, 5H), 
5.48-5.47 (t, J = 3.5 Hz, 1H), 4.48-4.46 (m, 1H), 4.20-4.17 (t, J = 5.3 Hz, 2H), 3.74-3.70 
(m, 1H), 3.55-3.50 (m, 1H), 3.39-3.30 (m, 5H), 2.78-2.76 (m, 2H), 1.67-1.35 (m, 10H). 
3C NMR (100 MHz, DMSO-d6): δ = 177.2, 156.6, 148.2, 140.6, 129.2, 129.1, 127.8, 
121.6, 79.8, 72.5, 65.7, 51.5, 44.6, 43.2, 37.7, 36.8, 33.0, 32.6, 30.5, 27.3, 27.1, 26.7, 
26.6, 22.3, 22.2. 
HR-MS (FAB, 70 eV): m/z calculated for C25H31NO7 = 457.2101, found = 457.2155 
[M]+.  
Rf = 0.4 (ethyl acetate: methanol = 9: 1). 
Yield: 45 mg (20% after 7 steps). 
 
8.11.27 Analytical data of compound 103: 
 
O
O
COOHHOOC
HH
H
O
H
N
(d.r. = 7:1)*
103
 
*= inseparable mixture ratio determined by 1H NMR spectroscopy 
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1H NMR (400 MHz, DMSO-d6): δ = 5.48-5.47 (t, J = 4.3 Hz, 1H), 4.48-4.42 (m, 1H), 
3.73-3.62 (m, 5H), 3.55-3.47 (m, 5H), 3.01-2.92 (m, 3H), 2.82-2.76 (m, 3H), 1.85-1.37 
(m, 14H), 0.90-0.87 (t, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, DMSO-d6 ): δ = 176.8, 159.3, 156.0, 136.8, 123.5, 121.3, 120.3, 
79.6, 74.3, 69.5, 51.9, 41.3, 32.3, 31.6, 30.3, 29.9, 26.6, 25.9, 22.7, 22.1. 
HR-MS (FAB, 70 eV): m/z calculated for C24H37NO7 = 451.257, found = 451.2592 
[M]+. 
Rf = 0.4 (dichloromethane: methanol = 9: 1). 
Yield: 25 mg (15 % after 7 steps). 
 
8.11.28 Analytical data of compound 104: 
 
O
O
HH
H
O
N
H
N
O
O
O
104  
 
1H NMR (400 MHz, CDCl3): δ = 8.91 (bs, 1H), 5.81-5.78 (dd, J = 2.8 Hz, 6.8 Hz, 1H), 
4.77-4.69 (m, 1H), 3.54-3.65 (m, 6H), 3.42-3.30 (m, 5H), 3.11-3.00 (m, 3H), 2.67-2.58 
(m, 1H), 2.43-2.33 (m, 1H), 2.05-1.98 (m, 1H), 1.31 (s, 3H), 1.22 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 180.7, 178.8, 154.5, 147.9, 124.4, 121.6, 78.4, 73.0, 
66.7, 65.2, 46.1, 44.4, 39.8, 32.7, 31.8, 29.5, 27.4, 27.1, 22.0, 20.8. 
HR-MS (FAB, 70 eV): m/z calculated for C19H25N2O6 = 377.1791, found = 377.1723 
[M-H]+. 
Rf = 0.5 (cyclohexane: ethyl acetate = 3: 2). 
[ ]20Dα : + 5.6o (c = 1, CHCl3). 
Yield: 45 mg (23 % after 6 steps). 
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8.11.29 Analytical data of compound 105: 
 
O
O
O
N
H
NO O
H
H H
105  
 
1H NMR (400 MHz, CDCl3): δ = 5.79-5.77 (dd, J = 2.8 Hz, 6.9 Hz, 1H), 4.75-4.68 (m, 
1H), 3.55-3.51 (m, 1H), 3.29-3.23 (m, 4H), 3.11-3.04 (dd, J = 9.6 Hz, 17.7 Hz,  2H), 
3.00-2.97 (dd, J = 6.6 Hz, 9.8 Hz, 1H), 2.66-2.56 (m, 1H), 2.42-2.35 (m, 1H), 2.02-1.98 
(m, 1H), 1.52-1.50 (m, 4H), 1.47-1.44 (m, 4H), 1.30 (s, 3H), 1.20 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 180.7, 178.7, 154.5, 148.1, 121.4, 78.2, 72.5, 65.4, 
54.1, 46.1, 44.9, 39.8, 32.7, 31.9, 31.1, 29.5, 27.5, 27.1, 24.5, 22.0, 22.2. 
HR-MS (FAB, 70 eV): m/z calculated for C20H27N2O5 = 375.1998 found = 375.1920 
[M-H]+.  
Rf = 0.3 (cyclohexane: ethyl acetate = 3.5: 0.5). 
[ ]20Dα : + 10.1o (c = 1, CHCl3). 
Yield: 53 mg (22% after 6 steps). 
 
8.11.30 Analytical data of compound 106: 
 
O
H
N
O
O
O
O
HN
H
HH
106  
 
1H NMR (400 MHz, CDCl3): δ = 8.95 (bs, 1H), 7.29-7.19 (m, 5H), 5.78-5.75 (dd, J = 
2.8 Hz, 6.7 Hz, 1H), 4.75-4.69 (m, 1H), 4.35-4.23 (m, 2H), 3.56-3.53 (m, 1H), 3.24-3.19 
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(m, 1H), 3.07-3.01 (m, 2H), 2.99-2.95 (m, 1H), 2.65-2.55 (m, 1H), 2.36-2.32 (m, 1H), 
2.02-1.98 (m, 2H), 1.29 (s, 3H), 1.22 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 180.7, 178.8, 156.3, 155.6, 147.8, 138.6, 128.8, 127.7, 
121.7, 78.5, 72.6, 69.8, 65.2, 54.1, 46.1, 45.2, 39.7, 32.6, 31.9, 31.1, 29.5, 27.4. 
HR-MS (FAB, 70 eV): m/z calculated for C22H27N2O5 = 399.1842, found = 399.1893 
[M+H]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 3: 2). 
[ ]20Dα : + 30.6o (c = 1, CHCl3). 
Yield: 49mg (20% after 7 steps). 
 
8.11.31 Analytical data of compound 107: 
 
O
O
H
H
NO O
H H
O
HN
Cl
107  
 
1H NMR (400 MHz, CDCl3): δ = 8.94 (bs, 1H), 7.31-7.15 (m, 4H), 5.85-5.83 (dd, J = 
2.8 Hz, 6.7 Hz, 1H), 4.83-4.75 (m, 1H), 4.35-4.32 (m, 2H), 3.62-3.59 (m, 1H), 3.32-3.27 
(m, 1H), 3.13-3.03 (m, 3H), 2.63-2.56 (m, 1H), 2.43-2.41 (m, 1H), 2.07-2.02 (m, 2H), 
1.36 (s, 3H), 1.28 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 180.7, 178.8, 155.7, 147.7, 140.7, 134.6, 130.1, 127.8, 
125.8, 121.7, 72.8, 69.8, 65.1, 54.1, 46.1, 44.6, 39.7, 31.9, 29.5, 27.4, 27.1. 
HR-MS (FAB, 70 eV): m/z calculated for C22H24ClN2O5 = 431.1452, found = 431.1400 
[M-H]+. 
Rf = 0.3 (cyclohexane: ethyl acetate = 3: 2). 
[ ]20Dα : + 2.5o (c = 1, CHCl3). 
Yield: 44 mg (16% after 6 steps). 
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8.11.32 Analytical data of compound 108: 
 
O
H
N
O
O
O
O
H
N
HH
H
(d.r. = 3:1)*
108
 
* = inseparable mixture, ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, CDCl3): δ = 9.09 (bs, 1H), 5.78-5.76 (dd, J = 2.5 Hz, 6.7 Hz, 1H), 
4.67-4.65 (m, 1H), 3.55-3.37 (m, 1H), 3.24-3.18 (m, 1H), 3.10-2.96 (m, 4H), 2.65-2.55 
(m, 1H), 2.40-2.29 (m, 1H), 1.99-1.95 (m, 1H), 1.45-1.42 (m, 2H), 1.29-1.20 (m, 14H), 
0.84-0.82 (t, J = 5.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 180.9, 178.9, 171.4, 156.2, 155.5, 147.9, 135.3, 121.6, 
120.6, 72.2, 70.7, 69.8, 65.2, 60.6, 54.1, 46.1, 41.2, 39.7, 33.2, 31.9, 31.6, 30.9, 30.0, 
29.4, 27.8, 27.1, 26.6, 22.7, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C21H31N2O5 = 391.2311, found = 391.2397 
[M-H]+. 
Rf = 0.3 (cyclohexane: ethyl acetate = 3: 2). 
Yield: 78 mg (31 % after 6 steps). 
 
8.11.33 Analytical data of compound 109: 
 
O
N
O
O
O
O
HN
HH
H
(d.r. = 3:1)*
109
Ph
 
*= inseparable mixture, ratio determined by 1H NMR spectroscopy 
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1H NMR (400 MHz, CDCl3): δ = 7.49-7.45 (m, 2H), 7.41-7.39 (m, 1H), 7.34-7.26 (m, 
7H), 5.83-5.81 (dd, J = 2.4 Hz, 6.9 Hz, 1H), 4.81-4.77 (m, 1H), 4.37-4.32 (m, 2H), 4.15-
4.04 (m, 1H), 3.80-3.70 (m, 1H), 3.67-3.60 (m, 1H), 3.24-3.19 (m, 1H), 3.13-3.11 (m, 
1H), 2.80-2.72 (m, 1H), 2.53-2.47 (m, 1H), 2.40-2.34 (m, 1H), 1.96-1.87 (m, 2H), 1.77-
1.55 (m, 6H), 1.30-1.11 (m, 5H). 
13C NMR (100 MHz, CDCl3): δ = 179.4, 177.4, 171.4, 155.6, 148.7, 138.7, 131.9, 129.5, 
129.3, 128.8, 128.7, 127.7, 126.5, 126.3, 121.6, 120.7, 79.5, 71.8, 69.7, 64.4, 60.6, 54.1, 
53.7, 48.1, 47.9, 45.2, 44.7, 43.9, 42.2, 39.2, 38.4, 34.6, 31.9, 29.5, 27.9, 27.1, 23.9, 21.9, 
21.6, 20.9, 14.4. 
HR-MS (FAB, 70 eV): m/z calculated for C31H34N2O5 = 514.2468, found = 514.2445 
[M]+. 
 Rf = 0.3 (cyclohexane: ethyl acetate = 4: 1). 
Yield: 31 mg (15 % after 6 steps). 
 
8.11.34 Analytical data of compound 110: 
 
O
H
N
O
O
O
O
HN
H
HH
Cl
110
(d.r. = 4:1)*  
* = inseparable mixture, ratio determined by 1H NMR 
 
1H NMR (400 MHz, CDCl3): δ = 8.68 (bs, 1H), 7.30-7.16 (m, 4H), 5.76-5.75 (dd, J = 
2.6 Hz, 6.5 Hz, 1H), 4.71-4.77 (m, 1H), 4.34-4.25 (m, 2H), 3.78-3.74 (m, 1H), 3.46-3.40 
(m, 1H), 3.10-2.98 (m, 3H), 2.67-2.56 (m, 2H), 2.38-2.26 (m, 1H), 1.86-1.82 (m, 1H), 
1.32 (s, 3H), 1.24 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 180.6, 178.8, 148.3, 147.8, 141.5, 140.8, 134.6, 130.3, 
130.1, 128.0, 127.8, 127.7, 126.1, 120.7, 69.8, 54.0, 45.7, 44.7, 39.5, 33.3, 31.9, 30.9, 
29.5, 27.8, 27.1. 
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HR-MS (FAB, 70 eV): m/z calculated for C22H24ClN2O5 = 431.1452, found = 431.1400 
[M-H]+. 
Rf = 0.2 (cyclohexane: ethyl acetate = 3: 2). 
Yield: 25mg (10% after 6 steps). 
 
8.11.35 Analytical data of compound 111: 
 
O
O
HH
H
O
N
H
N
O
O
O
111
(d.r. = 3:2)*  
* = inseparable mixture, ratio determined by 1H NMR 
 
1H NMR (400 MHz, CDCl3): δ = 8.70 (bs, 1H), 5.82-5.79 (dd, J = 2.7 Hz, 6.8 Hz, 1H), 
4.76-4.74 (m, 1H), 3.68-3.53 (m, 5H), 3.43-3.37 (m, 5H), 3.12-3.00 (m, 3H), 2.71-2.62 
(m, 1H), 2.42-2.29 (m, 1H), 2.05-1.78 (m, 1H), 1.35 (s, 3H), 1.26 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 180.5, 178.7, 178.5, 154.9, 148.5, 147.9, 120.6, 78.4, 
71.7, 66.8, 65.2, 64.4, 54.0, 46.1, 45.8, 39.5, 36.7, 33.4, 30.9, 29.5, 27.9, 27.4, 27.1, 21.7. 
HR-MS (FAB, 70 eV): m/z calculated for C19H25N2O6 = 377.1791, found = 377.1723 
[M-H]+. 
Rf = 0.3 (cyclohexane: ethyl acetate = 3: 2). 
Yield: 30 mg (15 % after 6 steps). 
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8.11.36 Analytical data of compound 112: 
 
O
H
N
O
O
O
O
N
HH
H
112
(d.r. = 3.8:1)*  
* = inseparable mixture, ratio determined by 1H NMR 
 
1H NMR (400 MHz, CDCl3): δ = 5.76-5.73 (dd, J = 2.3 Hz, 7.0 Hz, 1H), 4.75-4.72 (m, 
1H), 3.78-3.73 (m, 1H), 3.57-3.32 (m, 4H), 3.12-3.07 (m, 1H), 3.05-3.00 (m, 2H), 2.67-
2.61 (m, 1H), 2.36-2.29 (m, 1H), 1.80-1.76 (m, 1H), 1.60-1.53 (m, 8H), 1.34 (s, 3H), 1.27 
(s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 180.6, 178.6, 154.9, 148.6, 148.1, 120.4, 71.1, 69.8, 
54.1, 45.9, 39.5, 33.4, 31.9, 31.1, 29.5, 27.9, 27.1, 24.6, 24.5, 21.7. 
HR-MS (FAB, 70 eV): m/z calculated for C20H27N2O5 = 375.1998, found = 375.1900 
[M-H]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 3: 2). 
Yield: 28 mg (15 % after 6 steps). 
 
8.11.37 Analytical data of compound 113: 
 
O
O
HH
H
O
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H
N
O
O
O
O
(d.r. = 3:1)*
113
 
*= inseparable mixture, ratio determined by 1H NMR spectroscopy 
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1H NMR (400 MHz, CDCl3): δ = 9.12 (bs, 1H), 6.76-6.63 (m, 3H), 5.89 (s, 2H), 5.78-
5.76 (dd, J = 2.6 Hz, 6.5 Hz, 1H), 4.73-4.67 (m, 1H), 4.21-4.09 (m, 2H), 3.55-3.37 (m, 
1H), 3.23-3.18 (m, 1H), 3.08-2.95 (m, 2H), 2.55-2.61 (m, 1H), 2.36-2.27 (m, 1H), 2.00-
1.80 (m, 1H), 1.31-1.29 (m, 2H), 1.22 (s, 3H), 1.21 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 181.0, 179.0, 171.5, 156.3, 155.6, 148.1, 148.0, 147.8, 
147.0, 132.6, 121.7, 121.1, 120.8, 120.7, 108.5, 101.3, 78.5, 72.6, 69.9, 54.1, 46.1, 45.8, 
45.1, 39.7, 33.3, 32.7, 31.9, 30.9, 29.5, 27.8, 27.1, 24.1, 21.7, 21.3. 
HR-MS (FAB, 70 eV): m/z calculated for C23H25N2O7 = 441.174, found = 441.1782 [M-
H]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 3: 2). 
Yield: 82 mg (30 % after 6 steps). 
 
8.11.38 Analytical data of compound 114: 
 
O
O
O
HN
H
COOHHOOC
HH
114  
 
1H NMR (400 MHz, DMSO-d6): δ = 8.01 (bs, 1H), 5.49-5.47 (t, J = 3.7 Hz, 1H), 5.08-
5.03 (m, 1H), 3.46-3.36 (m, 4H), 3.26-3.09 (m, 1H), 2.82-2.64 (m, 1H), 1.99-1.55 (m, 
3H), 1.33-0.97 (m, 16H). 
 13C NMR (100 MHz, DMSO-d6): δ = 179.1, 178.9, 167.3, 166.1, 131.5, 130.3, 79.3, 
74.9, 69.4, 56.7, 47.8, 43.7, 41.4, 41.1, 40.8, 40.2, 40.0, 38.7, 35.7, 33.7, 30.5, 28.1, 24.4, 
21.2. 
HR-MS (FAB, 70 eV): m/z calculated for C21H30NO7 = 408.2101, found = 408.2196 [M-
H]+. 
Rf = 0.5 (ethyl acetate: methanol = 9:1). 
[ ]20Dα : - 24.8o (c = 1, CHCl3). 
Yield: 21 mg (16 % after 7 steps). 
 
 
 184
8.11.39 Analytical data of compound 115: 
 
O
H
N
O
O
O
O
N
HH
H
115  
 
1H NMR (400 MHz, CDCl3): δ = 5.83-5.80 (t, J = 5.0 Hz, 1H), 4.26-4.16 (m, 1H), 4.08-
3.95 (m, 2H), 3.93-3.89 (m, 2H), 3.39-3.34 (m, 4H), 3.19-3.15 (m, 2H), 3.08-3.05 (m, 
1H), 2.68-2.56 (m, 2H), 2.38-2.32 (m, 1H),  2.23-2.19 (m, 2H), 1.57-1.41 (m, 6H). 
13C NMR (100 MHz, CDCl3): δ = 178.6, 177.4, 153.3, 141.3, 140.8, 124.0, 123.1, 74.2, 
73.7, 72.6, 71.6, 68.5, 60.7, 52.8, 45.4, 43.8, 40.8, 33.9, 30.7, 28.3, 23.3. 
HR-MS (FAB, 70 eV): m/z calculated for C18H25N2O5 = 349.1685, found = 349.1629 
[M+H]+. 
Rf = 0.2 (cyclohexane: ethyl acetate = 3: 2). 
[ ]20Dα : + 15.8o (c = 2, CHCl3). 
Yield: 32 mg (20 % after 6 steps). 
 
8.11.40 Analytical data of compound 116: 
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O
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1H NMR (400 MHz, CDCl3): δ = 5.75-5.73 (t, J = 3.7 Hz, 1H), 4.09-4.03 (m, 1H), 3.99-
3.95 (m, 1H), 3.91-3.87 (m, 4H), 3.79-3.77 (d, J = 6.8 Hz, 4H), 3.27-3.21 (dd, J = 8.2 Hz, 
15.3 Hz, 1H), 3.03-3.02 (t, J = 4.0 Hz, 1H), 2.23-2.17 (m, 1H), 2.08-2.02 (m, 2H), 1.75-
1.62 (m, 6H), 1.27-1.20 (m, 5H). 
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13C NMR (100 MHz, CDCl3): δ = 168.4, 167.5, 149.1, 143.2, 136.7, 134.8, 129.5, 128.9, 
126.7, 120.9, 79.2, 78.0, 70.2, 68.5, 52.9, 52.6, 47.2, 37.4, 35.6, 31.3, 29.4, 28.9, 27.1, 
25.9, 21.9, 21.4. 
HR-MS (FAB, 70 eV): m/z calculated for C18H25N2O5 = 349.1685, found = 349.1622 
[M+H]+. 
Rf = 0.3(cyclohexane: ethyl acetate = 3: 2). 
[ ]20Dα : + 2.5o (c = 2, CHCl3). 
Yield: 20 mg (26 % after 7 steps).  
 
8.11.41 Analytical data of compound 117: 
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H
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O
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O
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1H NMR (400 MHz, CDCl3): δ = 8.15 (bs, 1H), 4.35-4.25 (m, 1H), 4.15-4.05 (m, 2H), 
3.98-3.90 (m, 1H), 3.70-3.60 (m, 4H), 3.52-3.37 (m, 4H), 3.22-3.18 (m, 1H), 3.17-3.09 
(m, 1H), 2.87-2.62 (m, 3H), 2.47-2.23 (m, 4H), 1.83-1.66 (m, 2H). 
13C NMR (100 MHz, CDCl3): δ = 179.5, 177.5, 158.4, 140.2, 120.6, 80.9, 75.2, 71.9, 
67.9, 66.3, 52.9, 48.9, 48.5, 42.1, 32.7, 29.1, 26.9. 
HR-MS (FAB, 70 eV): m/z calculated for C17H23N2O6 = 351.1478, found = 351.1424 
[M+H]+. 
Rf = 0.3 (cyclohexane: ethyl acetate = 3: 2). 
[ ]20Dα : + 6.5o (c = 1, CHCl3). 
Yield: 10 mg (20 % after 5 steps).  
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8.11.42 Analytical data of compound 118: 
 
O
O
O
H
N
H
N
O
O
HH H
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1H NMR (400 MHz, CDCl3): δ = 5.83-5.82 (t, J = 3.5 Hz, 1H), 4.23-4.25 (dd, J = 13.3 
Hz, 19.5 Hz, 1H), 4.11-4.09 (m, 2H), 3.95-3.89 (t, J = 11.8 Hz, 2H), 3.30-3.25 (dd, J = 
6.8 Hz, 13.5 Hz, 1H), 3.19-3.04 (m, 6H), 2.73-2.57 (m, 2H), 2.36-2.34 (m, 1H), 2.21-2.19 
(m, 1H), 1.50-1.31 (m, 5H), 1.28-1.22 (m, 5H), 0.88-0.85 (t, J = 6.1 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 179.9, 178.6, 161.4, 141.9, 125.3, 97.4, 74.9, 74.5, 
54.0, 46.5, 42.1, 41.3, 38.4, 35.2, 31.5, 31.3, 30.1, 29.9, 29.4, 27.1, 26.2, 22.7, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C19H27O5 = 363.1998, found = 363.1924 [M-
H]+. 
Rf = 0.5 (cyclohexane: ethyl acetate = 3: 2). 
[ ]20Dα : - 10.8o (c = 1, CHCl3). 
Yield: 30 mg (20 % after 6 steps). 
 
8.11.43 Analytical data of compound 119: 
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1H NMR (400 MHz, CDCl3): δ = 8.44 (bs, 1H), 5.76-5.74 (t, J = 4.8 Hz, 1H), 4.75-4.68 
(m, 1H), 3.93-3.90 (m, 1H), 3.86-3.83 (t, J = 6.4 Hz, 1H), 3.66-3.62 (m, 4H), 3.47-3.40 
(m, 4H), 3.36-3.31 (t, J = 11.0 Hz, 1H), 3.18-3.12 (m, 1H), 3.08-3.04 (dd, J = 5.9 Hz, 9.5 
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Hz, 1H), 2.62-2.54 (m, 1H), 2.45-2.41 (m, 1H), 2.13-2.09 (m, 1H), 1.90-1.81 (m, 1H), 
1.58-1.48 (m, 1H), 1.46-1.37 (m, 2H), 1.28-1.24 (m, 6H), 0.88-0.85 (t, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 180.1, 178.5, 154.4, 143.9, 135.3, 122.7, 82.4, 73.4, 
71.3, 66.8, 53.5, 46.2, 40.7, 34.2, 33.1, 32.4, 31.9, 25.7, 22.9, 22.7, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C22H32N2O6 = 420.226, found = 420.2295 
[M]+. 
Rf = 0.3(cyclohexane: ethyl acetate = 3: 2). 
[ ]20Dα : + 12.0o (c = 1, CHCl3). 
Yield: 22 mg (16 % after 7 steps). 
 
8.11.44 Analytical data of compound 120: 
 
 
O
HO
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O
O
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F
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1H NMR (400 MHz, CDCl3): δ = 8.03-8.01 (d, J = 8.0 Hz, 1H), 7.53-7.46 (m, 2H), 7.05-
6.92 (m, 4H), 6.90-6.89 (m, 2H), 5.19-5.16 (m, 1H), 4.85-4.82 (m, 2H), 4.45-4.43 (m, 
1H), 4.35-4.34 (m, 1H), 4.21-4.14 (m, 1H), 3.92-3.91 (m, 1H), 3.50-3.42 (m, 1H), 1.95-
1.89 (m, 1H), 1.80-1.73 (m, 1H), 1.56-1.54 (m, 2H), 1.34-1.25 (m, 4H), 0.91-0.88 (t, J = 
7.0 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 163.9, 160.3, 152.0, 147.4, 142.5, 140.7, 137.2, 132.4, 
129.4, 127.2, 126.3, 123.9, 120.9, 118.2, 114.0, 110.2, 109.5, 85.9, 78.2, 75.6, 45.3, 40.0, 
33.6, 32.9, 30.4, 23.6, 22.7, 14.2. 
19F NMR (338.6 MHz, CDCl3): -120.1.  
HR-MS (FAB, 70 eV): m/z calculated for C27H30FNO5 = 467.2108, found = 467.2198 
[M]+. 
 Rf = 0.3 (cyclohexane: ethyl acetate = 3: 2). 
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[ ]20Dα : + 36.1o (c = 1, CHCl3). 
Yield: 12 mg (15 % after 6 steps). 
 
8.11.45 Analytical data of compound 121: 
 
O
O
O
H
N
H
HH
COOHHOOC
121
F
 
 
1H NMR (400 MHz, DMSO-d6): δ = 7.79-7.78 (m, 1H), 7.40-7.38 (m, 1H), 7.09-7.07 
(m, 3H), 5.36-5.34 (t, J = 5.3 Hz, 1H), 4.27-4.19 (m, 2H), 4.01-3.94 (m, 1H), 3.87-3.85 
(m, 1H), 3.64-3.37 (m, 3H), 2.76-2.64 (m, 2H), 1.80-1.75 (m, 2H), 1.53-1.44 (m, 2H), 
1.29-1.27 (m, 6H), 0.90-0.88 (t, J = 7.0 Hz, 3H). 
13C NMR (100 MHz, DMSO-d6): δ = 178.5, 178.2, 160.5, 156.2, 147.3, 145.9, 141.8, 
136.5, 121.6, 120.5, 115.5, 110.9, 78.0, 76.2, 69.1, 51.8, 45.9, 42.1, 39.9, 32.0, 30.5, 29.1, 
27.2, 26.9, 25.6, 22.9, 14.6. 
19F NMR (338.6 MHz, DMSO-d6): -122.2.  
HR-MS (FAB, 70 eV): m/z calculated for C25H31FNO7 = 476.2163, found = 476.2122 
[M-H]+. 
Rf = 0.4 (ethyl acetate: methanol = 9:1). 
[ ]20Dα : - 2.9o (c = 1, CHCl3). 
Yield: 16 mg (20 % after 7 steps). 
 
8.11.46 Analytical data of compound 122: 
 
O
HO
OH
O
O
H
N
122  
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1H NMR (400 MHz, CDCl3): δ = 8.03-8.01 (d, J = 8.0 Hz, 1H), 7.49-7.48 (d, J = 8.0 Hz, 
1H), 6.92-6.86 (dd, J = 10.0 Hz, 12.8 Hz, 2H), 5.09-5.06 (m, 1H), 4.83-4.79 (dd, J = 4.4 
Hz, 8.8 Hz, 1H), 4.50-4.48 (m, 1H), 4.21-4.18 (m, 1H), 4.02-3.98 (m, 1H), 3.49-3.44 (dd, 
J = 9.2 Hz, 12.0 Hz, 1H), 3.16-3.13 (m, 2H), 1.94-1.89 (m, 1H), 1.81-1.75 (m, 1H), 1.59-
1.42 (m, 4H), 1.36-1.25 (m, 11H), 0.91-0.85 (m, 6H). 
13C NMR (100 MHz, CDCl3): δ = 160.8, 152.0, 146.9, 138.3, 129.0, 126.3, 122.9, 119.2, 
110.7, 108.2, 80.3, 76.5, 72.0, 42.9, 36.2, 33.6, 32.7, 30.3, 26.9, 25.6, 22.7, 22.2, 14.6, 
14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C26H37NO5 = 443.2672, found = 443.2691 
[M]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 3: 2). 
[ ]20Dα : + 5.0o (c = 2, CHCl3). 
Yield: 8 mg (15 % after 6 steps). 
 
8.11.47 Analytical data of compound 123: 
 
O
O
O
HN H
HO
OH
Cl
123  
 
1 NMR (400 MHz, CDCl3): δ = 8.23 (bs, 1H), 8.14-8.06 (m, 2H), 7.76-7.69 (m, 2H), 
7.21-7.20 (m, 3H), 7.06-7.05 (m, 1H), 5.73-5.71 (t, J = 3.7 Hz, 1H), 5.29-5.25 (m, 1H), 
5.01-4.94 (m, 1H), 4.88-4.85 (m, 2H), 4.29-4.28 (m, 2H), 4.13-4.10 (m, 1H), 3.95-3.88 
(m, 2H), 2.02-1.98 (m, 1H), 1.91-1.86 (m, 1H), 1.34-1.32 (m, 2H), 1.24-1.18 (m, 6H), 
0.85-0.81 (t, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 183.5, 183.4, 142.9, 140.7, 134.7, 133.9, 132.5, 130.7, 
130.1, 126.7, 126.4, 120.7, 117.4, 84.5, 79.5, 74.0, 47.6, 43.9, 41.3, 38.4, 35.8, 33.6, 31.8, 
27.5, 25.6, 25.2, 24.1, 22.7, 20.7, 14.2. 
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HR-MS (FAB, 70 eV): m/z calculated for C31H34ClNO5 = 535.2126, found = 535.2169 
[M]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 4: 1). 
[ ]20Dα : + 20.1o (c = 2, CHCl3). 
Yield: 23 mg (15 % after 6 steps). 
 
8.11.48 Analytical data of compound 124: 
 
O
O
H
N
O
O
H
HH
O
HN
124
(d.r. = 25:1)*  
* = inseparable mixture, ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, CDCl3): δ = 8.51 (bs, 1H), 5.77-5.74 (t, J = 4.8 Hz, 1H), 4.76-4.69 
(m, 1H), 3.95-3.91 (m, 1H), 3.87-3.84 (t, J = 6.4 Hz, 1H), 3.56-3.54 (m, 1H), 3.38-3.33 
(dd, J = 10.6 Hz, 11.5 Hz, 1H), 3.17-3.12 (m, 1H), 3.08-3.04 (m, 1H), 2.84-2.80 (m, 1H), 
2.57-2.55 (t, J = 4.7 Hz, 1H), 2.46-2.39 (m, 1H), 2.14-2.11 (m, 1H), 1.92-1.83 (m, 1H), 
1.58-1.54 (m, 1H), 1.48-1.45 (m, 1H), 1.28-1.26 (m, 13H), 0.88-0.85 (t, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 180.2, 178.5, 154.3, 143.9, 122.7, 118.9, 115.9, 115.7, 
82.4, 73.4, 69.8, 54.0, 50.6, 46.2, 40.7, 34.2, 33.1, 31.9, 29.5, 25.7, 22.9, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C23H33N2O5 = 417.2468, found = 417.2457 
[M-H]+. 
Rf = 0.5 (cyclohexane: ethyl acetate = 3: 2). 
Yield: 30 mg (16 % after 6 steps). 
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8.11.49 Analytical data of compound 125: 
 
O
HO
OH
O
O
H
N
125
Cl
 
 
1H NMR (400 MHz, CDCl3): δ = 8.02-8.00 (d, J = 8.0 Hz, 1H), 7.48-7.45 (d, J = 8.0 Hz, 
1H), 7.31-7.28 (m, 1H), 7.26-7.24 (m, 2H), 7.17-7.16 (m, 1H), 6.91-6.83 (m, 2H), 5.21-
5.15 (m, 1H), 4.87-4.82 (m, 2H), 4.42-4.38 (m, 1H), 4.33-4.31 (m, 1H), 3.90-3.86 (m, 
1H), 3.49-3.43 (t, J = 10.4 Hz, 1H), 1.92-1.90 (m, 1H), 1.80-1.74 (m, 1H), 1.60-1.52 (m, 
2H), 1.33-1.29 (m, 4H), 0.91-0.87 (t, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 162.5, 162.5, 151.9, 146.9, 143.9, 141.7, 135.0, 131.2, 
130.4, 128.9, 127.1, 124.9, 118.9, 118.0, 112.1, 110.2, 108.5, 83.9, 76.2, 75.5, 46.3, 41.0, 
34.5, 33.2, 31.4, 24.6, 21.7, 14.0. 
HR-MS (FAB, 70 eV): m/z calculated for C27H30ClNO5 = 483.1813, found = 483.1839 
[M]+. 
Rf = 0.3 (cyclohexane: ethyl acetate = 3: 2). 
[ ]20Dα : + 2.9o (c = 1, CHCl3). 
Yield: 12 mg (20 % after 6 steps) 
 
8.11.50 Analytical data of compound 126: 
 
O
O
O
HN
H
H
N
O O
HH
126  
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1H NMR (400 MHz, CDCl3): δ = 8.51 (bs, 1H), 5.77-5.74 (t, J = 5.0 Hz, 1H), 4.87-4.40 
(m, 1H), 3.91-3.83 (m, 2H), 3.13-3.04 (m, 5H), 2.83-2.80 (m, 1H), 2.59-2.55 (m, 1H), 
2.45-2.39 (m, 1H), 1.84-1.78 (m, 1H), 1.61-1.53 (m, 3H), 1.47-1.24 (m, 26H), 0.88-0.85 
(m, 6H). 
13C NMR (100 MHz, CDCl3): δ = 180.2, 178.5, 158.7, 144.0, 122.7, 82.4, 72.5, 71.3, 
53.6, 46.2, 41.3, 41.0, 40.6, 34.2, 33.2, 31.9, 30.4, 30.1, 29.8, 29.7, 29.7, 29.5, 27.1, 27.0, 
25.7, 22.9, 22.8, 14.3, 14.2. 
 HR-MS (FAB, 70 eV): m/z calculated for C29H47N2O5 = 503.3563, found = 503.3581 
[M-H]+. 
 Rf = 0.4 (cyclohexane: ethyl acetate = 3: 2). 
[ ]20Dα : + 25.8o (c = 2, CHCl3). 
Yield: 50 mg (23 % after 6 steps). 
 
8.11.51 Analytical data of compound 127: 
 
O
O
O
N
H
COOHHOOC
HHN
F
127
(d.r. = 6:1)*  
* = inseparable mixture, ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, DMSO-d6): δ = 7.11-7.06 (m, 4H), 5.51-5.48 (t, J = 5.0 Hz, 1H), 
5.08-5.03 (m, 10H), 3.54-3.37 (m, 2H), 2.72-2.64 (m, 1H), 1.94-1.69 (m, 3H), 1.35-0.97 
(m, 8H). 
13C NMR (100 MHz, DMSO-d6): δ = 180.1, 178.5, 167.3, 163.2, 154.6, 148.7, 118.8, 
116.1, 79.4, 74.9, 69.4, 56.7, 49.9, 47.7, 43.7, 41.4, 40.6, 40.0, 38.7, 36.7, 35.6, 33.7, 
32.9, 31.7, 27.3, 26.7, 24.5, 21.2. 
19F NMR (338.6 MHz, DMSO-d6 ): -123.8.  
HR-MS (FAB, 70 eV): m/z calculated for C25H31FN2O7 = 490.2115, found = 490.2199 
[M]+. 
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Rf = 0.3 (ethyl acetate: methanol = 9:1). 
Yield: 42 mg (20 % after 7 steps). 
 
8.11.52 Analytical data of compound 128: 
 
O
H
N
O
O
O
O
H
N
H
HH
128
(d.r. = 2.6:1)*  
* = inseparable mixture, ratio determined by 1H NMR 
 
1H NMR (400 MHz, CDCl3): δ = 9.09 (bs, 1H), 5.79-5.77 (dd, J = 2.5 Hz, 6.4 Hz, 1H), 
4.72-4.65 (m, 2H), 3.55-3.37 (m, 1H), 3.24-3.19 (m, 1H), 3.10-2.96 (m, 4H), 2.65-2.55 
(m, 1H), 2.40-2.28 (m, 1H), 2.00-1.95 (m, 1H), 1.48-1.39 (m, 2H), 1.27-1.20 (m, 14H), 
0.85-0.81 (m, 6H). 
13C NMR (100 MHz, CDCl3): δ = 180.9, 178.9, 171.4, 156.2, 155.5, 147.9, 135.3, 121.6, 
120.6, 70.7, 69.8, 65.2, 60.6, 54.1, 46.1, 45.8, 41.2, 39.6, 33.2, 31.9, 31.6, 31.1, 30.9, 
29.9, 29.4, 27.4, 27.1, 26.6, 22.7, 14.2, 14.1. 
HR-MS (FAB, 70 eV): m/z calculated for C24H39N2O5 = 435.2781, found = 435.2719 
[M+H]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 3: 2). 
Yield: 56 mg (29 % after 7 steps).  
 
8.11.53 Analytical data of compound 129: 
 
O
O
O
HN
HH
H
H
N
O
O
129  
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1H NMR (400 MHz, CDCl3): δ = 8.41 (bs, 1H), 5.73-5.71 (t, J = 3.0 Hz, 1H), 4.86-4.39 
(m, 1H), 3.88-3.83 (m, 1H), 3.42-3.39 (m, 1H), 3.28-3.05 (m, 2H), 2.57-2.54 (m, 1H), 
2.40-2.07 (m, 2H), 1.89-1.80 (m, 2H), 1.68-1.65 (m, 4H), 1.30-1.08 (m, 15H), 0.87-0.84 
(t, J = 6.5 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 180.7, 178.9, 171.4, 169.6, 158.4, 157.5, 143.9, 135.3, 
122.8, 85.2, 82.4, 69.9, 63.4, 54.1, 50.0, 49.4, 46.2, 40.6, 34.1, 33.5, 31.9, 29.4, 27.1, 
25.8, 25.1, 24.9, 22.7, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C24H35N2O5 = 431.2624, found = 431.2656 
[M-H]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 3: 2). 
[ ]20Dα : + 11.9o (c = 1, CHCl3). 
Yield: 60 mg (31 % after 6 steps). 
 
8.11.54 Analytical data of compound 130: 
 
O
O
O
H
N
H
HH
COOHHOOC
130
Cl
(d.r. = 3:2)*  
* = inseparable mixture, ratio determined by 1H NMR 
 
1H NMR (400 MHz, DMSO-d6): δ = 7.82-7.77 (m, 1H), 7.41-7.37 (m, 1H), 7.32-7.29 
(m, 1H), 7.26-7.23 (m, 2H), 5.40-5.37 (t, J = 5.0 Hz, 1H), 4.44-4.37 (m, 1H), 4.22-4.15 
(m, 2H), 4.00-3.99 (m, 1H), 3.94-3.93 (m, 1H), 3.87-3.85 (d, J = 10.4 Hz, 1H), 3.17-3.65 
(m, 1H), 3.05-3.01 (m, 2H), 2.98-2.92 (m, 1H), 2.91-2.77 (m, 2H), 2.02-1.94 (m, 1H), 
1.87-1.77 (m, 1H), 1.53-1.35 (m, 2H), 1.30-1.26 (m, 6H), 0.89-0.87 (t, J = 6.8 Hz, 3H).   
13C NMR (100 MHz, DMSO-d6): δ = 177.2, 178.1, 155.8, 148.5, 146.0, 142.8, 135.0, 
134.0,  121.2, 119.6, 112.7, 111.0, 71.5, 75.2, 70.1, 52.8, 44.2, 42.1, 40.9, 33.0, 31.5, 
30.1, 28.2, 27.0, 25.6, 22.8, 14.3. 
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HR-MS (FAB, 70 eV): m/z calculated for C25H31ClNO7 = 492.1867, found = 492.1882 
[M-H]+. 
Rf = 0.4 (ethyl acetate: methanol = 9:1). 
Yield: 15 mg (15 % after 7 steps). 
 
8.11.55 Analytical data of compound 131: 
 
O
O
O
H
N
COOHHOOC
H
H H
131
O
O
(d.r.= 4:1)*  
* = inseparable mixture, ratio determined by 1H NMR 
 
1H NMR (400 MHz, DMSO-d6): δ = 7.69-7.64 (m, 1H), 6.87-6.83 (m, 2H), 6.75-6.71 
(m, 1H), 5.36-5.33 (t, J = 4.4 Hz, 1H), 4.11-3.99 (m, 3H), 3.93-3.82 (m, 2H), 3.09-2.92 
(m, 1H), 2.82-2.71 (m, 4H), 2.02-1.94 (m, 1H), 1.83-1.77 (m, 1H), 1.50-1.47 (m, 2H), 
1.33-1.27 (m, 6H), 0.90-0.87 (t, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, DMSO-d6): δ = 179.5, 178.2, 154.3, 147.3, 146.9, 140.8, 135.5, 
122.6, 120.8, 114.6, 112.9, 101.3, 80.5, 73.2, 70.1, 50.8, 46.9, 40.2, 38.5, 35.2, 30.9, 28.5, 
27.6, 26.9, 25.6, 22.8, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C26H34NO9 = 502.2155, found = 502.2198 [M-
H]+. 
Rf = 0.4 (ethyl acetate: methanol = 9:1). 
Yield: 20 mg (15 % after 7 steps). 
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8.11.56 Analytical data of compound 132: 
 
(d.r. = 4:1)*
O
O
O
Cl
Cl HO
OH
H
132
 
* = inseparable mixture, ratio determined by 1H NMR 
 
1H NMR (400 MHz, CDCl3): δ = 8.06-7.97 (m, 2H), 7.80-7.77 (m, 1H), 7.48-7.41 (m, 
2H), 5.45-5.42 (m, 1H), 4.90-4.88 (m, 1H), 4.21-4.17 (m, 1H), 4.12-4.08 (m, 1H), 4.00-
3.96 (m, 1H), 2.08-2.02 (m, 1H), 1.88-1.82 (m, 1H), 1.63-1.48 (m, 2H), 1.36-1.25 (m, 
8H), 0.93-0.86 (t, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 186.8, 185.9, 164.1, 163.6, 149.7, 143.5, 141.3, 140.8, 
136.4, 131.7, 130.7, 128.9, 120.8, 113.3, 84.61, 72.5, 69.1, 54.0, 39.9, 35.8, 31.9, 31.8, 
29.5, 28.6, 25.9, 25.6, 22.8, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C26H30Cl2O5 = 492.1314, found = 492.1300 
[M+2H]+. 
Rf = 0.3 (cylohexane: ethyl acetate = 4:1). 
Yield: 20 mg (30 % after 5 steps). 
 
8.11.57 Analytical data of compound 133: 
 
O
O
O
HN
H
HO
OH
133  
 
1H NMR (400 MHz, CDCl3): δ = 8.03-8.02 (d, J = 8.0 Hz, 1H), 7.49-7. 47 (d, J = 8.0 
Hz, 1H), 7.34-7.27 (m, 2H), 7.05-7.02 (t, J = 7.2 Hz, 1H), 6.91-6.85 (q, J = 10.2 Hz, 2H), 
6.60 (bs, 1H), 5.20-5.17 (t, J = 5.2 Hz, 1H), 4.86-4.83 (dd, J = 4.4 Hz, 8.5 Hz, 1H), 4.19-
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4.16 (d, J = 13.8 Hz, 1H), 4.00-3.98 (m, 1H), 3.94-3.89 (dd, J = 3.0 Hz, 13.9 Hz, 1H), 
2.05-2.00 (m, 1H), 1.86-1.83 (m, 1H), 1.62-1.58 (m, 2H), 1.37-1.33 (m, 6H), 1.28-1.24 
(m, 2H), 0.93-0.89 (t, J = 7.0 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 165.1, 162.6, 148.3, 142.4, 141.2, 140.1, 137.4, 132.7, 
131.7, 127.9, 121.8, 112.3, 83.6, 73.8, 69.1, 53.0, 40.9, 35.8, 31.9, 31.8, 29.0, 28.2, 25.0, 
24.6, 22.8, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C26H32NO5 = 438.2202, found = 438.2298 
[M+H]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 4: 1). 
[ ]20Dα : - 15.0o (c = 2, CHCl3). 
Yield: 20 mg (20 % after 5 steps). 
 
8.11.58 Analytical data of compound 134: 
 
O
O
O
H
MeOOC COOMe
134  
 
1H NMR (400 MHz, CDCl3): δ = 5.71-5.70 (t, J = 1.7 Hz, 1H), 4.95-4.92 (m, 1H), 4.01-
3.94 (m, 1H), 3.79 (s, 3H), 3.76 (s, 3H), 3.61-3.57 (m, 1H), 3.42-3.37 (dd, J = 9.2 Hz, 
12.1 Hz, 1H), 3.35-3.32 (m, 1H), 3.05-3.03 (m, 2H), 2.30-2.25 (m, 1H), 2.22-2.18 (t, J = 
7.5 Hz, 1H), 1.72-1.69 (m, 1H), 1.62-1.53 (m, 4H), 1.33-1.22 (m, 16H), 0.90-0.85 (m, 
6H). 
13C NMR (100 MHz, CDCl3): δ = 172.8, 168.3, 167.8, 141.7, 138.1, 134.1, 119.8, 79.7, 
71.5, 65.5, 52.7, 52.5, 38.5, 36.4, 34.6, 32.1, 31.9, 30.6, 9.8, 29.6, 29.5, 29.4, 29.3, 28.5, 
25.6, 25.1, 22.9, 22.8, 14.3, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C33H54O7 = 562.3870, found = 562.3800 [M]+. 
Rf = 0.5 (cyclohexane: ethyl acetate = 9: 1). 
[ ]20Dα : - 10.9o (c = 1, CHCl3). 
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Yield: 32.5 mg (44% after 5 steps). 
 
8.11.59 Analytical data of compound 135: 
O
N
O
O
HO
HH
H
135
Ph
 
 
1H NMR (400 MHz, CDCl3): δ = 7.46-7.42 (m, 2H), 7.39-7.37 (m, 1H), 7.19-7.17 (m, 
2H), 5.81-5.78 (t, J = 5.1 Hz, 1H), 4.19-4.17 (t, J = 6.4 Hz, 1H), 4.01-3.98 (m, 1H), 3.79-
3.75 (m, 1H), 3.30-3.24 (dt, J = 4.1 Hz, 8.9 Hz, 1H), 3.20-3.16 (dd, 5.6 Hz, 9.2 Hz, 1H), 
2.76-2.71 (m, 2H), 2.47-2.39 (m, 1H), 2.25-2.19 (m, 1H), 2.05-1.99 (m, 1H), 1.85 (bs, 
1H), 1.58-1.51 (m, 2H), 1.29-1.25 (m, 6H), 1.24-1.22 (d, J = 6.8 Hz, 3H), 0.89-0.85 (t, J 
= 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 178.9, 177.4, 144.2, 131.9, 129.4, 128.9, 126.6, 126.3, 
122.5, 73.8, 73.6, 45.1, 39.9, 34.7, 33.4, 33.2, 32.1, 27.1, 25.9, 24.0, 22.8, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C24H30NO4 = 396.2253, found = 396.2298 [M-
H]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 4: 1). 
[ ]20Dα : + 39.3o (c = 1, CHCl3). 
Yield: 42 mg (52% after 4 steps). 
 
8.11.60 Analytical data of compound 136: 
 
O
COOMeMeOOC
O
O
H
N
H
136
(d.r. = 8:1)*  
* = inseparable mixture, ratio determined by 1H NMR spectroscopy 
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1H NMR (400 MHz, CDCl3): δ = 7.87-7.84 (m, 3H), 7.68-7.66 (m, 1H), 7.57-7.44 (m, 
3H), 6.80 (bs, 1H), 5.79-5.73 (t, J = 4.0 Hz, 1H), 4.72-4.66 (m, 1H), 4.31-4.30 (m, 1H), 
3.81 (s, 3H), 3.77 (s, 3H), 3.66-3.62 (m, 1H), 3.47-3.44 (m, 1H), 3.05-3.03 (m, 2H), 2.47-
2.42 (m, 1H), 1.74-1.67 (m, 1H), 1.59-1.57 (m, 2H), 1.36-1.22 (m, 9H), 0.92-0.88 (t, J = 
6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 168.3, 167.8, 150.8, 148.0, 146.4, 143.6, 142.3, 138.6, 
134.3, 134.0, 132.5, 128.9, 126.5, 126.0, 119.2, 116.5, 78.5, 78.1, 69.7, 52.7, 36.8, 32.0, 
30.2, 28.7, 26.0, 22.8, 19.5, 14.3. 
HR-MS (FAB, 70 eV): m/z calculated for C31H37NO7 = 535.257, found = 535.2500 
[M]+. 
Rf = 0.3 (cyclohexane: ethyl acetate = 4: 1). 
Yield: 13 mg (32 % after 5 steps). 
 
8.11.61 Analytical data of compound 137: 
 
O
O
O
H
N
H
NO O
H H
(d.r. = 8:1)*
137
Ph
O
O
 
* = inseparable mixture, ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, CDCl3): δ = 7.97-7.95 (m, 1H), 7.46-7.37 (m, 3H), 7.16-7.14 (m, 
3H), 6.47-6.45 (m, 2H), 5.85-5.84 (t, J = 2 Hz, 1H), 4.91-4.90 (m, 1H), 4.20-4.09 (m, 
2H), 3.83 (s, 3H), 3.78 (s, 3H), 3.31-3.29 (m, 1H), 3.19-3.15 (dd, J = 4.6 Hz, 8.9 Hz, 1H), 
2.37-2.25 (m, 2H), 1.60-1.58 (m, 1H), 1.33-1.31 (d, J = 6.8 Hz, 3H), 1.28-1.25 (m, 8H), 
0.89-0.86 (t, J = 6.7 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 179.0, 177.7, 164.9, 149.2, 145.0, 142.6, 132.0, 129.4, 
126.6, 121.0, 104.1, 98.9, 76.2, 74.9, 71.1, 55.8, 45.6, 40.8, 32.1, 29.5, 27.1, 26.1, 22.8, 
14.3. 
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HR-MS (FAB, 70 eV): m/z calculated for C33H41N2O7 = 577.2836, found = 577.2869 
[M+H]+. 
Rf = 0.3 (cyclohexane: ethyl acetate = 4: 1). 
Yield: 14.4 mg (50% after 5 steps). 
 
8.11.62 Analytical data of compound 138: 
 
O
N
O
O
O
O
H
N
HH
H
138
Ph
 
 
1H NMR (400 MHz, CDCl3): δ = 7.87-7.85 (m, 3H), 7.70-7.66 (m, 1H), 7.54-7.41 (m, 
5H), 7.39-7.37 (m, 1H), 7.17-7.14 (m, 2H), 7.02 (bs, 1H), 5.90-5.85 (t, J = 4.5 Hz, 1H), 
4.99-4.94 (m, 1H), 4.27-4.25 (m, 1H), 4.18-4.11 (m, 1H), 3.32-3.30 (m, 1H), 3.27-3.24 
(m, 1H), 2.89-2.84 (m, 1H), 2.74-2.71 (m, 1H), 2.36-2.31 (m, 1H), 2.17-2.16 (m, 2H), 
1.61-1.57 (m, 2H), 1.45-1.43 (m, 2H), 1.33-1.24 (m, 7H), 0.89-0.86 (t, J = 6.7 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 178.8, 177.2, 164.6, 137.5, 134.3, 132.6, 131.9, 129.4, 
128.9, 128.9, 126.5, 126.2, 125.9, 122.4, 76.6, 71.6, 69.7, 54.0, 51.8, 45.5, 40.6, 36.2, 
33.1, 32.2, 29.5, 27.1, 26.0, 25.1, 22.8, 14.3. 
HR-MS (FAB, 70 eV): m/z calculated for C35H38N2O5 = 566.2781, found = 566.2751 
[M]+. 
Rf = 0.3 (cyclohexane: ethyl acetate = 9: 1). 
[ ]20Dα : + 3.6o (c = 1, CHCl3). 
Yield: 12 mg (60 % after 5 steps). 
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8.11.63 Analytical data of compound 139: 
 
O
O
O
H
MeOOC COOMe
139  
 
1H NMR (400 MHz, CDCl3): δ = 7.63-7.58 (m, 3H), 7.56-7.46 (m, 2H), 5.67-5.66 (t, J = 
3.4 Hz, 1H), 5.20-5.16 (m, 1H), 3.94-3.88 (m, 1H), 3.79-3.78 (m, 1H), 3.75 (s, 3H), 3.61-
3.55 (m, 1H), 3.49 (s, 3H), 3.15-3.07 (m, 1H), 3.02-2.95 (m, 1H); 2.24-2.19 (dd, J = 4.0 
Hz, 14.2 Hz, 1H), 2.01-1.94 (m, 1H), 1.72-1.69 (m, 2H), 1.57-1.55 (m, 1H), 1.37-1.32 
(m, 9H), 0.92-0.88 (t, J = 6.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 172.3, 168.5, 168.3, 165.9, 139.2, 137.5, 134.0, 133.4, 
132.3, 130.5, 130.4, 129.8, 129.6, 128.7, 128.6, 115.6, 83.1, 79.9, 78.8, 52.5, 52.3, 36.3, 
35.8, 31.9, 28.0, 26.1, 22.8, 20.9, 14.3. 
HR-MS (FAB, 70 eV): m/z calculated for C27H35O7 = 471.2305, found = 471.2338 
[M+H]+. 
Rf = 0.5 (cyclohexane: ethyl acetate = 4: 1). 
Yield: 10 mg (26% after 5 steps). 
[ ]20Dα : + 13.0o (c = 1, CHCl3). 
 
8.11.64 Analytical data of compound 140: 
 
O
O
O
H
COOMeMeOOC
140  
 
1H NMR (400 MHz, CDCl3): δ = 5.54-5.53 (t, J = 3.3 Hz, 1H), 4.93-4.89 (m, 1H), 4.05-
4.01 (m, 1H), 3.77 (s, 3H), 3.76 (s, 3H), 3.71-3.63 (m, 1H), 3.60-3.56 (m, 1H), 3.47-3.43 
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(dd, J = 0.76 Hz, 13.5 Hz, 1H), 3.04-3.01 (m, 2H), 2.38-2.35 (m, 2H), 2.21-2.14 (m, 1H), 
1.65-1.57 (m, 4H), 1.42-1.35 (m, 1H), 1.32-1.25 (m, 26H), 0.89-0.85 (m, 6H). 
13C NMR (100 MHz, CDCl3): δ = 173.5, 168.4, 168.2, 168.0, 167.9, 142.9, 138.7, 134.6, 
119.2, 84.1, 70.8, 69.3, 64.3, 52.5, 40.1, 36.5, 34.8, 32.8, 31.9, 29.9, 29.8, 29.7, 29.4, 
29.3, 28.4, 25.6, 25.2, 22.9, 22.8, 14.3, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C33H54O7 = 562.387, found = 562.3899 [M]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 4: 1). 
[ ]20Dα : + 29.0o (c = 2, CHCl3). 
Yield: 21 mg (28 % after 5 steps). 
 
8.11.65 Analytical data of compound 141: 
 
O
O
O
H
N
H
COOMeMeOOC
141  
 
1H NMR (400 MHz, CDCl3): δ = 7.86-7.80 (m, 3H), 7.67-7.65 (d, J = 8.2 Hz, 1H), 7.54-
7.44 (m, 3H), 6.84 (bs, 1H), 5.75-5.70 (t, J = 4.3 Hz, 1H), 5.04-4.97 (m, 1H), 4.02-3.99 
(m, 1H), 3.81 (s, 3H), 3.78 (s, 3H), 3.63-3.55 (m, 1H), 3.40-3.37 (m, 1H), 3.10-3.06 (m, 
2H), 2.46-2.42 (dd, J = 5.9 Hz, 12.6 Hz, 1H), 1.75-1.71 (m, 1H), 1.63-1.54 (m, 3H), 1.35-
1.25 (m, 6H), 0.92-0.88 (t, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 168.3, 167.8, 153.5, 151.4, 141.7, 137.9, 134.3, 134.1, 
132.5, 128.9, 126.5, 126.2, 126.0, 119.6, 80.1, 73.0, 52.7, 52.5, 38.7, 36.3, 31.9, 30.7, 
28.5, 27.1, 25.7, 22.8, 14.3. 
HR-MS (FAB, 70 eV): m/z calculated for C30H35NO7 = 521.2414, found = 521.2485 
[M]+. 
Rf = 0.3 (cyclohexane: ethyl acetate = 4: 1). 
[ ]20Dα : - 5.1o (c = 1, CHCl3). 
Yield: 16 mg (16 % after 5 steps). 
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8.11.66 Analytical data of compound 142: 
 
O
O
O
H
COOMeMeOOC
142  
 
1H NMR (400 MHz, CDCl3): δ = 5.67-5.66 (t, J = 2.3 Hz, 1H), 4.93-4.92 (m, 1H), 4.12-
4.09 (m, 1H), 3.76 (s, 3H), 3.75 (s, 3H), 3.72-3.69 (m, 1H), 3.68-3.62 (m, 1H), 3.59-3.54 
(dd, J = 1.6 Hz, 13.5 Hz, 1H), 3.06-3.01 (m, 2H), 2.42-2.36 (m, 1H), 2.42-2.36 (m, 1H), 
2.16-2.12 (m, 1H), 1.97-1.88 (m, 2H), 1.76-1.72 (m, 3H), 1.68-1.53 (m, 2H), 1.45-1.40 
(m, 3H), 1.38-1.23 (m, 9H), 0.91-0.87 (t, J = 7.0 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 175.7, 168.1, 142.2, 139.1, 133.4, 118.9, 78.9, 70.7, 
64.6, 52.5, 52.4, 43.3, 38.8, 35.9, 32.0, 30.3, 29.6, 28.9, 28.4, 25.9, 25.7, 25.5, 22.8, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C26H38O7 = 462.2618, found = 462.2699 [M]+. 
Rf = 0.3 (cyclohexane: ethyl acetate = 4: 1). 
[ ]20Dα : + 1.9o (c = 1, CHCl3). 
Yield: 18 mg (32 % after 5 steps). 
 
8.11.67 Analytical data of compound 143: 
 
(d.r. = 4:1)*
O
COOMeMeOOC
O
O
H
143
 
* = inseparable mixture, ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, CDCl3): δ = 5.62-5.60 (dd, J = 2.5 Hz, 4.8 Hz, 1H), 4.87-4.86 (m, 
1H), 4.09-4.04 (m, 1H), 3.70 (s, 6H), 3.63-3.58 (m, 1H), 3.50-3.46 (dd, J = 1.5 Hz, 13.6 
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Hz, 1H), 2.99-2.95 (m, 2H), 2.34-2.31 (t, J = 7.8 Hz, 2H), 2.12-2.07 (m, 1H), 1.73-1.68 
(m, 4H), 1.58-1.44 (m, 10H), 1.27-1.18 (m, 5H), 0.84-0.81 (t, J = 7.0 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 173.6, 168.2, 167.9, 142.2, 138.8, 133.7, 119.0, 78.9, 
71.0, 64.3, 52.5, 39.9, 38.9, 35.9, 34.1, 32.7, 32.6, 32.0, 31.4, 30.3, 28.5, 25.7, 25.3, 22.8, 
14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C27H40O7 = 476.2774, found = 476.2700 [M]+. 
Rf = 0.3 (cyclohexane: ethyl acetate = 4: 1). 
Yield: 14 mg (25 % after 5 steps). 
  
8.11.68 Analytical data of compound 144: 
 
O
O
H
COOMeMeOOC
O
144
(d.r. = 8:1)*  
* = inseparable mixture, ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, CDCl3): δ = 5.60-5.58 (dd, J = 1.7 Hz, 5.1 Hz, 1H), 4.94-4.86 (m, 
1H), 4.15-4.11 (dd, J = 6.4 Hz, 12.3 Hz, 1H), 3.81 (s, 3H), 3.78 (s, 3H), 3.70-3.67 (t, J = 
4.6 Hz, 1H), 3.47-3.42 (dd, J = 8.9 Hz, 12.3 Hz, 1H), 3.38-3.33 (m, 1H), 3.06-3.04 (m, 
1H), 3.03-2.99 (m, 1H), 2.29-2.21 (m, 3H), 1.86-1.83 (m, 2H), 1.75-1.69 (m, 3H), 1.60-
1.56 (m, 8H), 1.32-1.22 (m, 5H), 0.90-0.87 (t, J = 7.1 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 173.6, 168.2, 167.9, 142.2, 138.8, 133.7, 119.0, 78.9, 
71.0, 64.3, 52.5, 39.9, 38.9, 35.9, 34.1, 32.7, 32.6, 32.0, 31.4, 30.3, 28.5, 25.7, 25.3, 22.8, 
14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C27H40O7 = 476.2774, found = 476.2700 
[M]+. 
Rf = 0.5 (cyclohexane: ethyl acetate = 4: 1). 
Yield: 14 mg (25 % after 5 steps).  
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8.11.69 Analytical data of compound 145: 
 
O
O
O
H
O
HO OH
145  
 
1H NMR (400 MHz, CDCl3): δ = 8.04-8.00 (m, 1H), 7.92-7.87 (m, 2H), 7.48-7.46 (m, 
1H), 6.89-6.84 (m, 2H), 5.36-5.32 (t, J = 8.0 Hz, 1H), 4.89-4.86 (dd, J = 4.4 Hz, 8.5 Hz,  
1H), 4.19-4.16 (m, 1H), 4.09-4.08 (m, 1H), 3.97-3.92 (dd, J = 3.3 Hz, 14.0 Hz,  1H), 3.84 
(s, 3H), 3.80-3.76 (m, 1H), 2.06-2.03 (m, 1H), 1.87-1.81 (m, 1H), 1.60-1.57 (m, 2H), 
1.51-1.28 (m, 6H), 0.92-0.88 (t, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 187.7, 184.9, 165.8, 163.6, 149.8, 141.3, 136.6, 132.7, 
131.9, 131.7, 131.4, 126.2, 122.9, 113.7, 83.7, 72.1, 55.6, 36.5, 31.9, 28.8, 25.8, 22.8, 
14.3. 
HR-MS (FAB, 70 eV): m/z calculated for C27H33O6 = 453.2199, found = 453.2232 
[M+H]+.  
Rf = 0.4 (cyclohexane: ethyl acetate = 4: 1). 
Yield: 15 mg (17% after 5 steps). 
[ ]20Dα : - 62.5o (c = 2, CHCl3). 
 
8.11.70 Analytical data of compound 146: 
 
(d.r. = 8:1)*
O
HO
N
O
O
H
HH
Ph
146
 
* = inseparable mixture, ratio determined by 1H NMR spectroscopy 
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1H NMR (400 MHz, CDCl3): δ = 7.48-7.44 (m, 2H), 7.40-7.38 (m, 1H), 7.30-7.26 (m, 
2H), 5.81-5.78 (m, 1H), 4.07-4.06 (m, 1H), 3.64-3.59 (q, J = 6.4 Hz, 1H), 3.57-3.56 (t, J 
= 3.12 Hz, 1H), 3.26-3.16 (m, 3H), 2.72-2.66 (m, 1H), 2.54-2.48 (m, 1H), 1.91-1.86 (m, 
1H), 1.63-1.56 (m, 2H), 1.34-1.25 (m, 6H), 1.20-1.19 (d, J = 6.6 Hz, 3H), 0.91-0.88 (t, J 
= 6.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 178.1, 176.2, 142.6, 130.7, 128.1, 127.5, 125.2, 120.9, 
77.9, 70.3, 67.8, 43.5, 37.8, 34.7, 32.2, 31.1, 29.7, 25.2, 21.9, 21.4, 19.1, 13.4. 
HR-MS (FAB, 70 eV): m/z calculated for C24H30NO4 = 396.2253, found = 396.2298 [M-
H]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 4: 1). 
Yield: 30 mg (50 % after 5 steps).  
 
8.11.71 Analytical data of compound 147: 
O
N
O
O
HO
HH
H
147
Ph
 
 
1H NMR (400 MHz, CDCl3): δ = 7.46-7.43 (m, 2H), 7.42-7.37 (m, 1H), 7.22-7.20 (m, 
2H), 5.77-5.74 (t, J = 5.0 Hz, 1H), 3.93-3.89 (m, 1H), 3.33-3.29 (m, 2H), 3.28-3.25 (dd, J 
= 4.5 Hz, 9.0 Hz, 1H), 3.20-3.17 (dd, J = 5.9 Hz, 9.5 Hz, 1H), 2.89-2.86 (m, 1H), 2.72-
2.67 (td, J = 4.6 Hz, 15.1 Hz, 1H), 2.51-2.44 (m, 1H), 2.12-2.04 (m, 2H), 1.64-1.57 (m, 
2H), 1.49-1.39 (m, 2H), 1.30-1.21 (m, 7H), 0.90-0.86 (t, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 179.2, 177.7, 144.6, 132.1, 129.5, 129.4, 128.9, 126.7, 
121.4, 80.9, 79.9, 76.4, 45.3, 39.8, 37.9, 33.8, 33.2, 32.1, 27.2, 25.9, 22.9, 19.7, 14.3. 
HR-MS (FAB, 70 eV): m/z calculated for C24H30NO4 = 396.2253, found = 396.2298 [M-
H]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 4: 1). 
Yield: 73 mg (70% after 4 steps). 
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[ ]20Dα : + 21.0o (c = 2, CHCl3). 
 
8.11.72 Analytical data of compound 148: 
 
O
O
O
H
HO
OH
148  
 
1H NMR (400 MHz, CDCl3): δ = 6.72 (s, 2H), 5.63-5.62 (d, J = 3.9 Hz, 1H), 4.90-4.89 
(m, 1H), 4.09-4.04 (m, 2H), 3.97-3.93 (m, 1H), 3.51-3.48 (d, J = 13.5 Hz, 1H), 3.31-3.24 
(m, 1H), 2.99-2.92 (dd, J = 2.8 Hz, 24.1 Hz, 1H), 2.51-2.46 (q, J = 7.1 Hz, 2H), 1.98-1.93 
(m, 1H), 1.75-1.65 (m, 1H), 1.39-1.25 (m, 30H), 0.89-0.83 (m, 6H). 
13C NMR (100 MHz, CDCl3): δ = 186.9, 185.9, 173.9, 143.9, 143.1, 140.6, 136.8, 136.3, 
119.4, 84.3, 70.8, 69.4, 40.5, 36.5, 34.9, 32.1, 31.9, 29.9, 29.5, 29.4, 28.8, 25.6, 25.2, 
24.7, 22.9, 22.8, 14.3, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C33H53O5 = 529.3815, found = 529.3895 
[M+H]+. 
 Rf = 0.4 (cyclohexane: ethyl acetate = 3: 2). 
[ ]20Dα : - 2.2o (c = 2, CHCl3). 
Yield: 16 mg (23 % after 5 steps). 
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8.11.73 Analytical data of compound 149: 
 
(d.r. = 20:1)*
O
N
O O
H
HH
HO
149
Ph
 
* = inseparable mixture, ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, CDCl3): δ = 7.49-7.45 (m, 2H), 7.41-7.37 (m, 1H), 7.27-7.26 (m, 
2H), 5.79-5.77 (t, J = 4.7 Hz, 1H), 3.97-3.93 (t, J = 6.6 Hz, 1H), 3.83-3.82 (m, 1H), 3.80-
3.76 (m, 1H), 3.32-3.28 (m, 1H), 3.26-3.24 (m, 1H), 3.18-3.14 (dd, J = 6.4 Hz, 9.7 Hz, 
1H), 2.65-2.62 (dd, J = 4.6 Hz, 7.7 Hz, 2H), 2.17-2.16 (m, 1H), 2.09-2.05 (m, 1H), 1.62-
1.51 (m, 2H), 1.29-1.25 (m, 8H), 0.90-0.86 (t, J = 6.7 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 179.0, 177.6, 144.0, 136.1, 131.9, 129.4, 129.3, 128.9, 
126.6, 126.5, 123.4, 83.2, 72.8, 71.0, 44.6, 39.0, 37.0, 33.7, 31.9, 31.6, 25.7, 22.7, 22.6, 
14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C23H28NO4 = 382.2097, found = 382.2011 [M-
H]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 4: 1). 
Yield: 10 mg (65% after 4 steps). 
 
8.11.74 Analytical data of compound 150: 
 
O
N
O
O
HO
HH
H
150
Ph
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1H NMR (400 MHz, CDCl3): δ = 7.46-7.42 (m, 2H), 7.39-7.34 (m, 1H), 7.19-7.17 (m, 
2H), 5.76-5.73 (t, J = 4.7 Hz, 1H), 4.09-4.06 (t, J = 6.4 Hz, 1H), 4.00-3.94 (m, 1H), 3.72-
3.70 (m, 1H), 3.32-3.27 (dt, J = 3.72 Hz, 8.8 Hz, 1H), 3.18-3.14 (dd, J = 5.7 Hz, 9.2 Hz, 
1H), 3.04-3.00 (m, 1H), 2.78-2.71 (ddd, J = 3.52 Hz, 5.6 Hz, 16.0 Hz, 1H), 2.47-2.43 (m, 
1H), 2.41-2.37 (m, 1H), 1.96-1.91 (m, 1H), 1.58-1.50 (m, 2H), 1.29-1.27 (m, 6H), 1.26-
1.24 (d, J = 6.8 Hz, 3H), 0.89-0.85 (t, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 179.2, 177.8, 145.0, 132.1, 129.45, 128.9, 126.7, 
121.6, 76.7, 73.6, 72.8, 45.3, 40.4, 33.5, 32.1, 31.3, 31.2, 26.1, 24.3, 22.9, 16.4, 14.3. 
HR-MS (FAB, 70 eV): m/z calculated for C24H30NO4 = 396.2253, found = 396.2298 [M-
H]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 4: 1). 
[ ]20Dα : + 6.0o (c = 1, CHCl3). 
Yield: 53 mg (50% after 5 steps).  
 
8.11.75 Analytical data of compound 151: 
 
(d.r. = 2.8:1)*
O
HO
H
COOMeMeOOC
151
 
* = inseparable mixture, ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, CDCl3): δ = 5.59-5.58 (t, J = 3.2 Hz, 1H), 3.79 (s, 3H), 3.77 (s, 
3H), 3.72-3.69 (m, 1H), 3.61-3.54-3.54 (m, 1H), 3.46-3.42 (m, 1H), 3.34-3.25 (m, 1H), 
3.05-3.03 (m, 1H), 3.02-2.98 (m, 1H), 1.99 (bs, 1H), 1.96-1.93 (dd, J = 3.4 Hz, 7.1 Hz, 
2H), 1.70-1.60 (m, 2H), 1.57-1.53 (m, 2H), 1.34-1.30 (m, 4H), 1.28-1.27 (d, J = 6.4 Hz, 
3H), 0.91-0.87 (t, J = 6.6 Hz, 3H). 
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13C NMR (100 MHz, CDCl3): δ = 168.5, 168.4, 143.3, 140.3, 137.8, 136.8, 134.4, 133.1, 
118.4, 115.0, 83.7, 82.9, 82.2, 76.0, 74.6, 52.6, 52.5, 43.9, 41.0, 36.3, 34.8, 33.2, 31.9, 
31.8, 28.4, 28.2, 26.0, 25.7, 22.8, 20.8, 19.3, 14.3. 
HR-MS (FAB, 70 eV): m/z calculated for C20H31O6 = 367.2042, found = 367.2072 
[M+H]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 3: 2). 
Yield: 68 %. 
 
8.11.76 Analytical data of compound 152: 
 
O
O
O
H
N
COOHHOOC
H
H
H
152
(d.r. = 4:1)*  
* = inseparable mixture, ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, DMSO-d6): δ = 8.01 (bs, 1H), 5.67-5.65 (t, J = 4.0 Hz, 1H), 4.60-
4.56 (m, 1H), 3.89-3.47 (m, 3H), 3.10-3.05 (m, 2H), 2.85-2.70 (m, 2H), 2.56-2.19 (m, 
3H), 1.96-1.70 (m, 2H), 1.33-1.27 (m, 16H), 0.90-0.86 (m, 6H). 
13C NMR (100 MHz, DMSO-d6): δ = 182.0, 179.9, 158.3, 140.5, 121.3, 80.9, 75.3, 69.2, 
54.0, 45.9, 42.9, 35.2, 33.6, 31.7, 30.3, 27.9, 26.6, 22.9, 22.3, 14.9, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C24H38NO7 = 452.2727, found = 452.2795 [M-
H]+. 
Rf = 0.5 (ethyl acetate: methanol = 9:1). 
Yield: 8.0 mg (30 % after 7 steps). 
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8.11.77 Analytical data of compound 153: 
 
O
N
O
O
N
O
HH
H
Ph
153
Ph
 
 
1H NMR (400 MHz, CDCl3): δ = 7.34-7.28 (m, 8H), 7.15-7.13 (m, 2H), 5.83-5.81 (dd, J 
= 2.0 Hz, 6.9 Hz, 1H), 5.03 (s, 2H), 4.08-4.05 (d, J = 14.4 Hz, 1H), 3.95-3.91 (d, J = 14.3 
Hz, 1H), 3.54-3.48 (m, 1H), 3.26-3.21 (m, 1H), 3.18-3.11 (m, 1H), 2.81-2.73 (m, 1H), 
2.51-2.44 (m, 1H), 1.97-1.89 (m, 2H), 1.64-1.60 (m, 4H), 1.25-1.19 (m, 6H). 
13C NMR (100 MHz, CDCl3): 179.4, 177.5, 165.6, 156.3, 147.2, 137.5, 131.9, 129.5, 
128.8, 128.5, 128.0, 126.7, 121.7, 91.7, 78.6, 76.2, 44.6, 38.2, 36.1, 31.4, 29.9, 26.0, 25.8, 
21.9, 21.6. 
HR-MS (FAB, 70 eV): m/z calculated for C30H32N2O4 = 484.2362, found = 484.2301 
[M]+. 
Rf = 0.3 (cyclohexane: ethyl acetate = 4: 1). 
[ ]20Dα : + 16.2o (c = 1, CHCl3). 
Yield: 6 mg (10 % after 6 steps). 
 
8.11.78 Analytical data of compound 154: 
 
O
H
N
O
O
N
O
HH
H
Ph
154  
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1H NMR (400 MHz, CDCl3): δ = 7.35-7.28 (m, 5H), 5.79-5.77 (dd, J = 2.4 Hz, 7.3 Hz, 
1H), 5.02 (s, 2H), 4.05-4.02 (d, J = 14.4 Hz, 1H), 3.92-3.88 (d, J = 14.2 Hz, 1H), 3.44-
4.38 (m, 1H), 3.11-3.02 (m, 3H), 2.66-2.62 (m, 1H), 2.34-2.28 (m, 1H), 1.96-1.86 (m, 
2H), 1.62-1.55 (m, 4H), 1.28-1.25 (m, 6H). 
13C NMR (100 MHz, CDCl3): δ = 179.6, 177.6, 156.1, 147.8, 138.0, 128.5, 128.3, 127.9, 
121.5, 78.5, 76.0, 64.4, 45.6, 39.6, 36.2, 30.7, 29.9, 25.9, 25.5, 21.8, 21.6. 
HR-MS (FAB, 70 eV): m/z calculated for C24H28N2O4 = 408.2049, found = 408.2011 
[M]+. 
Rf = 0.3 (cyclohexane: ethyl acetate = 3: 2). 
[ ]20Dα : + 3.9o (c = 2, CHCl3). 
Yield: 8 mg (12 % after 6 steps). 
 
8.11.79 Analytical data of compound 155: 
 
O
O
H
H
NO O
H H
155  
 
1H NMR (400 MHz, CDCl3): δ = 8.44 (bs, 1H), 5.86-5.83 (dd, J = 2.9 Hz, 6.8 Hz, 1H), 
4.02-3.98 (d, J = 17.9 Hz, 1H), 3.91-3.87 (d, J = 17.9 Hz, 1H), 3.78-3.72 (m, 1H), 3.10-
3.07 (m, 2H), 2.79-2.73 (dd, J = 7.0 Hz, 16.4 Hz, 1H), 2.67-2.60 (m, 1H), 2.38-2.28 (m, 
1H), 2.25-2.21 (m, 1H), 1.99-1.95 (m, 1H), 1.87-1.84 (m, 1H), 1.72-1.65 (m, 2H), 1.58-
1.48 (m, 4H), 1.29-1.17 (m, 4H). 
13C NMR (100 MHz, CDCl3): δ = 210.9, 179.8, 177.9, 147.5, 122.7, 79.2, 70.5, 54.0, 
45.2, 41.4, 39.6, 35.6, 29.5, 25.8, 22.4, 21.6, 21.5. 
HR-MS (FAB, 70 eV): m/z calculated for C17H22NO4 = 304.1471, found = 304.1456 
[M+H]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 3: 2). 
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Yield: 22 mg (15% after 5 steps). 
[ ]20Dα : + 2.0o (c = 2, CHCl3). 
 
8.11.80 Analytical data of compound 156: 
 
O
O
H
NO O
H H
156
Ph
 
 
1H NMR (400 MHz, CDCl3): δ = 7.49-7.45 (m, 2H), 7.41-7.40 (m, 1H), 7.29-7.25 (m, 
2H), 5.90-5.88 (dd, J = 2.8 Hz, 6.9 Hz, 1H), 4.04-3.99 (d, J = 17.9 Hz, 1H), 3.93-3.89 (d, 
J = 18.0 Hz, 1H), 3.23-3.19 (m, 2H), 2.83-2.77 (dd, J = 7.0 Hz, 16.4 Hz, 1H), 2.75-2.71 
(m, 1H), 2.40-2.31 (m, 1H), 2.03-2.00 (m, 1H), 1.89-1.86 (m, 1H), 1.71-1.51 (m, 6H), 
1.32-1.20 (m, 4H). 
13C NMR (100 MHz, CDCl3): δ = 210.6, 178.7, 176.9, 147.6, 131.8, 129.5, 129.0, 126.6, 
122.9, 79.3, 70.6, 44.0, 41.4, 38.4, 35.7, 29.9, 25.9, 22.8, 21.6. 
HR-MS (FAB, 70 eV): m/z calculated for C23H25NO4 = 379.1784, found = 379.1700 
[M]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 9: 1). 
Yield: 19 mg (10% after 5 steps). 
[ ]20Dα : + 4.0o (c = 2, CHCl3). 
 
8.11.81 Analytical data of compound 157: 
 
O
O
H
MeOOC COOMe
157  
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1H NMR (400 MHz, CDCl3): δ = 5.75-5.73 (t, J = 3.7 Hz, 1H), 4.09-4.03 (m, 1H), 3.99-
3.95 (m, 1H), 3.90 (s, 3H), 3.79 (s, 3H), 2.23-2.16 (m, 1H), 2.08-2.02 (m, 2H), 1.75-1.61 
(m, 6H), 1.27-1.20 (m, 4H). 
13C NMR (100 MHz, CDCl3): δ = 211.9, 168.4, 167.5, 149.1, 143.2, 136.7, 134.8, 129.5, 
128.9, 120.8, 79.2, 70.2, 52.9, 52.8, 47.2, 37.4, 35.6, 29.9, 28.9, 27.1, 25.9, 21.9, 21.4. 
HR-MS (FAB, 70 eV): m/z calculated for C19H24O6 = 348.1573, found = 348.1526 [M]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 4: 1). 
Yield: 26 mg (15% after 5 steps). 
[ ]20Dα : + 6.0o (c = 1, CHCl3). 
 
8.11.82 Analytical data of compound 158: 
 
(d.r. = 8:1)*
O
N
O
HO
OH
H
158
 
* = inseparable mixture, ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, CDCl3): δ = 6.54-6.51 (dd, J = 1.7 Hz, 12.1 Hz, 1H), 6.22-6.18 (dd, 
J = 1.0 Hz, 12.0 Hz, 1H), 5.74-5.63 (m, 1H), 4.11 (s, 3H), 3.97-3.88 (m, 5H), 1.60-1.70 
(m, 2H), 1.20-1.32 (m, 6H), 0.92-0.83 (m, 4H). 
13C NMR (100 MHz, CDCl3): δ = 165.2, 148.4, 147.5, 147.0, 134.5, 129.2, 119.9, 114.2, 
112.4, 90.7, 69.9, 61.1, 36.8, 35.2, 31.4, 28.3, 23.6, 21.9, 20.6. 
HR-MS (FAB, 70 eV): m/z calculated for C20H25NO4 = 343.1784, found = 343.1723 
[M]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 4: 1).. 
Yield: 10 mg (10 % after 6 steps). 
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8.11.83 Analytical data of compound 159: 
 
O
N
O
O
H
H H
O
159
Ph
 
 
1H NMR (400 MHz, CDCl3): δ = 7.48-7.45 (m, 2H), 7.41-7.39 (m, 1H), 7.28-7.26 (m, 
2H), 5.92-5.89 (dd, J = 2.8 Hz, 6.7 Hz, 1H), 3.99-3.98 (d, J = 2.3 Hz, 2H), 3.86-3.79 (m, 
1H), 3.23-3.20 (dd, J = 4.4 Hz, 2H), 2.82-2.77 (dd, J = 6.8 Hz, 16.4 Hz, 1H), 2.75-2.69 
(m, 1H), 2.44-2.33 (m, 2H), 1.40 (s, 3H), 1.38 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 210.3, 178.7, 176.9, 147.0, 131.8, 129.5, 129.5, 129.0, 
126.6, 126.3, 122.9, 78.8, 71.4, 54.0, 43.9, 41.3, 38.3, 29.6, 29.5, 27.4, 22.9, 22.7. 
HR-MS (FAB, 70 eV): m/z calculated for C20H22NO4 = 340.1471, found = 340.1400 
[M+H]+. 
Rf = 0.5 (cyclohexane: ethyl acetate = 8:1). 
Yield:  38 mg (10% after 5 steps). 
[ ]20Dα : + 14.0o (c = 1, CHCl3). 
 
8.11.84 Analytical data of compound 160: 
 
O
O
H
N
O
O
H
HH
160  
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1H NMR (400 MHz, CDCl3): δ = 8.78 (bs, 1H), 5.88-5.85 (dd, J = 2.9 Hz, 6.8 Hz, 1H), 
3.98-3.97 (d, J = 3.9 Hz, 2H), 3.79-3.69 (m, 1H), 3.14-3.05 (m, 2H), 2.79-2.74 (dd, J = 
6.9 Hz, 16.5 Hz, 1H), 2.63-2.59 (m, 1H), 2.38-2.23 (m, 2H), 1.39 (s, 3H), 1.35 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 210.7, 180.0, 178.2, 146.9, 135.3, 122.8, 78.8, 71.3, 
69.8, 54.0, 45.1, 41.3, 39.5, 31.9, 29.5, 29.0, 27.3, 22.7, 22.4. 
HR-MS (FAB, 70 eV): m/z calculated for C14H16NO4 = 262.1158, found = 262.1190 [M-
H]+. 
Rf = 0.3 (cyclohexane: ethyl acetate = 3: 2). 
[ ]20Dα : + 22.0o (c = 1, CHCl3). 
Yield: 31 mg (10 % after 5 steps). 
 
8.11.85 Analytical data of compound 161: 
 
O
N
O
Ph
H
N
O
O
HH
H
161  
 
1H NMR (400 MHz, CDCl3): δ = 7.33-7.28 (m, 5H), 5.83-5.81 (dd, J = 2.5 Hz, 7.4 Hz, 
1H), 5.05 (s, 2H), 4.05-3.93 (m, 3H), 3.19-3.05 (m, 3H), 2.36-2.23 (m, 3H), 1.29-1.25 (m, 
6H). 
13C NMR (100 MHz, CDCl3): δ = 178.5, 176.2, 160.7, 143.9, 141.2, 129.9, 129.4, 127.6, 
126.2, 116.9, 78.3, 75.2, 68.9, 53.6, 43.2, 28.0, 27.5, 26.9, 25.1, 11.5. 
HR-MS (FAB, 70 eV): m/z calculated for C21H23N2O4 = 367.1736, found = 367.1704 
[M-H]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 3: 2). 
[ ]20Dα : + 5.0o (c = 2, CHCl3). 
Yield: 8 mg (15 % after 6 steps). 
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8.11.86 Analytical data of compound 162: 
 
(d.r. = 4.3:1)*
O
N
O
Ph NO
O
HH
H
162
Ph
 
* = inseparable mixture, ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, CDCl3): δ = 7.36-7.30 (m, 8H), 7.15-7.13 (m, 2H), 5.87-5.85 (dd, J 
= 2.4 Hz, 7.0 Hz, 1H), 5.03 (s, 2H), 3.51-3.45 (m, 1H), 3.27-3.22 (m, 2H), 3.18-3.14 (dd, 
J = 6.4 Hz, 9.9 Hz, 1H), 2.81-2.72 (m, 1H), 1.93-1.91 (m, 2H), 1.75-1.74 (m, 2H), 1.32-
1.30 (m, 6H). 
13C NMR (100 MHz, CDCl3): δ = 179.3, 177.5, 156.0, 146.5, 137.4, 136.3, 131.8, 129.5, 
128.6, 128.5, 126.7, 121.7, 78.3, 76.3, 64.9, 44.6, 38.0, 31.7, 29.9, 27.5, 25.7, 22.9, 21.8. 
HR-MS (FAB, 70 eV): m/z calculated for C27H28N2O4 = 444.2049, found = 444.2087 
[M]+. 
Rf = 0.5 (cyclohexane: ethyl acetate = 4: 1). 
Yield: 7.3 mg (13 % after 6 steps).  
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8.11.87 Analytical data of compound 163: 
 
(d.r. = 20:1)*
O
N
O
Ph NO
O
HH
H
Ph
163
 
* = inseparable mixture, ratio determined by 1H NMR spectroscopy 
 
1H NMR (400 MHz, CDCl3): δ = 7.37-7.31 (m, 8H), 7.15-7.14 (m, 1H), 7.13-7.12 (m, 
1H), 5.85-5.82 (t, J = 4.5 Hz, 1H), 5.05 (s, 2H), 4.02-3.98 (m, 2H), 3.38-3.27 (m, 2H), 
3.21-3.15 (m, 2H), 2.65-2.62 (m, 2H), 1.70-1.64 (m, 2H), 1.31-1.23 (m, 8H), 0.91-0.87 (t, 
J = 7.0 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 179.2, 177.4, 156.0, 142.6, 137.5, 131.8, 129.5, 128.9, 
128.6, 128.4, 126.7, 124.0, 83.6, 76.3, 70.0, 44.3, 38.6, 33.6, 31.9, 27.0, 25.7, 22.8, 22.2, 
14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C30H34N2O4 = 486.2519, found = 486.2573 
[M]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 3: 2). 
Yield: 7.6 mg (10 % after 6 steps). 
 
8.11.88 Analytical data of compound 164: 
 
O
O
O
N
N
F
164  
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1H NMR (400 MHz, CDCl3): δ = 6.96-6.90 (m, 2H), 6.88-6.85 (m, 2H), 6.25-6.12 (m, 
1H), 5.88-5.70 (m, 1H), 5.30-5.25 (m, 1H), 5.06-5.01 (m, 1H), 4.21-4.17 (dd, J = 5.3 Hz, 
13.0 Hz, 1H), 3.70-3.65 (m, 2H), 3.62-3.58 (m, 4H), 3.10-2.88 (m, 4H), 2.79-2.74 (m, 
1H), 2.60-2.20 (m, 1H), 1.39 (s, 3H), 1.36 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 158.5, 154.9, 148.1, 145.9, 140.7, 120.5, 118.9, 118.2, 
116.6, 116.0, 80.2, 74.1, 65.8, 50.9, 49.9, 48.6, 48.3, 28.9, 27.5, 26.1. 
19F NMR (338.6 MHz, CDCl3): -123.8. 
HR-MS (FAB, 70 eV): m/z calculated for C21H27FN2O3 = 374.2006, found = 374.2099 
[M]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 4: 1). 
[ ]20Dα : - 19.2o (c = 1, CHCl3). 
Yield: 30 mg (40 % after 4 steps).  
 
8.11.89 Analytical data of compound 165: 
 
O
O
O
H
N
165  
 
1H NMR (400 MHz, CDCl3): δ = 6.22-6.15 (m, 1H), 5.89-5.78 (m, 1H), 5.33-5.21 (m, 
1H), 5.09-5.03 (m, 1H), 4.25-4.17 (dd, J = 5.4 Hz, 13.2 Hz, 1H), 3.75-3.69 (m, 2H), 3.16-
3.09 (m, 2H), 2.77-2.73 (m, 1H), 2.63-2.25 (m, 1H), 1.67-1.55 (m, 2H), 1.40 (s, 3H), 1.38 
(s, 3H). 1.36-1.33 (m, 6H), 0.89-0.86 (t, J = 6.0 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 158.8, 148.9, 140.5, 121.1, 116.2, 80.1, 74.2, 65.9, 
42.2, 32.9, 29.6, 27.8, 27.0, 26.6, 22.9, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C17H29NO3 = 295.2147, found = 295.2199 
[M]+. 
Rf = 0.6 (cyclohexane: ethyl acetate = 4: 1). 
[ ]20Dα : - 7.1o (c = 1, CHCl3). 
Yield: 20 mg (35 % after 4 steps).  
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8.11.90 Analytical data of compound 166: 
 
O
O
O
N
166  
 
1H NMR (400 MHz, CDCl3): δ = 6.25-6.15 (m, 1H), 5.86-5.77 (m, 1H), 5.35-5.25 (m, 
1H), 5.07-5.02 (m, 1H), 4.29-4.19 (dd, J = 5.0 Hz, 13.0 Hz, 1H), 3.79-3.65 (m, 2H), 3.62-
3.58 (m, 4H), 2.76-2.70 (m, 1H), 2.65-2.30 (m, 1H), 1.71-1.52 (m, 6H), 1.38 (s, 3H), 1.32 
(s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 158.9, 148.3, 140.3, 121.4, 117.0, 80.5, 74.8, 65.3, 
47.7, 46.8, 30.2, 27.8, 27.2, 26.9, 25.8, 25.3. 
HR-MS (FAB, 70 eV): m/z calculated for C16H25NO3 = 279.1834, found = 279.1898 
[M]+. 
Rf = 0.6 (cyclohexane: ethyl acetate = 4: 1). 
[ ]20Dα : + 20.2o (c = 1, CHCl3). 
Yield: 25 mg (30 % after 4 steps). 
  
8.11.91 Analytical data of compound 167: 
 
O
O
O
N
O
167  
 
1H NMR (400 MHz, CDCl3): δ = 6.29-6.10 (m, 1H), 5.96-5.87 (m, 1H), 5.43-5.35 (m, 
1H), 5.11-5.05 (m, 1H), 4.30-4.25 (dd, J = 4.9 Hz, 12.5 Hz, 1H), 3.96-3.87 (m, 4H), 3.72-
3.40 (m, 6H), 2.87-2.79 (m, 1H), 2.75-2.40 (m, 1H), 1.38 (s, 3H), 1.32 (s, 3H). 
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13C NMR (100 MHz, CDCl3): δ = 156.3, 149.3, 141.3, 120.4, 116.0, 80.7, 74.4, 67.9, 
67.3, 65.3, 47.9, 47.6, 30.6, 26.9, 26.4. 
HR-MS (FAB, 70 eV): m/z calculated for C15H23NO4 = 281.1627, found = 281.1623 
[M]+. 
Rf = 0.5 (cyclohexane: ethyl acetate = 3: 2). 
[ ]20Dα : - 19.3o (c = 2, CHCl3). 
Yield: 15 mg (20 % after 4 steps).  
 
8.11.92 Analytical data of compound 168: 
 
O
O
O
H
N
168  
 
1H NMR (400 MHz, CDCl3): δ = 8.1 (bs, 1H), 6.20-6.15 (m, 1H), 5.90-5.81 (m, 1H), 
5.40-5.30 (m, 1H), 5.17-5.04 (m, 1H), 4.28-4.22 (dd, J = 4.8 Hz, 12.0 Hz, 1H), 3.74-3.54 
(m, 3H), 2.85-2.75 (m, 1H), 2.79-2.48 (m, 1H), 1.79-1.43 (m, 10H), 1.38 (s, 3H), 1.33 (s, 
3H). 
13C NMR (100 MHz, CDCl3): δ = 156.9, 147.3, 140.9, 121.0, 116.9, 80.4, 75.0, 68.8, 
49.0, 34.5, 33.9, 30.1, 29.2, 27.8, 27.0, 22.9, 220.2. 
HR-MS (FAB, 70 eV): m/z calculated for C17H27NO3 = 293.1991, found = 293.1999 
[M]+. 
Rf = 0.5 (cyclohexane: ethyl acetate = 4: 1). 
[ ]20Dα : + 4.1o (c = 2, CHCl3). 
Yield: 14 mg (22 % after 4 steps).  
 
 
 
 
 
 
 
 222
8.11.93 Analytical data of compound 169: 
 
O
O
O
H
N
O
O
169
Ha
Hb
 
 
1H NMR (400 MHz, CDCl3): δ = 7.13-7.09 (d, JHa-Hb = 15.4 Hz, 1H), 6.00-5.96 (d, J Ha-
Hb = 15.6 Hz, 1H), 5.93-5.89 (m, 1H), 4.96-4.95 (m, 1H), 4.60-4.58 (m, 1H), 4.00-3.95 
(dd, J = 5.3 Hz, 13.7 Hz, 1H), 3.72 (s, 3H), 3.66-3.61 (m, 1H), 3.44-3.42 (m, 1H), 2.73-
2.68 (m, 1H), 2.54-2.49 (m, 1H), 1.90-1.86 (m, 2H), 1.70-1.64 (m, 2H), 1.59-1.54 (m, 
1H), 1.39 (s, 3H), 1.34 (s, 3H), 1.16-1.08 (m, 3H). 
13C NMR (100 MHz, CDCl3): δ = 167.3, 155.2, 145.4, 125.9, 119.2, 80.9, 73.3, 69.7, 
65.8, 54.0, 51.8, 49.9, 33.6, 31.9, 29.5, 28.8, 25.7, 24.9. 
HR-MS (FAB, 70 eV): m/z calculated for C19H29NO5 = 351.2046, found = 351.2018 
[M]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 9: 1). 
[ ]20Dα : - 14.1o (c = 2, CHCl3). 
Yield: 30 mg (35 % after 7 steps). 
 
8.11.94 Analytical data of compound 170: 
 
O
O
O
O
O
N
O
170
Ha
Hb
 
 
1H NMR (400 MHz, CDCl3): δ = 7.13-7.09 (d, JHa-Hb = 16.0 Hz, 1H), 5.99-5.96 (d, JHa-
Hb = 15.6 Hz, 1H), 5.91-5.89 (m, 1H), 5.02-4.97 (m, 1H), 4.03-3.99 (dd, J = 5.7 Hz, 13.7 
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Hz, 1H), 3.73 (s, 3H), 3.67-3.66 (m, 1H), 3.63-3.61 (m, 4H), 3.44-3.42 (m, 4H), 2.77-
2.70 (m, 1H), 2.56-2.49 (m, 1H), 1.39 (s, 3H), 1.34 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 167.3, 155.1, 145.3, 145.2, 125.7, 119.3, 80.9, 74.4, 
69.7, 66.8, 65.7, 54.1, 51.8, 31.9, 29.5, 28.7, 27.6, 26.1. 
HR-MS (FAB, 70 eV): m/z calculated for C17H25NO6 = 339.1682, found = 339.1651 
[M]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 3: 2). 
[ ]20Dα : - 29.5o (c = 1, CHCl3). 
Yield: 30 mg (36 % after 7 steps). 
 
8.11.95 Analytical data of compound 171: 
 
O
O
OO
O
N
N
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Hb
 
 
1H NMR (400 MHz, CDCl3): δ = 7.15-7.11 (d, JHa-Hb = 15.6 Hz, 1H), 6.98-6.93 (m, 2H), 
6.87-6.84 (m, 2H), 6.01-5.97 (d, JHa-Hb = 15.6 Hz, 1H), 5.95-5.91 (m, 1H), 5.04-4.99 (m, 
1H), 4.06-4.01 (dd, J = 5.7 Hz, 13.8 Hz, 1H), 3.73 (s, 3H), 3.70-3.66 (m, 1H), 3.61-3.58 
(m, 4H), 3.10-2.98 (m, 4H), 2.78-2.73 (m, 1H), 2.56-2.15 (m, 1H), 1.40 (s, 3H), 1.35 (s, 
3H). 
13C NMR (100 MHz, CDCl3): δ = 167.3, 158.9, 156.6, 154.9, 148.1, 145.3, 125.7, 119.3, 
118.9, 118.8, 115.9, 115.7, 80.9, 74.4, 65.8, 54.1, 51.8, 50.6, 31.9, 29.5, 28.7, 27.6, 26.1. 
19F NMR (338.6 MHz, CDCl3): -123.8.  
HR-MS (FAB, 70 eV): m/z calculated for C23H29FN2O5 = 432.2061, found = 432.2011 
[M]+. 
Rf = 0.5 (cyclohexane: ethyl acetate = 2: 1). 
Yield:  40 mg (38% after 5 steps). 
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[ ]20Dα : - 1.5o (c = 1, CHCl3). 
 
8.11.96 Analytical data of compound 172: 
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1H NMR (400 MHz, CDCl3): δ = 7.13-7.09 (d, JHa-Hb = 15.6 Hz, 1H), 5.99-5.96 (d, JHa-
Hb = 15.6 Hz, 1H), 5.93-5.90 (t, J = 7.2 Hz, 1H), 4.97-4.96 (m, 1H), 4.65-4.63 (m, 1H), 
4.00-3.91 (m, 2H), 3.72 (s, 3H), 3.67-3.61 (m, 1H), 2.73-2.65 (m 1H), 2.55-2.48 (m, 1H), 
1.93-1.90 (m, 2H), 1.65-1.54 (m, 4H), 1.39 (s, 3H), 1.34 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 167.3, 155.6, 145.4, 145.1, 125.9, 119.2, 80.9, 73.4, 
69.7, 65.7, 54.1, 52.9, 51.8, 33.4, 31.9, 29.5, 28.8, 27.6, 26.0, 23.7. 
HR-MS (FAB, 70 eV): m/z calculated for C18H27NO5 = 337.1889, found = 337.1859 
[M]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 9: 1). 
[ ]20Dα : - 3.0o (c = 1, CHCl3). 
Yield: 28 mg (35 % after 7 steps).  
 
8.11.97 Analytical data of compound 173: 
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1H NMR (400 MHz, CDCl3): δ = 7.14-7.09 (d, JHa-Hb = 15.6 Hz, 1H), 6.00-5.96 (d, JHa-
Hb = 15.6 Hz, 1H), 5.93-5.89 (m, 1H), 4.99-4.96 (m, 1H), 4.70-4.67 (m, 1H), 4.01-3.96 
(dd, J = 5.3 Hz, 13.7 Hz, 1H), 3.73 (s, 3H), 3.68-3.61 (m, 1H), 3.15-3.10 (q, J = 6.6 Hz, 
2H), 2.71-2.66 (m, 1H), 2.55-2.50 (m, 1H), 1.47-1.43 (m, 2H), 1.39 (s, 3H), 1.34 (s, 3H), 
1.27-1.24 (m, 6H), 0.89-0.85 (t, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 167.3, 156.1, 145.4, 125.9, 119.2, 80.9, 73.5, 65.7, 
51.8, 41.2, 31.6, 30.1, 28.8, 27.6, 26.6, 26.0, 22.7, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C19H31NO5 = 353.2202, found = 353.2269 
[M]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 9: 1). 
[ ]20Dα : - 12.8o (c = 1, CHCl3). 
Yield: 30 mg (35 % after 7 steps).  
 
8.11.98 Analytical data of compound 174: 
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1H NMR (400 MHz, CDCl3): δ = 7.15-7.11 (d, JHa-Hb = 15.6 Hz, 1H), 6.00-5.96 (d, JHa-
Hb = 15.6 Hz, 1H), 5.94-5.91 (m, 1H), 5.01-4.95 (m, 1H), 4.04-3.99 (dd, J = 5.8 Hz, 13.8 
Hz, 1H), 3.73 (s, 3H), 3.67-3.63 (dd, J = 3.3 Hz, 13.6 Hz, 1H), 3.39-3.36 (m, 4H), 2.73-
2.69 (m, 1H), 2.56-2.49 (m, 1H), 1.58-1.54 (m, 2H), 1.50-1.49 (m, 4H), 1.39 (s, 3H), 1.34 
(s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 167.4, 155.1, 145.5, 145.2, 126.1, 119.1, 80.8, 73.9, 
69.7, 65.9, 54.0, 51.8, 45.9, 31.9, 29.5, 28.8, 27.5, 26.2, 25.9, 24.6. 
HR-MS (FAB, 70 eV): m/z calculated for C18H27NO5 = 337.1889, found = 337.1859 
[M]+. 
Rf = 0.4 (cyclohexane: ethyl acetate = 9: 1). 
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[ ]20Dα : - 25.0o (c = 1, CHCl3). 
Yield: 24 mg (30 % after 7 steps). 
 
8.11.99 Analytical data of compound 175: 
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1H NMR (400 MHz, CDCl3): δ = 7.19-7.15 (d, JHa-Hb = 16.8 Hz, 1H), 6.01-5.97 (dd, J = 
4.7 Hz, 9.2 Hz, 1H), 5.78-5.73 (d, JHa-Hb = 16.2 Hz, 1H), 4.48-4.46 (m, 1H), 4.26-4.21 (d, 
J = 18.2 Hz, 1H), 4.05-4.00 (d, J = 18.2 Hz, 1H), 3.76 (s, 3H), 3.73-3.71 (m, 1H), 2.92-
2.86 (dd, J = 9.3 Hz, 13.2 Hz, 1H), 1.84-1.67 (m, 4H), 1.33-1.28 (m, 4H), 0.91-0.88 (t, J 
= 7.0 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 210.1, 165.5, 146.9, 142.2, 135.5, 115.9, 77.9, 72.3, 
40.1, 33.4, 32.1, 27.1, 25.9, 22.8, 14.2. 
HR-MS (FAB, 70 eV): m/z calculated for C15H22O4 = 266.1518, found = 266.1529 [M]+. 
Rf = 0.5 (cyclohexane: ethyl acetate = 9: 1). 
[ ]20Dα : + 6.1o (c = 2, CHCl3). 
Yield: 20 mg (30% after 6 steps). 
 
8.11.100 Analytical data of compound 176: 
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1H NMR (400 MHz, CDCl3): δ = 6.63-6.51 (m, 1H), 5.74-5.63 (m, 1H), 4.44-4.43 (m, 
1H), 4.11-4.09 (m, 3H), 3.88-3.87 (m, 2H), 1.29-1.20 (m, 8H), 0.89-0.83 (m, 5H). 
13C NMR (100 MHz, CDCl3): δ = 166.4, 145.1, 143.7, 125.5, 120.6, 99.1, 72.1, 63.1, 
35.8, 28.6, 22.4, 22.0, 21.8, 21.3, 14.1. 
HR-MS (FAB, 70 eV): m/z calculated for C14H21NO2 = 235.1572, found = 235.1511 
[M]+. 
Rf = 0.5 (cyclohexane: ethyl acetate = 4: 1). 
Yield: 17 mg (30 % after 5 steps).  
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Thesis in a nutshell: 
Small and medium ring oxygen heterocycles are essential and significant structural 
frameworks in many natural products having a wide range of biological activities. Total 
synthesis of those natural products guided a path to synthesize small and medium ring 
ethers embedded in their structure as well. Recently ring-closing metathesis reaction has 
been used widely in the synthesis of natural products containg small and medium ring 
ethers. In this context this thesis was aimed to synthesisze small and medium ring ethers 
scaffolds by ring-closing metathesis reaction.  
One major half of this thesis is dedicated to the ring-closing metathesis in diene-ene 
moiety in synthesizing small and medium ring systems. Diene-ene ring-closing 
metathesis has been applied in synthesizing macrocycles in natural product synthesis. The 
same diene-ene ring-closing metathesis reaction behaves in an interesting and hitherto 
unknown way to synthesize small and medium ring ether systems. In this perspective 
competition between the formation of larger and smaller rings was observed. In the light 
of diene-ene ring-closing metathesis reaction, competitions between five- versus seven-
membered ring formation, six- versus eight-membered ring formation and seven- versus 
nine-membered ring formation were studied.  
To acquire the knowledge about the competition reactions, the open chain precursors of 
the competition were synthesized from commertially available substituted propargyl 
alcohol. A common aldehyde intermediate was synthesized from the propargyl alcohol by 
means five steps synthetic procedure. The diene-ene open chain precursor for the 
competion of five- versus seven-membered ring ethers was synthesized from the 
aldehyde intermediate by well known Wittig olefination reaction. When this diene-ene 
precursor was exposed to metathesis reaction using either 1st or 2nd generation Grubbs 
ruthenium carbene complex, five-membered ring ether with mono unsaturation and 
seven-membered ring ether with double unsaturation were obtained. It was also 
demonstated that the formation of the five- and seven-membered rings was not kinetically 
controlled but it was thermodynamically controlled.  
The open chain precursor to explore the competition between the six- versus eight-
membered rings was synthesized by vinylation of the aldehyde. When the diene-ene 
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precursor was exposed in the metathesis condition, only more thermodynamically stable 
six-membered mono-unsaturated cyclic ether was formed devoid of any trace of eight-
membered ring ether.  
The precursor to investigate the competion between seven-versus nine-membered ring 
ethers was obtained by allylation of the aldehyde intermediate. When this diene-ene 
precursor was treated under the metathesis condition, only the more thermodynamically 
stable seven-membered ring ether was obtained without any trace of nine-membered ring 
ether. 
It was evident that in the metathesis condition, the intiation of the reaction occurred by 
the formation of ruthenium carbene at the isolated olefin moiety and terminated at the 
diene moiety, hence forming the small sized ring ethers. Synthesizing the larger ring 
ethers containing double unsaturation was envisioned by this diene-ene metathesis 
condition by introducing the bulky group on the isolated olefin moiety. Hence the initial 
ruthenium carbene must form in the diene moiety first and terminate in the isolated olefin 
to afford the larger ring ethers. The advanced intermediates containing bulky groups in 
the isolated olefin moiety were synthesized from the same aldehyde intermediate. When 
those advanced intermediates were treated with the 2nd generation Grubbs ruthenium 
carbene complex, surprisingly the rings did not close to offer either eight-membered or 
nine-membered ring ethers though the initial ruthenium carbene formed in the conjugated 
diene moiety. So it was concluded from the above study that the formation of the small 
and medium size ring ethers in the metathesis condition is totally thermodynamic.  
The other half of this thesis dealt with the solid-supported solution phase synthesis of 
oxepane library. Oxepane, seven-membered cyclic ether is abundant in various natural 
products having broad range of biological activities. Hence those biologically active pre 
validated oxepane containing natural products may provide powerfull guiding principles 
for oxepane based library development. While developing small molecule combinatorial 
library in solution phase, the synthetic strategy must be practical, sensible and rapid. In 
this context the solution phase combinatorial synthesis of an oxepane library was 
developed using solid-supported reagents and scavengers. In this synthetic strategy, the 
oxepane scaffold was synthesized by the key ring-closing enyne metathesis reaction. 
After achieving the oxepane scaffold, it was diversified to generate the fully 
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functionalized oxepane library. The library generation was commenced from the 
combinatorial coupling of different commercially available substituted propargyl alcohols 
with the substituted α-bromo ethyl acetates. After functional group modifications of this 
coupling product, the ring-closing enyne metathesis precursor was synthesized. Upon 
exposure of this precursor to either 1st or 2nd generation Grubbs ruthenium carbene 
complex, an oxepane scaffold containing a free alcohol group and a diene moiety was 
formed. On one hand, the free alcohol group in the oxepane scaffold was derivatized to 
esters and carbamates. On the other hand, the diene moiety was derivatized by well 
known Diels-Alder reaction to generate the library.  
To reduce the extensive workup and purification procedure in each of the steps in the 
synthetic strategy and thus speed up the library generation, the use of solid supported 
reagents and scavengers emerged. The sulfonic acid resin was used to scavenge the 
Grignard reagent used in the allylation reaction en route to the oxepane scaffold. A solid-
supported chelating ligand was used to scavenge the ruthenium metal from the enyne 
metathesis reaction mixture. A solid-supported resin bound primary amine was used to 
scavenge the excess acid chlorides and isocyanates from the esterification and carbamate 
formation reaction. The same polymer bound sulfonic acid resin was used to remove the 
execess primary and secondary amines as well as the base used in the carbamate 
formation reaction. In most of the steps in this synthetic strategy a polymer bound 
scavenging reagent was used to eliminate the extensive workup procedure and labourious 
purification steps. The diene moiety in the oxepane scaffold was also functionalized using 
cross metathesis reaction by Grubbs ruthenium carbene. The free alcohol group in the 
oxepane moiety was oxidized to ketone and further functionalized to the oximes.  
At the end combining all the experience using solid-supported reagents and scavengers in 
this strategy a one pot synthetic stategy was developed to generate the fully 
functionalized oxepane library. In this one pot stategy, all the reactions were carried out 
devoid of any workup and purification steps. The only purification step was carried out at 
the end of the route to provide the pure oxepane molecule for the further studies. Finally, 
a small library (containing 110 molecules) of fully functionalized oxepane was 
synthesized. This one pot synthetic strategy was proved to be competent, practical and 
viable for the rapid generation of the oxepane molecules. It was envisioned that the 
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synthesized oxepane molecules would be used in future for both forward and reverse 
chemical genomics and chemical genetics studies to indentify the target of interest and as 
well as in cell based assays to detect the inhibitors or activators in the signaling pathways.  
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Abbreviations: 
Ac                                      Acetyl (CH3CO) 
aq.                                      Aqueous  
Ar                                      Aromatic 
Bn                                      Benzyl (PhCH2) 
Bu                                      Butyl 
CDI                                    Carbonyl diimidazole 
Cp                                      Cyclopentyl 
CSA                                   Camphor sulfonic acid 
Cy                                      Cyclohexyl 
DBU                                   1,8-Diazabicyclo[5.4.0]undec-7-en 
DCC                                   N,N-Dicyclohexyl carbodiimide 
DCM                                  Dichloromethane (CH2Cl2) 
DIBAL-H                           Diisobutylaluminiumhydride 
DIPCl                                 Diisopinocamphenylboron chloride 
DMAP                                N,N-Dimethylamino pyridine 
DMF                                   N,N-Dimethyl formamide 
DMSO                               N,N-Dimethyl sulfoxide  
d.r.                                     Diastereomeric ratio 
ee                                       Enantiomeric excess 
EI                                       Electron Impact 
ent                                      Enantiomer 
equiv.                                 Equivalent 
Et                                       Ethyl (CH3CH2) 
eV                                      Electron volt 
FAB                                   Fast atom bombardment  
Fmoc                                 9-Fluorenylmethoxycarbonyl 
GC-MS                             Gas chromatography-mass spectroscopy 
h                                        Hour 
HMPA                              Hexamethylphosphoramide 
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HPLC                               High performance liquid chromatography 
HR-MS                            High resolution mass spectroscopy 
Hz                                    Hertz 
IBX                                  2-iodoxybenzoic acid 
Ipc                                    Isopinocamphenyl 
i-Pr                                   iso propyl 
LC-MS                             Liquid chromatography-mass spectroscopy 
LDA                                 Lithium diisopropylamide 
Me                                    Methyl (CH3) 
Min                                  Minute 
mmol                                Milimol 
MOM                               Methoxy methyl (CH3OCH2) 
NaHMDS                         Sodium hexamethyldisilazide 
NBS                                 N-bromosuccinimide 
NIS                                  N-iodosuccinimide 
n-Bu                                 normal butyl (CH3CH2CH2CH2) 
NMR                                Nuclear magnetic resonance 
nOe                                  Nuclear overhauser effect 
p                                       para 
PCC                                 Pyridinium chlorochromate 
Ph                                    Phenyl (C6H5) 
Piv                                   Pivaloyl [(CH3)3CCO] 
Ppm                                 Parts per million 
PTLC                               Preparative thin layer chromatography 
Py                                    Pyridine 
Rf                                     Retention factor 
rt                                      Room temperature 
TBAF                              Tetrabutylammonium fluoride 
t-Bu                                 tertiary butyl [(CH3)3C] 
TBS                                 tertiary butyl dimethyl silyl [(CH3)3CSi(CH3)2] 
TBDPS                            tertiary butyl diphenyl silyl [(CH3)3CSi(C6H5)2] 
 
 
 234
Tf                                    Triflate 
TFA                                Trifluoroacetic acid 
THF                                Tetrahydrofuran 
THP                                Tetrahydropyran 
TIPS                               Triisopropylsilyl [(Me2CH)3Si] 
TLC                                Thin layer chromatography 
TEMPO                          2,2,6,6-tetramethyl-1-piperidinyloxy 
TMS                               Trimethyl silyl [(CH3)3Si] 
TPAP                              Tetrapropylammonium perruthenate 
Ts                                    Tosyl (p-toluenesulfonyl) 
TS                                   Transition state 
[ ]20Dα                                Specific optical rotation 
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